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This dissertation discloses a project encompassing a synthetic strategies and new 
methods for the synthesis of some functionalized N-heterocyclic compounds. Much 
attention have been focused to synthesize N-heterocyclic compounds due to their 
interesting biological properties in medicinal chemistry. Among the various N-
heterocycles, carbazole and its derivatives are frequently embedded in numerous 
natural products and active pharmaceutical ingredients in various drug structures. In 
this thesis, carbazomycin G, a carbazole alkaloid owns a special interest due to their 
versatile biological properties. We have developed a methodology for the synthesis of 
carbazomycin G through 12-steps involving several new method development for the 
key intermediates via Suzuki cross coupling, indium reduction and especially Pd-
catalyzed intramolecular ring closing reaction to obtain the carbazole moiety.  
Furthermore, we have developed a methodology to synthesize few particular N-
heterocyclic compounds such as benzo[c]cinnoline and Boscalid® due to their 
attractive biological features and their applications in medicinal chemistry. 
Benzo[c]cinnoline and its derivatives are known for their various pharmacological 
activities and particularly anticancer property. The synthesis consists of two steps 
involving Suzuki cross coupling reaction followed by a redox process that leads to 
cyclic compound benzo[c]cinnoline. Another notable compound Boscalid® that is an 
important class of fungicide synthesized by means of three optimized steps and often 
applied to protect the agricultural crops. Moreover, a high rate and new reduction 
method based on sodium borohydride and cobalt sulfate was developed and 
optimized for the reduction of various reducible functional groups. The outline of the 
thesis including different synthetic strategies and new methodologies are summarized 







Chapter 1: Introduction 
N-heterocyclic compounds are very important structural motifs 
widely found in numerous natural products and known as 
potentially active pharmaceutical ingredients (APIs). Synthetic 
strategies and new methodology for the synthesis of several N-
heterocyclic compounds are discussed. An overview of these new 
methods is presented in this thesis.  
 
 
Chapter 2: Statistical Experimental Design and 
Multivariate Modelling  
Statistical experimental design was utilized in this thesis and 
discussed briefly. This important technique determines the 
variables for method development and process optimization in 
synthetic organic chemistry. 
 
 
Chapter 3 (Paper I): A Highly Efficient Pd(PPh3)4-
Catalyzed Suzuki Cross-Coupling Method for the 
Preparation of 2-Nitrobiphenyls from 1-Chloro-2-
nitrobenzenes and Phenylboronic Acids 
 
 
A highly efficient method for Suzuki cross coupling between 
congested 1-chloro-2-nitrobenzene and phenylboronic acid was 
developed and optimized for the synthesis of 2-nitrobiphenyl. The 
optimized reaction condition was developed by means of statistical 
experimental design and multivariate analysis. The developed 
method was tested with various substituted chloro and bromo 





Chapter 4 (Paper II): Indium Powder as the Reducing 
Agent in the Synthesis of 2-Aminobiphenyls 
 
A method was developed for reduction of 2-nitrobiphenyls to 2-
aminobiphenyls using In-powder as the reductant in acidic 
medium. The developed method was proven tolerant to various 
functional groups and resulted medium to excellent yields. 
 
Chapter 5 (Paper III): Synthesis of the Carbazole 
Scaffold Directly from 2-Aminobiphenyl by Means of 
Tandem C H Activation and C N Bond Formation 
 
An efficient and rapid method for the synthesis of carbazole moiety 
was developed and investigated using 2-aminobiphenyl.The 
method involves tandem Pd(II)-catalyzed intramolecular C-H 
activation and C-N bond formation and showed good functional 
group tolerance. This method was also suitable with corresponding 
2-acetaminobiphenyls to obtain the N-acetyl carbazoles. 
 
 
Chapter 6: Total Synthesis of Carbazomycin G 
 
A concise total synthesis of natural product, carbazomycin G was 
achieved through 12-synthetic steps. The synthesis involves several 
new methodologies for the synthesis of important intermediate that 
utilized to further to obtain the natural product. 
 
 
Chapter 7 (Paper IV): A Concise Synthesis to 
Benzo[c -Dinitro- -Biphenyls 
Attained from a Novel Tailored Suzuki Cross-Coupling  
 
 
An efficient two step synthesis leading to benzo[c[cinnoline 
scaffold was developed. The method involves the synthesis of 2,2’-
nitrobiphenyls and subsequently the nitro group is partially reduced 
and directly cyclized  into benzo[c]cinnoline. 
 
 
Chapter 8: A novel synthesis of Boscalid® 
 
Boscalid® is an important fungicide used commonly in the 
agriculture. We have developed a novel three step synthesis 
leading to Boscalid® compound.  
 
 
Chapter 9: A High Rate and Efficient Reduction 
Method Based on Sodium Borohydride and 
Cobalt sulfate 
 
A fast and high yielding reduction method was developed using 
sodium borohydride and cobalt sulfate heptahydrate. The method 
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Heterocyclic chemistry is a fascinating branch and paramount importance in organic 
chemistry. Heterocyclic compounds played a major role in biological processes and 
appear as essential structural moiety in several natural products includes plant 
alkaloids, vitamins, carbohydrates, amino acids, nucleic acids and many natural and 
synthetic dyes. Typically, heterocycles possess promising structural activity for the 
design of new medicines.[1] Therefore, much attention have been focused in our group 
to synthesize functionalized N-heterocyclic compounds such as imidazole,[2] 
carbazole[3] and benzo[c]cinnoline[4] due to their promising biological properties.[5] 
Several research work on imidazole have been reported by our research group 
concerns the design and development of functionalized imidazole and imidazole 
backbone in particular.[6] 
In this thesis, we focused mainly the synthetic strategies and new methodologies for 
the synthesis of functionalized carbazoles, and benzo[c]cinnolines. We have utilized 
the Pd-catalyzed Suzuki cross-coupling reactions [7] as a key step for developing the 
methodology towards the functionalized heterocyclic compounds. Pd-catalyzed cross-
coupling reactions are powerful tools in organic chemistry to form carbon-carbon and 
carbon-heteroatom bonds.[8] Significant achievements in this field have been made in 
last decades in connection with numerous publications and patents.[9] The important 
class of synthetic transformation are valuable in both academia and industry for the 
synthesis of fine chemicals and provide key steps for building complex bioactive 
molecules and in total synthesis.[10] The award of 2010 Nobel Prize in chemistry was 
a monumental accomplishment and jointly given to Richard Heck, Ei-ichi Negishi 





Carbazole is an important aromatic heterocyclic compound consisting dibenzo-
pyrrole system. Carbazole and its derivatives are of special interest in medicinal 
chemistry and appears as an essential structural framework in several natural products
[12] and potential active pharmaceutical ingredients (APIs) in numerous drugs such as
anti-inflammatory,[13] antibacterial,[14] antifungal,[15] antiviral,[16] and anticancer.[17] 
My current group have developed a novel methodology by means of transition metal 
catalyzed C-H bond functionalization. Number of synthetic methods have been 
reported previously.[3] Nevertheless, This method is associated with several major 
shortcomings including requires protecting/auxiliary group, prolonged reaction time, 
and use of expensive catalysts. Moreover, lack of substrate availability and generality 
in intermediates synthesis. In order to address the limitations discussed, we have 
developed a straightforward and rapid method for the synthesis of carbazole, 
discussed more detail in chapter 5. The developed method is a valuable key step in 
various applications including several natural products, pharmaceuticals and 
agrochemicals. In particular, we have utilized this novel methodology for the 
synthesis of antibiotic carbazole alkaloid, carbazomycin G (discussed in Chapter 6), a 
fungicide, Boscalid® (discussed in Chapter 8) and biologically important moiety 
benzo[c]cinnoline (discussed in Chapter 7) are shown in Figure 1.1.  
Figure 1.1 Biologically active important synthetic targets 
Our novel methodology for the synthesis of various N-heterocyclic compounds are 





Scheme: 1.1. Overview of the project description 
 
 
Chapter 2 details the importance of statistical experimental design and its 
applications in synthetic organic chemistry. We have utilized this technique in 
Chapter 3 (paper I) in order to explore the important parameters in a chemical 
reaction. 
Chapter 3 (Paper I) designates the method development for the synthesis of highly 
congested and substituted 2-nitrobiphenyls using Suzuki cross-coupling reaction with 
chloronitroarenes and phenylboronic acid. Coupling with chloroarenes using simple 
catalytic system is still remains challenging in organic chemistry. It is often require a 
bulky ligand and complex catalyst in order to facilitate the reaction. Therefore, we 
have investigated and optimized a method using Statistical experimental design and 
multivariate modelling. The developed method was suitable with number of different 
functionality on chloronitroarene. We also tested with various bromonitrarenes and 
afforded excellent yield and selectivity of the corresponding 2-Nitrobiphenyls.  
Chapter 4 (Paper II) describes the method for the reduction of nitro to amino 
groups. In the previous chapter, we have synthesized a series of 2-nitrobiphenyls. We 
wanted to develop an efficient method to reduce the nitro group into corresponding 
amino compounds. Though numerous methods were reported to the reduction of nitro 
12 
to amino groups, we have simplified and improved a method using Indium powder as 
the reductant in acidic condition. The improved method afforded excellent yield of 
the corresponding 2-aminobiphenyls. 
Chapter 5 (Paper III) illustrates the direct ring closing reaction of 2-aminobiphenyls 
into carbazole scaffold. The developed method involves tandem intramolecular C-H 
activation and C-N bond formation that leads to the cyclized product. The presented 
method was suitable with several of electron withdrawing and donating groups and 
afforded medium to excellent yield. Moreover, the method is also suitable with 2-
acetaminobiphenyls to obtain the corresponding N-acetyl carbazoles. 
Chapter 6 depicts the total synthesis of natural product carbazomycin G. We have 
developed a methodology for the synthesis of carbazomycin G using twelve synthetic 
steps starting from commercially available compound. We have developed novel 
synthetic methodology for the synthesis of several intermediates and afforded 
medium to good yields.   
Chapter 7 (Paper IV) represents the two-step synthesis of unsymmetrically 
substituted benzo[c]cinnolines. The first step involves a Suzuki cross coupling 
reaction to synthesize a key intermediate 2,2’-dinitrobiphenyls followed by redox
reaction that leads to cyclized product, benzo[c]cinnoline. We have developed a 
method that is suitable for both symmetrical and unsymmetrical substituted 
benzo[c]cinnolines via Suzuki cross coupling reaction based on Chapter 3. 
Chapter 8 describes a method development for the synthesis of boscalid. We have 
optimized and investigated the synthesis of Boscalid® by in 3-steps. First step 
involves the 2-nitrobiphenyl via Suzuki cross coupling reaction (based on Chapter 3), 
followed by reduction of nitro to amino group (based on Chapter 4) and finally an 
amide coupling with nicotinic acid. The presented method is very rapid and highly 




Chapter 9 details a reduction method using stoichiometric amount of sodium 
borohydride and copper sulfate heptahydrate. The method is very rapid and produce 
hydrogen in-situ for the reduction of various functional groups in a short time. 
Through this method, numerous functionalities are reduced and excellent yields and 
selectivity were obtained. 
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Statistical experimental design (DoE) and optimization is a powerful technique in 
synthetic chemistry to identify the various types of problems in the research and 
industrial field. Ronald Fisher developed the statistical approach in 1958[1]. This 
approach is largely applied for optimizing the chemical processes in industry [2,3] and 
less frequently applied in academics, [4,5] is mainly due to the lack of experts to use 
this technique in academia. Thus, many research papers are fail to discover the 
substrate scope of new reactions.[6] Previously, the traditional method one 
factor/variable at a time (OFAT also called OVAT) [7] was often used for reaction 
optimization. However, the method proceeded completely via trial and error approach 
and difficult to identify the optimum conditions for a certain process. Moreover, 
OVAT method ignores the interaction between the variables or factors of the 
reaction. 
In the past decades, the application of DoE has been greatly increased to the field of 
process developments and optimization. This is evidenced by the number of 
publications related to the field.[8] In this chapter, we describes the importance of the 
statistical experimental design to optimize the chemical reaction that allows the 
variation of multiple factors and instantly monitor the reaction variables for a 
particular process. Furthermore, this method allows the evaluation of a large number 
of reaction variables with shorter number of experiments. DoE has a significant 
advantage to detect the interactions between the factors or variables that affect the 
product yield and quality. In compare with the OVAT method, DoE method is more 
efficient and effective to determine the highest yielding conditions. Additionally, it 
gives more information about the performance of the reaction with the similar or 
potentially reduced number of experiments than in the OVAT method.  
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2.2 Screening experiments and Ishikawa diagram 
 
In synthetic organic chemistry, many factors or experimental variables that may 
affect the result of a reaction. A screening of the experiments are required in order to 
determine the variables and their interaction that might have significant effect on the 
result of the reaction, which is measured by using one or more responses. A pre-
experimental design is necessary in order to identify a root cause to the problem of 
the reaction. For these reasons, a useful diagram was developed by a Japanese quality 
control expert, Kaoru Ishikawa that can be applied in reviewing the experimental 
variables. It is a simple problem analysis tool, which often-called cause and effect 
diagram (Figure 2.1).[9] 
The diagram is useful to determine the cause and effect of the reaction and helps to 
identify the root cause of the problem in an easy way. Moreover, it gives better 
understanding of complex problems by means of visual analysis.[10] In general, 
Ishikawa diagrams have a box at the right hand side represents the effect of the 
reaction known as responses.  This diagram demonstrates the experimental variables 
of the reaction symbolizes the horizontal line in which the stem denotes the general 
causes, namely bones. These bones should draw at the left hand side, which are 
labelled with the cause to be investigated. Each of the larger bones having smaller 
bones, which indicates the more specific aspects of a certain cause, and sometimes 
there might be third level of bones or more. When most of the probable causes are 










Figure 2.1.  General outline of the Ishikawa diagram  
 
 
2.3 Selection of variable and design of experiments 
 
When the experimental variables were selected to do the experimental design based 
on the Ishikawa diagram Figure 2.1.), it is also important that the other variables 
should be at a fixed level in an experimental design. The subsequent step is to choose 
the experimental design in order to estimate the influence of the different experiment 
variables on the result. There are several experimental design methods are available, 
and some of them are full factorial, fractional factorial, saturated design, central 
composite design and mixture design. The most common screening methods are full 
factorial or fractional factorial designs. These designs are useful to determine the 
linear influence of the variables and the interaction between the experimental 
variables, especially the variable with maximum influence can be identified. The 
fractional factorial design is particularly useful when there are many variables are 
needed to be analyzed in order to optimize the reaction and there is not much time 
and the raw materials available. Moreover, it reduce the number of experiments 
compared to the full factorial design. However, with the poor accuracy of the design, 





2.4 Factorial design 
 
In a factorial design, the impact of all the experimental variables and the interaction 
effects are investigated. For example, the 2k design is a major set of building block 
and frequently used for many experimental designs. The 2k design refer the number 
of K factors (number of experimental variables) and each factors with two level. The 
level of each factor is assigned by minus (–) for low level and plus (+) for high level. 
In addition, a ‘center point’ experiment, a zero level (0) must include in the design 
with all the variables at their middle value. It allows determining the confidence 
intervals and the risk of nonlinear relationships is minimized. The geometrical view 
and design matrix for 23 factorial design shown in Figure 2.2. 
 




In chapter 3 (paper I) the experimental design with four variables at two levels were 
discussed for the Suzuki cross coupling reaction. The design matrix for 24 factorial 










2.4.1 Interpretation and response surface analysis 
 
For each experiment in the factorial design, various responses (y1, y2, …yn) are 
measured. Based on the statistical experimental design in Figure 2.3, a model matrix 
equation (1) was created. This matrix was multivariate modelling correlated to the 
response vector y (yield of the target compound) to accomplish a model equation as 
shown in equation 2.  
M = [1  x1  x2  x3  x4  x1x2  x1x3  x1x4  x2x3  x2x4  x3x4  x1x2x3  x1x2x4  x1x3x4  x2x3 
x4 x1x2x3x4]                                                                                                 (1)  












ii xxxxxxxfy                                          (2) 
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The experimental variables used in a coded arrangement, see equation (3) to enable 
both the model building as well as the consequent model interpretation.  
  i =1, … , 4  
(3) 
 
The model parameters, (the ’s) were studied using cumulative normal probability 
plot (Figure 2.4). Using the cumulative normal distribution plot, which illustrates that 
the model appears to be collected by the following main model parameters 1, 2, 3 
(positive signs) and 4 (negative sign). Furthermore, the interaction terms 14 and 34 
(negative sign) and 134 (positive sign) contributes significantly in the model. By 
using a multivariate model composed of these regression coefficients, the iso-contour 
projections of the response surfaces were produced.  
Figure 2.4. Cumulative normal distribution (CND) plot with the regression coefficients plot 
 
 
Response surface methodology (RSM) is an important tool for analyzing and 
optimizing reaction products and processes. It is a set of mathematical and statistical 
techniques for empirical model building used for the development of functional 
relationship between the response variables and the number of control variables. The 
 21 
iso-contour projections of the response surfaces (Figure 2.5), predict the experimental 
conditions to generate maximum yield.  




The various applications and importance of the experimental design compared to the 
OVAT method were discussed in this chapter. The DoE and the response analysis 
interpretation could be very useful to reaction optimization for the development of 
novel synthetic methodology. It can able to predict the optimum experimental 
condition with high yielding product. The method has been very useful in industrial 
chemistry for the development of novel reaction methodology and improving 
methods with the existing transformations. We have utilized this technique (chapter 
3) for the optimization of Suzuki cross coupling reaction with highly congested 
chloro-substituents. We believe that the reported design of experiments will be a 
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Suzuki cross coupling [1] is an important carbon-carbon bond forming method used in 
organic synthesis of both academic and industrial interest, frequently used in the 
production of series of valuable compounds. Typically, the biphenyl scaffold are 
prepared by means of the Pd-catalyzed Suzuki cross coupling of aryl halides and 
arylboronic acids. [2] In particular, the unsymmetrically substituted biphenyl 
constitutes an important building blocks of herbicides,[3] liquid crystals,[4], ligands,[5] 
agrochemicals,[6] polymers [7] natural products and numerous biologically active 
pharmaceuticals.[8] Akira Suzuki discovered the Suzuki reaction (Scheme 3.1) in 
1979. In recognition of this valuable approach, Suzuki received a Nobel Prize in 
2010, together with Negishi and Heck for their discoveries in Pd-catalyzed cross 
coupling reactions.[9] A selection of an important targets[10] prepared by using the 
Suzuki cross coupling is shown in Figure 3.1.  
Scheme 3.1. General Outline of Suzuki cross-coupling reaction 
 
There exist a series of Pd-catalyzed cross-coupling reactions, the Negishi coupling,[11] 
the Stille coupling,[12] the Hiyama coupling[13] and the Kumada coupling[14] are 
available for the preparation of biphenyl moiety. In compare with the other coupling 
methods, Suzuki cross-coupling reaction has recognized the most popular in recent 
times and provides an attractive features including mild reaction conditions, readily 
availability of boronic acids and its derivatives (MIDA esters,[15] trifluoroborates[16] 
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and boronic esters[17]) which are easy to prepare and environmentally safer than the 
other organometallic reagents and could be used for the scope and utility of Suzuki 
coupling. Moreover, the boron containing by-products are non-toxic and can be easy 
to remove even in large-scale synthesis. Based on these viewpoints, it is clear that the 
Suzuki cross coupling is a more sustainable reaction and are applicable in the 
industry for the preparation of biologically active pharmaceuticals and fine 
chemicals. 
Figure 3.1. Important synthetic targets produced using Suzuki cross-coupling reaction 
 
Among several biphenyl scaffold, synthesis of 2-nitrobiphenyl by means of the 
Suzuki cross coupling have attracted our attention and constitutes in several N-
heterocyclic compounds thus utilized as an important synthetic targets in medicinal 
chemistry. Several synthetic methods has been described earlier for the synthesis of 
2-nitrobiphenyls. In 2005, Freeman and collaborators [18] revealed a method for the 
synthesis of 2-nitrobiphenyls using Pd(PPh3)4 as a catalyst. However, the method 
required long reaction time (up to 42 h) and a huge excess of base in order to 
synthesize the target 2-nitrobiphenyls. Recently, Gooßen and collaborators [19] 
reported a method for the synthesis of 2-nitrobiphenyls by using a decarboxylative 
Hiyama coupling reaction, which operate using a trimetallic Pd/Cu/Ag catalytic 
system at high temperatures.  
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Nevertheless, the Suzuki cross coupling reaction has appeared as the method with the 
most attractive features for the preparation of biphenyls, includes the mild reaction 
conditions and its tolerance towards water and in general high functional group 
tolerance and high regio and stereoselectivities. 
Previously, the Suzuki cross-coupling reaction was achieved by reacting 
organoboronic acids with aryl halides in the presence of a base and Pd(PPh3)4 as 
catalyst.[20] Aryl halides such as Iodides, Bromides and triflates are well known 
coupling partner for Suzuki cross coupling reaction. However, the coupling with aryl 
chlorides remains a challenging task in organic chemistry due to the bond strength of 
C-Cl, which is highly reluctance towards the oxidative addition. The chloro 
compounds are cheaper than bromo and iodo compounds that motivate for using 
chloroarenes. Previously, some Suzuki coupling methods has been described 
involving chloroarenes as coupling partner.[21] Further substantial improvement were 
not revealed until various palladium complexes were introduced as catalysts to 
facilitate the Suzuki cross-coupling reaction.[22] In order to extend the scope and 
utility of the Suzuki cross coupling with aryl chlorides, one strategy involves the 
introduction of expensive ligands,[23] which increase the electron density around the 
Pd-center and thus facilitate the cleavage of the C-Cl bond to enable cross 
coupling.[24, 25] (Table 3.1). However, these ligands are usually expensive and not 
feasible in the large-scale reactions. Herein, we have reported an efficient Pd-
catalyzed ligandless method for the synthesis of substituted 2-nitrobiphenyls under 
microwave irradiation. This method was successfully adapted for the synthesis of the 



















3.2 General mechanism of Suzuki cross coupling reaction 
 
The general mechanism [26] of Suzuki cross coupling is outlined in Figure 3.2. It 
involves four main steps, oxidative addition, ligand exchange, transmetallation and 
reductive elimination. The mechanism of each step has been described in detail. The 
oxidative addition is the rate-determining step of the catalytic cycle,[27] involves the 
palladium catalyst coupled with organic halide to form the organopalladium complex 
(path a), in which the palladium is oxidized from Pd(0) to Pd(II). The next step is the 
displacement of the halide with base to form the more reactive species (path b) 
depending on the base used. The third step (path d) involves the transmetallation with 
boron ate complex (which is formed by activation of boronicacid with base in path c) 
to form the organopalladium species. The final step of the mechanism is the reductive 
elimination (path e) to achieve the target-coupled product and regenerates the 
palladium catalyst and thus completing the catalytic cycle. 





3.3 Methods and discussion 
 
For our total synthesis of the natural product Carbazomycin G [28] (discussed in 
Chapter 6), we needed an appropriate methodology to synthesize the highly 
congested substituted 2-nitrobiphenyls. Previously a Suzuki cross-coupling method 
[29] was developed in our group, using the 1-iodo-2-nitrobenzene with phenylboronic 
acid. The method afforded 2-nitrobiphenyls in good to excellent yield with Pd(PPh3)4 
as catalyst. In order to extend the scope of this available method, attempts to prepare 
the congested 1-iodo-2-nitrobenzene 3.4 using a disclosed method by Crich and 
collaborators.[30]  The method afforded only 30% yield of the desired iodo compound 
3.4 (Scheme 3.2). However, reproducibility of the reaction was an additional 
problem. We assumed that it might occur due to the presence of unknown impurity in 
the Iodine. Therefore, this strategy was abandoned.  
Scheme 3.2. Attempt to Suzuki cross coupling reaction 
 
Few years ago, we have developed a novel method for the fast halogenation of some 
heterocyclic compounds by means of N,N´-dihalo-5,5-dimethyl-hydantoinin as the 
halogenating agent.[31] We wanted to utilize this method and attempted for the 
preparation of congested 1-halo-2-nitrobenzenes with different halogenating agent 
such as DIH, DBH and DCH. As a result, the method failed for bromination using 
DBH and iodination using DIH. Surprisingly, the method works excellently with 
DCH 3.3 reacting with compound 3.2 to afford the quantitative conversion to provide 
the congested 1-chloro-2-nitrobenzene 3.6. Subsequently, the chloro compound 3.6 
was attempted to Suzuki cross coupling with phenylboronic acid 3.7 using the 
method disclosed previously in our group,[29] attained only 30% conversion yield of 
the desired biphenyl compound 3.8 (Scheme 3.3). 
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Scheme 3.3. Optimization of Suzuki cross coupling strategy 
 
3.4 Optimization of Suzuki cross-coupling reaction 
 
The outcome of the Suzuki cross-coupling reaction (Scheme 3.3) was encouraged us 
to investigate to optimize the Suzuki cross-coupling reaction using the statistical 
experimental design,[32] multivariate analysis,[33] and response surface 
methodology.[34] The importance of this technique in organic synthesis has been 
discussed briefly in chapter 2.  A primary thing is to figure out the possible variables 
that could affect the rate of the reaction, which could be predictable by using the 
Ishikawa diagram (cause and effect diagram).[35] The Ishikawa diagram for Suzuki 
cross coupling of chlorinated compound for the synthesis of congested 2-
nitrobiphenyl is shown in Figure 3.3. 
 
Figure 3.3. Ishikawa diagram for Suzuki cross coupling reaction 
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3.4.1 Statistical experimental design 
 
In this viewpoint based on the reaction profile, (Figure 3.3). We assumed that the four 
variables namely, reaction temperature (x1), reaction time (x2), quantity of base (x3) 
and amount of catalyst loading (x4) that could affect the reaction rate in terms of yield 
and selectivity. For the four experimental variables x1-x4, we have created a statistical 
experimental design with 18 experiments using the formula. 2k+c = 24+2= 18, where 
k, is the number of variables and c, is the center experiment. The summarized results 
of the experimental design are shown in Table. 3.2. 
Table 3.2 Optimization of the Suzuki Cross Coupling reaction using statistical experimental design 
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3.4.2 Multivariate Modelling 
 
In order to simplify the estimation of the model terms, the experimental variables x1-
x4 were scaled using the equation (1) which produced the design matrix D for the 
scaled variables x1-x4, and then used to produce the model matrix M by using 
equation (2). In these equations, zk is the experimental variable in which k expressed 
in real units and variable xk is the same variable provided in scaled units. zk,L and zk,H 
are the selected low (L) and high (H) level experimental values expressed in real units 
of the experimental variable zk. The selected levels (L, 0, H) are provided above in the 
Table 1. The scaling using the equation (1) gives all the experimental variables of low 
values in xk,L = –1 and correspondingly the high values xk,H = +1.  
 
                                                      (1) 
Model matrix M can be obtained based on design matrix D as follows, 
                                           (2)   
 
Multiple linear regression,[36] expressed in equation (3) used to estimate the model 
shown in equation (4) by means of MATLAB[37] computer software and in-house 
coded routines that has been benchmarked earlier against the commercial software, 
such as SAS.[38]  
 
                                                                    (3)   
 
This matrix was multivariate correlated to the response vector y (yield of target 
biphenyl compound) to achieve a model of the form as shown in equation (4) 
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                       (4) 
 
The estimated regression coefficients were studied with a cumulative normal 
distribution (CND) plot (Figure 3.4). Based on the CND plot, the model appears to be 
composed by the following main model parameters 1, 2, 3 (positive signs) and 4 
(negative sign). Moreover, the interaction terms 14 and 34 (negative sign): and 134 
(positive sign) contributes substantially in the model. The final multivariate model, 
see Equation (5),  By using a multivariate model composed of these regression 
coefficients, the iso-contour projections of the response surfaces were produced and 
presented in Figure 3.5. 
 
                      (5) 
 
Figure 3.4 Cumulative normal distribution (CND) plot with the regression coefficients plot adjacent 




The iso-contour projections of the response surfaces (Figure 3.5), predict that the 
following experimental conditions will provide an improved yield: a low quantity of 
base (Na2CO3) [0.10 g], a short reaction time [30 min.], a high reaction temperature 
[120 oC], and a low catalyst loading [0.022 mmol]. The following up experiment 
using the predicted conditions revealed a yield of 53%, which represent the best yield 
for this cross-coupling reaction (Scheme 3.4). 
Figure 3.5 Iso-contour projections of the response surface describing the yield of the biphenyl 3.8 
from the Suzuki cross-coupling reaction between congested aryl chloride 3.6 and the phenylboronic 
acid 3.7. 
 
Iso-Contour projection of the response surface prepared for predictive purposes. The iso-contour 
lines made by the model Equation (4) show the predicted yield (y) of target 2-nitrobiphenyl 3.8. How 
to read the graphic: the outer horizontal frame line shows the variation in the quantity of the sodium 
carbonate (x3), and the vertical frame line displays the effect of the reaction time (x2). Each variable 
has five discrete levels [–2 –1 0 +1 +2]. The 25 subplots within the outer frame lines show the iso-
contour lines projections of the response surfaces when the two experimental variables — reaction 
temperature (x1) and quantity of Pd catalyst (x4) — are continuously varied within a range that 
corresponds to [–2 +2]. 
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Scheme 3.4 Optimized Suzuki cross coupling reaction 
 
3.5 Scope and limitation of optimized Suzuki cross coupling 
reaction 
 
Herein, we have developed and optimized a simple and efficient Pd(PPh3)4-catalyzed 
Suzuki cross coupling method for the highly congested chloroarene with 
phenylboronic acid. (Scheme 3.4). These results encouraged us to investigate whether 
this method could be a general method for the synthesis of 2-nitrobiphenyls using the 
Suzuki cross coupling reaction. The scope and limitation of the developed method 
were examined with variety of substituted chloroarenes and bromoarenes. The 
method tolerates with both electron withdrawing and donating groups. Table 3.3 
illustrates the coupling of variety of chloroarenes and phenylboronic acid with 
different functionality. The only change in the experimental condition was the 
reduced amount of phenylboronic acid (1.5 eq) was used compared to the optimized 
conditions of Suzuki coupling (2.3 eq). We have tested 18 different functionality of 
chloroarenes underwent for Suzuki cross coupling reaction afforded medium to 
excellent yield and good selectivity of corresponding biphenyl compounds in almost 
all the cases. The method attained low yield in case with electron withdrawing group 
in the ortho positions. (Table 3.3, compound 3.8o). Moreover, we obtained the 
hydrodebrominated compound during the reaction instead of the desired bromonitro 





Table 3.3 Scope and limitation of the Suzuki cross-coupling method with chloroarenes[a] 
 
We have also tested with different substituted bromoarenes 3.5 in order to see how 
the developed method works with these substrates. As a result, the method gave 
excellent yield of biphenyl product 3.8 in all the cases except the reaction with 
carboxyl group substrate, desired biphenyl product was not detected for compounds 
3.8æ and 3.8ø (Table 3.4).  Overall, the optimized Suzuki cross-coupling strategy 
was operated very well for variety of functionalities for both the aryl halides and 
phenylboronic acids. In general, it might be suitable method for the preparation of 2-
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nitrobiphenyls via Suzuki cross-coupling reaction with different aryl halides, more 
specific with less reactive aryl chlorides. The desired 2-nitrobiphenyl is an important 
intermediate in several biologically active compounds and natural products. 









We have developed and optimized an efficient Suzuki cross-coupling method for the 
synthesis of 2-nitrobiphenyls using 1-chloro-2-nitrobenzenes and phenylboronic acids 
as reaction partners. The method exhibits high functional group tolerance with both 
1-chloro-2-nitrobenzenes and the phenylboronic acids and afforded medium to 
excellent yield and good selectivity of the desired 2-nitrobiphenyls. The method was 
initially developed to couple highly congested aryl halides with phenylboronic acid. 
In compare with the previously disclosed studies by using chlorobenzenes as a 
reactant in the Suzuki cross-coupling reaction, we utilized a simple and readily 
available catalyst Pd(PPh3)4. The optimized study demonstrates the importance of 
multivariate design and modeling in explorative synthesis to develop new synthetic 
methodology. In the present case, the DoE methodology replaced the need for 
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Reduction reaction plays an important role in organic synthesis. A variety of organic 
synthesis involves the reduction at some point to accomplish towards the target 
molecule. A large number of organic functionalities are reduced into various useful 
functional groups. Several synthetic methods have been reported earlier for the 
reduction of different functionalities. Among them, catalytic hydrogenation and 
reduction with metal hydrides reveals the most important reduction reaction. The 
other reduction methods involves various metals, metal salts and other organic 
compounds. 
In this chapter, we mainly focused the synthesis of aromatic amines from nitro 
compounds. Aromatic amines are extensively used as starting materials and important 
intermediates for the production of variety of compounds such as dye materials, 
agrochemicals, medicines, polymer surfactants, and chelating agents. [1] Number of 
methods exist for the transformation of nitro to amino group, includes catalytic 
hydrogenation using Palladium on carbon [2] and Raney Nickel, [3] is the most 
important and used method for the industrial processes where no side product was 
occurred except water. The major problem of this method involves the reduced 
selectivity in the presence of other reducible functionalities. In such cases, the other 
methods involves using the NaBH4-CuSO4 system [4] and Pd-catalyzed reduction with 
silicon hydrides [5] as well as with Bechamp reduction with Fe and HCl [6] are to be 
used. Moreover, methods incorporating with SnCl2, [7] Sm, [8] Zn, [9] TiCl3, [10] sodium 
dithionite [11] and Indium powder with NH4Cl [12] for the selective reduction of nitro 





A project devoted to synthesize the carbazole [13] (Chapter 5) and Boscalid® [14] 
(Chapter 8) scaffold, we needed access to synthesize the 2-aminobiphenyls, which is 
an important intermediates in several natural products and fungicides.[1] A method has 
been reported previously in our group for the synthesis of the intermediates 2-
nitrobiphenyls by means of Suzuki cross coupling reaction. [15]  
We needed a simple and efficient method for the reduction of 2-nitrobiphenyls into 2-
aminobiphenyls.The method involves indium powder with NH4Cl solution [12] is 
attracted our attention due to their simplicity of the reaction with nitroarenes. Indium 
is one of the low valent metal and used as reducing agents.[16] It has several 
applications including the mild conditions, non-toxic and unreactive towards the air 
and water made the reagent suitable in organic synthesis for the reduction of different 
functionalities. The first ionization potential of Indium (5.8 eV) is lower than the 
other reducible groups such as, Sn (7.3 eV), Zn (9.4 eV) and close to alkali metal Na 
(5.1 eV). These data suggests that the metal indium contribute readily in single 
electron transfer reaction.  
4.2 Method and discussions 
 
Several reduction methods have been described earlier using Indium metal for 
different functional group hydrogenation. For example, selective reduction of nitro 
compounds into their corresponding anilines, [12] heterocyclic ring reduction in 
quinolones and isoquinolines, [17] reductive elimination of 1,2-dibromides,[18] ketone 
deoxygenation,[19] pinacol coupling.[20] Furthermore, the selective reduction of 
alkenes [21] and azides [22] into corresponding reduced products are achieved  by using 
the Indium metal. Table 4.1 shows the list of previously described reduction methods 
of nitro compounds into corresponding amine by means of Indium powder under 





Table 4.1. Previously disclosed Indium reduction method  
 
However, in order to utilize indium reduction method reported by Moddys and 
collaborators,[12] we need a very high dilution of the substrates in solvent medium, 
excess of indium powder and long reaction time up to 72 hours. It prompted us to re-
investigate the method to explore and simplify towards our biphenyl compound 
application. We have performed the reduction with our substrate 2-nitrobiphenyl 4.1 
afforded full conversion of substrate 4.1 into desired amine compound 4.2 based on 
GC analysis (Table 4.2. entry 1). However, these trials gave only 41% of the isolated 
amine compound 4.2. The obstacles involves several steps in the workup procedure. 
Such as filtration, pH adjustment, extraction, solvent removal and finally silica gel 
chromatography.  





4.3 Proposed mechanism of Indium reduction 
 
The mechanism of the indium reduction has not been clearly examined in the 
described literature procedures. We proposed a mechanism parallel with Zinc 
reduction (Figure 4.1). Our proposed mechanism shows that we need three 
equivalents of indium to carry out the reduction depending on the oxidation state of 
indium. The desired amine product was achieved via nitroso and hydroxylamine as 
intermediates. We wanted to investigate the reaction with reduced amount of indium 
powder from 7 equiv to 3.5 equiv, afforded quantitative conversion (Table 4.2. entry 
2) and further  reduced the quantity of indium to 2 equiv, gave 87% conversion yield 
in 90 min (entry 3). The prolonged reaction time from 90 min to 150 min afforded 
full conversion. (entry 4).  These results suggests that we need two or three 
equivalents of indium powder for each nitro group based on the final oxidation state 
of the indium.  
Figure.4.1. Proposed mechanism for Indium reduction of the nitro group 
 
During the indium reduction methods, we also observed that the particle size was 
crucial relevant to the reaction rate and performance of the reaction. We used freshly 
opened bottle of indium powder (100 mesh, 99.99% purity) in order to accomplish 
quantitative conversion. Nevertheless, the reactivity of indium was impaired after 
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some days in storage under room temperature, which might be due to the surface 
oxidation.  
4.4 Scope and Limitations  
 
We have investigated the scope of the reaction with different nitro compounds under 
the same experimental conditions. (Scheme 4.1) All of the trials afforded only low to 
medium isolated yield and turn into decomposition of products after sometimes. 
Scheme 4.1.  Initial investigation of Indium reduction for the synthesis of 2-aminobiphenyls[a] 
 
Therefore, we wanted to explore the method with experimental variables to improve 
the outcome of the reaction. For example, altering the reaction temperature from 78 
oC to 120 oC in a sealed tube reactor, reduce the volume of solvent from 10 mL to 4 
mL and lowered the quantity of NH4Cl from (16 mmol to 1.03 mmol). These 
conditions provide a quantitative conversion yield of the desired amine product. 
(Scheme 4.2, 4.2g). These results suggested that it required three equivalent of 
indium and the mechanism based on In2+ oxidation state. 
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We then examined a scope of the reaction with different substituted 2-nitrobiphenyls 
4.1, afforded 2-aminobiphenyls in excellent isolated yield and high purity in all the 
cases except in 4.2k and 4.2l compound, which is measured by GC-analysis. In 
contrast to other methods, the major advantage of the improved method includes 
simple work-up procedure that leads to desired product in high purity and selective 
reduction of nitro group in presence of other reducible groups.  
Scheme 4.2. Scope and limitations of Indium reduction for the synthesis of 2-aminobiphenyls using 





We have developed and improved an indium reduction method for the synthesis of 2-
aminobiphenyls from corresponding 2-nitrobiphenyls. The improved method utilizes 
3 equivalent of Indium powder and reduced amount of solvent and NH4Cl solution. In 
contrast with previous reported methods, our improved method works very simple, 
requires only filtration of the post reaction mixture followed by the evaporation of the 
solvent afforded the desired target molecule. It also provides selective reduction of 
nitro compounds in the presence of other reducible groups and high functional group 
tolerance afforded high purity of the product. The mechanistic proposal illustrates 
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Synthesis of the Carbazole Scaffold  
Directly from 2-Aminobiphenyls 
5.1 Introduction 
 
Carbazole is an important N-heterocyclic compound appear as an essential structural 
motif in numerous biologically active natural products and potentially active 
pharmaceutical ingredients (APIs) [1] (Figure 5.1) as well as in dye industry and 
material science.  It is one of the important nitrogen containing aromatic compound 
possessing innumerable biological activities such as anticancer, [2] antiviral, [3] 
antibiotic [4] antifungal [5] and anti-inflammatory properties. [6] Carbazole has been 
isolated from various natural sources over the past few decades. [7] In 1965, 
Chakraborty et al reported the first antibiotic carbazole alkaloid murrayanine isolated 
from stem bark of murraya koenigii [8] (curry leaf tree) (Figure 5.1a), a richest source 
of carbazole alkaloids from the terrestrial plants.  








Figure 5.1a. Murraya Koenigii (curry leaf tree) (Knölker 2005) [1]  
 
 
5.2 Retrosynthetic route 
 
The outline of our retrosynthetic pathway leading to carbazole is illustrated in Figure 
5.2. The target carbazole 5.6 was achieved through direct ring closing of 2-
aminobiphenyls 5.4 using intramolecular C-H activation and C-N bond formation. [10] 
The subsequent compound 5.4 was accessed via functional group interconversion 
(FGI) using reduction of biphenyl compound 5.3. The biphenyl moiety was obtained 
via Suzuki cross coupling of chloroarenes 5.2 with phenylboronic acid 5.1. In this 
viewpoint, we have developed a more straightforward and rapid method for the 
synthesis of the target molecule.  







Owing to the tremendous application of carbazoles 5.6, considerable attention has 
been focused to construct the carbazole scaffold. Several research groups have been 
involved earlier to synthesize the carbazole scaffold 5.6 using different synthetic 
methodology.[9] In this chapter, we have reported a novel synthetic methodology for 
the synthesis of carbazole 5.6 (scheme 5.1). [10] The new strategy involves three 
important synthetic steps, Step 1 involves Suzuki cross-coupling reaction to prepare 
different derivatives of 2-nitrobiphenyls 5.3 using 1-chloro-2-nitroarenes 5.1 and 
phenylboronic acid 5.2 followed by reduction of nitro group into amine compound 5.4 
using Indium powder in step 2. We have discussed more elaborately the Suzuki cross 
coupling reaction and Indium reduction in Chapter 3 and 4. In this chapter, we mainly 
focus the intramolecular C-H bond activation followed by C-N bond formation leads 
to carbazole 5.6 framework.  
Scheme 5.1. Carbazole three step novel synthesis 
 
Transition metal catalyzed C-H bond activation[11] has emerged as an efficient 
methodology for the synthesis of several biologically active N-heterocyclic 
compounds and enables widespread application in organic synthesis especially using 
Pd-catalyzed intramolecular C-H activation combined with C-N bond formation. 
Several methods have been reported earlier for synthesis of carbazole using protected 
2-aminobiphenyls.[12,10a] A decade ago, Buchwald and collaborators[12a,13] described a 
method that allowed to the synthesis of the carbazole scaffold by means of  tandem C–
H functionalization and C–N bond formation (Scheme 5.2, path a). The major 
drawbacks of this method includes long reaction time and require protecting or 




decade, a few additional methods for the synthesis of carbazoles have been described 
based on tandem C–H activation and C–N bond formation.  
Gaunt and collaborators [12b] disclosed a Pd-catalyzed method with hypervalent iodine 
compound, phenyliodosyl diacetate as the reoxidant for the palladium catalyst 
Pd(OAc)2 (Scheme 5.2, path b). A significant improvement of this method involved 
the low reaction temperature. However, the method suffer with drawbacks, 
specifically, the need of protecting group and the formation of stoichiometric 
quantities of the reduced oxidant as the side product. Subsequently, Chang and 
collaborators [14] and Hirano, Miura, and collaborators [12d] described two additional 
methods for the carbazole involving copper as the catalyst (Scheme 5.2, path c and d). 
Both of these methods also require protecting group and stoichiometric quantities of 
oxidants, such as PhI(OAc)2, and MnO2 were used. 
Recently, a direct ring closing method disclosed by Satoh, Miura and collaborators [12e] 
using Ir(III)/Cu-based catalytic system with air as the terminal oxidant (Scheme 5.2, 
path f). Until now, this is the only method involved intramolecular amination to the 
preparation of the carbazole scaffold from unprotected 2-aminobiphenyl, but this 
process requires an expensive iridium based catalyst along with several other additives 
to facilitate the  ring-closing reaction.  
Compared with protected amino group, a free amine group has been less frequently 
used owing to its tight coordination with metal complex that suppress the catalytic 
activity. However, the major drawbacks of these reported methods includes, need of 
protecting/auxiliary group, long reaction time, and needs of expensive catalyst. We 
wanted to develop a more straightforward and practical procedure for the synthesis of 
carbazole which is highly required. Herein, we have developed a direct method for 
ring closing of 2-aminobiphenyls by means of intramolecular C-H functionalization 
followed by ring closing C-N bond formation to produce carbazole. (Scheme 5.2, path 
g). We have also developed a ring closing method using N-protected 2-






Scheme 5.2. Carbazole synthesis using intramolecular C-H activation and C-N bond formation 
 
5.3 Results and Discussion 
 
The project discussed in chapter 6, the total synthesis of Carbazomycin G, [15] several 
new synthetic reaction were required, such as preparation of congested 2-nitrobiphenyl 
by means of Suzuki coupling and required efficient reduction method to convert nitro 
into amino group. Initially, we attempted the ring closing reaction using the Buchwald 
method [13] for our substrates 5.8. However, the method not operated well and afforded 
only 29% conversion yield of compound 5.9 based on GC analysis (Scheme 5.3). We 
have also performed several trial reactions with varying the experimental conditions 
and parameters. However, these trails not improved the yield of the target product, 
nevertheless attained different unidentified compounds. It might be due to the 





Scheme 5.3 Attempt to produce carbazole scaffold leading to Carbazomycin G/H 
 
In order to improve the method, we investigated the ring closing protocol using the 
free amine as a substrate. The free amine can be oxidized with different reaction 
conditions.[16] However, we wanted to develop a direct cyclization method using 2-
aminobiphenyl 5.4 as a substrate to achieve the target molecule. Table 5.1 shows the 
screening of the ring closing reaction of 2-aminobiphenyl 5.4 with altering the reaction 
time and the catalytic systems. We observed the target carbazole 5.6 combined with 
two different side products 5.3 & 5.5 (Table 5.1, entry 1-7). Evidently the catalytic 
system with Pd(OAc)2 and IMes.HCl (1,3-Bis(2,4,6-trimethylphenyl)imidazolium 
chloride) ligand  operated reasonably well towards the desired target product (Table 
5.1, entry 7) and obtained 67% of the target product 5.6. This reaction condition as a 
starting point to determine the high yielding protocol. 





 A number of experiments were conducted and monitored by GC analysis after a 
period of 5-20 min. As a result, increased amount of palladium catalyst from 5-20 
mol% revealed a major effect towards the target carbazole 5.6 compound. However, 
the target product yield was decreased after a time of 10-15 min in addition with 
formation of side products 5.3 & 5.5 (Figure 5.3a). Further optimizations were 
conducted by using the systematic variation with reaction temperature and time 
(Figure 5.3b). High yielding reaction condition was found based on the reaction profile 
and provided almost a quantitative conversion of the substrate. The optimized protocol 
was then repeated with different amount of catalyst varying from 5-20 mol% using the 
freshly opened bottle of catalyst and ligand (Figure 5.3c). The results illustrates that 
using 20 mol% of Pd at 120 oC under microwave irradiation afforded quantitative 
conversion yield of carbazole. The reduced quantity of Pd loading yielded the 
corresponding oxidized product 2-nitrobiphenyl. Using 5 mol% of Pd, afforded 23% 
yield of the oxidized product. The formation of the oxidized product is less when the 
amount of Pd loading is increased from 5-20 mol%. The developed method was also 
suitable with 2-acetaminobiphenyl 5.5 to produce corresponding N-acetylcarbazoles 
5.7.  





5.4 Proposed reaction mechanism 
 
Based on previous mechanistic studies,[12a,13] we have proposed a reaction mechanism 
for ring closing of both the protected and un-protected 2-aminobiphenyls 5.4 & 5.5 
leading to corresponding carbazole compounds 5.6 & 5.7 via intramolecular C-H 
activation and subsequent C-N bond formation (Figure 5.4). Pre-association of the 
substrates 5.4 & 5.5 to palladium acetate enables the ortho-palladation (Figure 5.4, 
step i) followed by the production of six-membered palladacycle with concomitant 
release of acetic acid (step ii and iii).  The final step involves the reductive elimination 
leads to the target product with reduced palladium species Pd(0) (Figure 5.4, step iv). 
The Pd (0) is reoxidized to Pd(II) by means of hydrogen peroxide and thus completing 
the catalytic  cycle. The side product 5.3 and 5.5 can also be obtained under the 
experimental conditions. 
Figure 5.4 Proposed mechanism for the carbazole framework
 
In overall, we have developed an efficient method for the synthesis of carbazoles 5.6 
via Palladium catalyzed ring closing reactions. The method involves direct ring closing 
of 2-aminobiphenyls 5.4 using intramolecular C-H functionalization and C-N bond 
formation under microwave irradiation for shorter time afforded medium to excellent 





5.5 Scope and limitations 
 
A scope and limitation of the developed method has been investigated with different 
derivatives of 2-aminobiphenyls 5.4 with substitution on both the rings, As a result, the 
method compatible with both protected and unprotected 2-aminobiphenyls involving 
different electron donating and withdrawing groups. The Table 5.4 shows different 
derivatives of carbazoles were synthesized using oxidative cyclization reactions of 2', 
4' and 4-substituted 2-aminobiphenyls. The method tolerates both electron 
withdrawing and donating groups for the synthesis of carbazoles  at 120 oC for 20 
minutes, resulting moderate to good yield were obtained (Scheme 5.4, 5.6a-5.6f). The 
reaction was unsuccessful without protection of the hydroxy group. However, attempt 
to protect the -OH with TBS-Cl (Scheme 5.4, 5.6f) was successful, obtained 61% 
isolated yield of the desired carbazole product. However, the product has been 
decomposed based on the NMR studies.  






For substrates with 2', 3' and 4' substituted 2-aminobiphenyls, we also attained a 
moderate to good yield of the desired carbazole except with methoxy substituent 
(Scheme 5.4).  For example, we obtained only 10% of product with methoxy 
substituents at ortho and meta positions (5.6l and 5.6m) and moderate yield obtained at 
para position (5.6n). This might be due to the inductive effect of methoxy substituent 
that would disrupt the intermediate and the expected methoxy group would be 
oxidized in presence of the oxidative conditions. The same applies to the hydroxy 
substituents. Furthermore, this method could be suitable and efficient for the synthesis 
of unsymmetrical carbazoles. In general, electrophilic substitution on carbazole 
favours the position 3 and 6. However, in our method it allows substitution also at 
position 2 and 4 that might be useful for the synthesis of different carbazole containing 
natural products. 






We have attempted whether our method would tolerate for the protected 2-
aminobiphenyls 5.5 (Scheme 5.6) to synthesize N-acetylcarbazoles 5.7. The substrate, 
2-acetaminobiphenyl 5.5 was synthesized via acetylation of 2-aminobiphenyls 5.4 
using acetyl chloride, followed by ring closing reaction under the same conditions as 
in Scheme 5.4 and 5.5, except the Pd-catalyst loading (5 mol%) and the reaction time 
(3 h).  Using this method, the reaction with methoxy substituent at meta and para 
position (Scheme 5.6, 5.7g and 5.7h) was successful and only 25 % conversion yield 
was obtained at ortho position (5.7f). The substituent at meta position (Scheme 5.6, 
compound 5.7g) provided two regioisomer, the major isomer 7'-methoxy derivative 
obtained in 61% isolated and the 5'-methoxy substituted compound in 12% yield due 
to the steric hindrance of the substituent. Substrates with methyl group at ortho and 
para position gave low to moderate yield (Scheme 5.6, 5.7c and 5.7d) and ethyl group 
at para position afforded good yield (5.7e) Additionally, only 20% conversion yield 
was obtained with strong electron withdrawing groups (CF3) (5.7b).  
Eventually, the ring closing reaction of both the protected and unprotected 2-
aminobiphenyls were investigated with various substitution pattern on both the ring 
with different substituent pattern. The rapid method for the synthesis of carbazole 
under the mild conditions could be useful for the synthesis of different natural 

















We have developed a novel synthetic route to carbazole by means of three synthetic 
steps especially the step involves Pd(II)-catalyzed intramolecular C-H activation and 
C-N bond formation is noteworthy. The developed methods operated excellently, 
tolerated with variety of electron releasing and withdrawing groups, and obtained good 
to excellent yield of the target carbazole scaffold. Moreover, the novel described 
method is used to synthesize the carbazomycin G, a carbazole 1,4-quinone alkaloid. 
Further development and synthesis of various biologically active natural products 
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Carbazomycin is one of the important class of carbazole alkaloid isolated from 
Streptoverticillium ehimense, have possessing numerous biological properties 
involving anticancer,[1] antibacterial[2] and antifungal[3] activities. Carbazomycin 
alkaloids A–H (Figure 6.1) were first discovered and structure elucidated by 
Nakamura and co-workers.[4] The other type of carbazole alkaloid, hyellazoles (Figure 
6.1) were isolated from blue green alga (Hyella cae~pifosa) [5]. These naturally 
occurring carbazole alkaloids are highly challenging target molecule to organic 
chemists to develop novel synthetic methodologies due to their enormous application 
in medicines. In compare with the other carbazomycins, several research groups have 
interested in total synthesis of carbazomycin G, because of its interesting substitution 
pattern with chiral center and important biological applications. 
 







Several synthetic approach of Carbazomycin G 6.15 were already reported. [6] 
Particularly using a consecutive transition metal-mediated C-C and C-N bond 
formations is noteworthy. (Scheme 6.1). This methodology was applied in total 
synthesis of carbazomycins including A, [7] B, [7] C, [8] D, [8] and E. [9] and other 
important carbazole alkaloids. [10] Knölker et al [11] developed the first iron-mediated 
total synthesis of carbazomycin G and H (Scheme 6.1, path c). Knölker et al also 
reported another method [12] involving Pd-catalyzed oxidative cyclization of 
arylamino-1,4-benzoquinone for the synthesis of carbazomycin G and H (Scheme 6.1, 
path a). In 2000, Hibino and co-workers [13] reported a synthesis of carbazomycin G 
through an allene mediated electrocyclic reaction (Scheme 6.1, path b). In 2014, Hu et 
al [14] described a method involving thermal ring expansion and self-redox cascade 
reaction (Scheme 6.1, path d). Additionally, total synthesis of carbazomycin G 
synthesized by means of Fischer indole cyclization method [15] was also reported 
(Scheme 6.1, path e). 
Here, we reported a method involves several synthetic schemes for the synthesis of 
novel intermediates in order to obtain the target molecule. Our approach is based on 
the Pd-catalyzed intramolecular C-H activation followed by C-N bond formation to 
attain the congested carbazole [16] moiety in order to synthesize the target molecule 



















6.2 Retrosynthetic pathway  
 
Our retrosynthetic analysis leading to carbazomycin G is shown in Figure 6.2. The 
target natural product 6.15 was accessible via regioselective methylation of 1,4-
quinone 6.14. The quinone moiety 6.14, the key intermediate, prepared by oxidation of 
the novel carbazole compound 6.13 with nitric acid. The required carbazole moiety 
6.13 can be synthesized through Pd-catalyzed intramolecular C-H activation and 
subsequent C-N bond formation of aminobiphenyl 6.10, which can be prepared via 
reduction of nitrobiphenyl 6.9. Furthermore, the central biphenyl moiety 6.9 was 
obtained by Suzuki cross coupling of crowded chloro compound 6.7. To obtain the 
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highly substituted chloro compound, needed access to synthesize the nitrophenol 6.5, 
which can be prepared in four steps from 2,6-dimethoxy toluene 6.1 using the 
previously disclosed procedure.[17]  
 





6.3 Method and discussion  
 
Our approach for the total synthesis of carbazomycin G involves twelve synthetic 
steps, starting from commercially available 2,6-dimethoxy toluene 6.1. A nitro phenol 
6.5 intermediate compound was synthesized earlier in our group [17] in 4-steps 
involving oxidation, acetylation, nitration and de-protection. Attempts to introduce the 
iodide to compound 6.5 was successful following literature procedure. [18] However, 
the reaction was hardly reproducible. We assumed that it might be of impure iodine. 
Therefore, we abandoned this strategy to proceed further to do Suzuki cross coupling 
reaction with congested iodoarene 6.7. Later on, a novel method was developed in our 
group for the fast halogenation of heterocycles using N,N′-dihalo-5,5-
dimethylhydantoin.[19] The developed method made us wonder whether this could 
operate for the iodination with N,N′-diiodo-5,5-dimethylhydantoin (DIH) as iodinating 
reagent. Nevertheless, a trial of iodination of compound 6.5 was failed. Afterwards, we 
attempted to perform bromination of compound 6.5 with the corresponding N,N′-
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dibromo-5,5-dimethylhydantoin (DBH) as brominating agent. However, this attempt 
was also not successful. Attempts with N,N′-dichloro-5,5-dimethylhydantoin (DCH) 
successfully  afforded  chlorinated compound 6.7a in quantitative yield. Subsequently, 
we established a Suzuki cross coupling reaction of congested chloroarene 6.7a with 
phenylboronic acid 6.8. We have attempted the Suzuki cross coupling reaction with 
our previously reported methodology [20], however low yields (29%) of the coupled 
product 6.9 were only obtained. Therefore, we have optimized and developed a novel 
method for the synthesis of congested 2-nitrobiphenyls [21] (discussed in chapter 3) 
(Scheme 6.2). 
 
Scheme 6.2. Suzuki cross coupling method to produce congested 2-nitrobiphenyls 
 
Intermediate 2-nitrobiphenyl compound (6.9) was synthesized in 50% yield to 
synthesis the carbazomycin G 6.15. For synthesis of carbazomycin H, we have 
performed a reaction with 3-methoxy phenylboroinc acid 6.8a under the same Suzuki 
cross coupling conditions afforded 6.9a in 50% yield. Reduction of nitro group yielded 
6.10. Several synthetic methods were available for nitro group reduction. [22] However, 
we screened the reaction with various experimental conditions using indium powder 
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based on a method reported by Moody et al.[23] We initially tested the indium method 
using from two different suppliers (Aldrich and Alfa Aesar). Both methods afforded 
only 3% yielded at 100 oC. Increased reaction duration (3 h) and temperature (120 oC) 
resulted quantitative yield of desired amine compound 6.10 (Table 6.1, entry 7). 
Table 6.1. Screening of reduction method using In/NH4Cl[a] 
 
 
Both nitro compounds 6.9 & 6.9a were successfully converted into their 
corresponding amines using Indium mediated reduction method. Amine 6.10 
underwent direct cyclization using our new method involves intramolecular C-H 
activation and C-N bond formation (discussed in Chapter 5). [16] However, this method 
was not successful to compounds bearing oxidizible functional groups such as 
methoxy and hydroxyl groups. Compounds with protected hydroxyl groups in 6.9 
using tetrabutyl dimethylsilylchloride (TBS-Cl) resulted in 98% yield of compound 
6.16 followed by reduction of nitro compound of 6.16 afforded compound 6.17. 
However, the subsequent ring closing reaction was failed (Scheme 6.3), resulting 
decomposition of products. 
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Subsequent acetylation ( both hydroxyl and amine) was carried out of 6.10 using acetic 
anhydride to obtain compound 6.11, followed by next step with ring closing reaction 
afforded medium yield (37 %) of the ring-closed product 6.12 after 3 hours. However, 
prolonged reaction time from 3 hours to 5 hours gave 70% isolated yield of compound 
6.12. In the case of carbazomycin H intermediates, the protection step to obtain 
compound 6.11a was successful and followed by the ring-closing step afforded two 
structural isomers of compound, 9-acetyl-1, 3, 6-trimethoxy-2-methyl-9H-carbazol-4-
yl acetate 6.12a and 9-acetyl-1, 3, 8-trimethoxy-2-methyl-9H-carbazol-4-yl acetate 
6.12b. The separation of these two isomers were unsuccessful. Therefore, we 
abandoned the strategy to continue further with the synthesis of Carbazomycin H. 
From this point, we focused only the total synthesis of carbazomycin G. We could able 
to achieve the congested novel carbazole moiety 6.13 in 94% yield after the de-
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protection of the acetyl groups. The last two steps involves oxidation of the compound 
6.13 followed by regioselective methylation. The oxidation of methoxy phenol 
compound 6.13 into 1,4-quinone 6.14 was successfully synthesized in 83% yield based 
on the oxidation method reported in our group[24] using nitric acid. The final step 
involves the regioselective methylation [6c] (1,2-addition at C-1) of 1,4-quinone 
compound 6.14 with methyl lithium afforded the carbazomycin G 6.15 in 51% yield 
(Scheme 6.4) with addition of some unidentified products. 





We have developed a novel synthetic methodology to synthesis a carbazole alkaloid 
Carbazomycin G in twelve-step synthesis with medium to excellent yields in each 
step. Thus, the total synthesis afforded an overall yield of 8.1%. This total synthesis is 
associated with a couple of fascinating transition metal catalyzed organic reactions, 
including Suzuki cross coupling of congested chloroarenes and intramolecular C-H 
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Cinnolines are an important heterocyclic compound and the structural moiety are often 
found in various potentially active pharmaceutical compounds.[1] Cinnoline and its 
derivatives are known to display interesting biological properties such as anti-
cancer,[2a] antibacterial,[2b] antimicrobial,[2c] antifungal,[2d] anti-inflammatory,[2e] 
antiulcer,[2f] anti-hypertensive,[2f] topoisomerase inhibitor[2g] and cytotoxic activities.[2h] 
Among various cinnoline derivatives, benzo[c]cinnolines are of particular interest in 
medicinal chemistry due to their promising anticancer properties.[3] Subsequently, 
various important cinnoline derivatives have been identified as biologically active 
compounds and shown in Figure. 7.1.[4]  
Figure 7.1. Biologically active Cinnoline derivatives 
 
 
Previously in our research group, reported a synthetic method for the synthesis of 
symmetrical benzo(c)cinnolines[5] by means of the 2, 2’-dinitro-1-1’-biphenyls which 
were synthesized via Ullmann coupling.[6] The method using the Suzuki cross 
coupling[7] reaction to synthesize the symmetrically substituted 2, 2’-dinitro-1-1’-
biphenyls[8] was not very successful which afforded low yields only. Recently, for a 
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project related to the synthesis of carbazole scaffold [9] (discussed in Chapter 5), we 
needed access to synthesize 2-nitrobiphenyls that we could able to produce via our 
previously disclosed Suzuki cross coupling reaction of 2-nitro-1-iodobenzenes with 
phenylboronic acid.[8] We revisited the method and improved a protocol using 
optimization study that allows 2-nitro-chlorobenzenes as well as 2-nitro-
bromobenzenes as reaction partners with phenylboronic acid for the synthesis of 2-
nitrobiphenyls[10] in excellent yield and selectivity. By these encouraging results we 
wanted to explore the developed method could also be suitable for the synthesis of 2, 
2’-dinitrobiphenyls 7.3 and thereby access to synthesize the corresponding 
unsymmetrically substituted benzo(c)cinnolines 7.8. The important features of 
benzo[c]cinnoline 7.8 derivatives incited to synthesize the moiety based on the 
efficient methodology by means of two steps (Scheme 7.1). 
Scheme.7.1. Two step synthesis of benzo[c]cinnoline 
 
 
In addition to our method, benzo(c)cinnolines 7.8 were synthesized previously by 
using different synthetic methodologies. In 2007, Scobie et al reported a three-step 
synthesis involving a base catalyzed condensation of 2-amino-2’-nitrobiaryls.[11] 
Recently, Pal and collaborators described a method using photocatalytic reduction of 
2, 2’-dinitro-1-1’-biphenyls.[12] Simultaneously, Sridhar et al reported a method via 
consecutive C-C and C-N bond formation.[13] These reported methods required several 
additives were necessary in order to carry out the reaction as well as require long 




7.2 Results and discussion 
 
We initially attempted a Suzuki cross coupling reaction to synthesize 2, 2’-
dinitrobiphenyls 7.3 using 2-nitrochlorobenzenes 7.1 and 2-nitro phenylboronic acid 
7.2 as reaction partners. However, the method was unsuccessful and obtained only the 
homocoupled product of the 2-nitro phenylboronic acid 7.2. Therefore, we wanted to 
investigate the rate of the reaction in the presence of electron withdrawing substituent. 
For example, we have performed a reaction with CF3 group, afforded the desired 
coupled product although in low yield only. Interestingly, an ipso-type nucleophilic 
substitution was observed at high temperature with solvent as the nucleophile. 
Therefore, we abandoned the strategy to further investigate the reaction. The screening 
of the reaction with 2-nitrochlorobenzenes 7.1 was shown in Table. 7.1. 
Widdowson and Wilhelm[14] stated that the nitro group in the ortho position is not only 
acting as an electron withdrawing group, but also as a coordinating group for incoming 
palladium in the Suzuki cross coupling and thereby act a significant influence on the 
C–C coupling. Moreover, the recent study by Sakaki, Nakao, and collaborators [15] 
described that the NO2 group of nitroarenes, even operated as the leaving group in the 
Suzuki cross coupling. These observations exemplifies the difficulties of using ortho-
nitro substituted reagents in the Suzuki cross-coupling experiments. 
Table 7.1. Screening of Suzuki cross coupling reaction to produce 2-nitrobiphenyls[a] 
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Furthermore, we started to examine the Suzuki cross coupling reaction with 2-
nitrobromo benzenes  and phenylboronic acid  as reaction partner. The reaction 
afforded a moderate yield of the unsubstituted coupled product 2,2’-dinitro-1,1’-
biphenyl  (Scheme 7.2, Step 1). The subsequent step (Scheme 7.2, Step 2) involves 
the redox process involving a partial nitro group reduction using acetophenone  
followed by intramolecular cyclization leads to benzo[ ]cinnoline scaffold  in 
excellent yield with acetic acid  as a side product. The mechanism of the reductive 
cyclization of 2,2’-dinitro-1,1’- biphenyl   into corresponding benzo[ ]cinnolines 
 has been discussed previously in our group.[5] 
 
. Two step synthesis of benzo[ ]cinnoline involving Suzuki cross coupling reaction and 
domino reductive cyclization. 
 
 
 7.3 Scope and limitations 
 
A scope and limitation of the Suzuki cross coupling reaction has been investigated 
with different functionality on the 1-bromo-2-nitrobenzenes  with various electron 
withdrawing and donating groups. As a result, all of these reactions except the 3-
bromo-4-nitrobenzoic acid ( ) afforded the corresponding 2,2’-dinitrobiphenyls 
( - ) in a moderate to excellent yield. (Scheme 7.3). For example, protecting 
carboxylic acid group as a methyl ester (methyl 4-bromo-3-nitrobenzoate) afforded a 
moderate yield of the benzo[ ]cinnoline carboxylic acid ( ) due to the ester 
hydrolysis under the basic conditions. The substrates bearing with electron-donating 
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groups provided low yield (  and ) and high yield were obtained with strong 
electron-withdrawing substituents such as COCH3 and CF3 (  and ). In case of 
weak deactivating group, it gave moderate yield ( ). These results revealed that the 
electron withdrawing groups deactivate the aromatic ring, decrease the electron 
density on C-Br bond towards the oxidative addition and facilitates the 
transmetallation with boronicacid even in the presence of strong deactivating groups. 
With the low yield of biphenyl, we obtained the hydrodebrominated compound and 
nitrobenzene in range of 40-50% yield via protodeboration under basic conditions.  
 





We have initially attempted to synthesize the target benzo[c]cinnolines  from 2,2’-
dinitrobiphenyls  using shorter time (30 min) at 120oC under microwave irradiation. 
As a result, the reaction afforded the benzo[ ]cinnoline- -oxide  (less reduced form 
of product) as the major product and benzo[ ]cinnoline  (expected product) as the 
minor product (scheme 7.4).  We wanted to attain the benzo[c]cinnoline as our target 
molecule. Therefore, we have examined the rate of the reaction by increasing the 
reaction time from 30 min to 3 hours and slightly increased the temperature from 120 
oC to 130 oC that attained an excellent yield (95%) of the target benzo[ ]cinnoline . 
 
 Screening reaction conditions for the domino reductive cyclization[a] 
 
 
We examined the scope of the reaction with different functionality as we made in the 
Suzuki cross coupling which afforded high to excellent yield in all the cases and the 
method was compatible with both the activating and deactivating substituents such as 
–CH3, -OCH3, -Cl, -CF3, -COOH and the developed method was not suitable in the 





 Scope and limitation of the domino reductive intramolecular cyclization for the 
synthesis of Benzo[ ]cinnolines[a] 
 
 
Benzo[c]cinnolines carboxylic acid 7.8b has been synthesized in two different 
substrates. One strategy involves from the corresponding 2,2'-dinitro-1,1’-biphenyl 
carboxylic acid methyl ester 7.5h , since the ester group was hydrolyzed under the 
basic conditions. The second strategy was synthesized from the analogous 1-(2,2'-
dinitro-[1,1'-biphenyl]-4-yl)ethan-1-one 7.3b. In this substrate, the acetyl group 
functioned as a reducing agent intramolecularly (in the place of acetophenone 7.6) for 
the two-nitro groups that leads to the formation of the cyclized product 
benzo[c]cinnoline carboxylic acid (8b). When an experiment performed with identical 
conditions in the presence of acetophenone 7.6, the identical benzo[c]cinnoline-3-
carboxylic acid 7.8b was obtained due to the intramolecular reaction of the acetyl 





In summary, we have developed an efficient two-step protocol for the synthesis of 
un-symmetrically and symmetrically substituted benzo[ ]cinnolines. The key 
intermediate 2,2’-dinitro-biphenyls were successfully synthesized by means of a 
Suzuki cross coupling protocol of 1-bromo-2-nitrobenzenes with 2-nitro 
phenylboronic acid as a coupling partner followed by a domino reductive 
intramolecular cyclization leads to the target molecule.  Overall, the method was 
compatible with both electron withdrawing and donating groups except the presence of 
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Boscalid® is a widely used carbaxamide-based fungicide in agricultural sector.[1] It was 
launched by BASF in 2003 and approved as a fungicide in many countries.[2]  
Globally, more than 1,000 tons of Boscalid® is produced in a year.[3] 
Synthesis/production of Boscalid® 8.8 were reported in numerous patents and 
publications[4,5] 
Figure 8.1. Structure of Boscalid® 
 
The industrial synthesis of Boscalid® is shown in Scheme 8.1. The most important step 
(Step 1) is the formation of carbon-carbon bond using Pd-catalyzed Suzuki cross-
coupling of 1-chloro-2-nitrobenzene 8.1 and 4-chloro phenylboronic acid 8.2 for the 
production of 4’-chloro-2-nitro-1,1’-biphenyl 8.3. Subsequent hydrogenation of nitro 
group into amino group afforded compound 8.4 followed by amide coupling with 2-
chloro-nicotinyl chloride 8.6 afforded the fungicide Boscalid® 8.8.[4] However, this 
synthetic route requires long reaction times and high reaction temperatures to achieve 
the desired target molecule. In this viewpoint, we mainly focused to develop a method 
to minimize the reaction durations and optimized mild temperatures for each step 










8.2 Methods and discussion 
8.2.1 Suzuki cross coupling reaction (step 1) 
 
We have initially investigated the Suzuki cross coupling reaction[6] between the 1-
chloro-2-nitrobenzene 8.1 and 4-chlorophenyl boronic acid 8.2 based on previously 
disclosed methods from our group.[7]  We have performed a number of reactions by 
varying the quantity of boronic acid 8.2, reaction temperature, base, catalyst and 
solvent towards the biphenyl product. Table.8.1 depicts the screening of Suzuki cross-
coupling reaction and afforded low to medium yield. The reaction using Pd(PPh3)4 and 
methanol/water solvent system attracted our attention  (Table.8.1, entry 3) to further 
develop the method. Therefore, we have continued the process to optimize the reaction 
at high temperature. The rate of the reaction has been increased steadily from 1 hour to 
8 hours and obtained almost a quantitative conversion with high yield and good 





Table. 8.1. Screening of Suzuki cross coupling producing 2-nitrobiphenyls[a] 
 
Recently, we have developed an efficient Suzuki cross coupling method for the 
synthesis of 2-nitro-1,1’-biphenyls using 1-chloro-2-nitrobenzene 8.1 and 1-bromo-2-
nitrobenzene as a coupling partner with phenylboronic acid.[8] The established method 
was developed by optimization process for the highly congested 1-chloro-2-
nitrobenzenes. The new method was examined with variety of substituted 1-chloro-2-
nitro and 1-bromo-2-nitrobenzenes in short time (30 min) under microwave heating 
(120 °C) and afforded excellent yields of various 2-nitro-1,1’-biphenyl 8.3 compounds. 
The 2-nitro-1,1’-biphenyl 8.3 derivatives are an important intermediate and act as a 
precursor for the synthesis of carbazole framework.[9] 
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Table.8.2. Attempts to produce the 2-nitro-1,1’-biphenyls[a] 
 
 
For example, 4’-chloro-2-nitrobiphenyl 8.3 was prepared in high yield under 
microwave heating. The method also works under thermal heating (120 °C) with sealed 
tube for 30 min afforded a quantitative conversion yield of 2-nitro-1,1’-biphenyl 8.3. 
In compare with the patents by BASF, our method is suitable in both thermal and 
microwave heating in short time (30 min) and could be useful for the industrial method 
of preparation. The Suzuki cross coupling method also worked very well with various 
solvents (Table.8.3) in order to use them in flow reactor technology [10] in our group 








Table.8.3 Screening of Suzuki coupling with different solvent system 
 
8.2.2 Reduction method (Step 2) 
 
Previously, numerous methods were reported to the reduction of nitro to amino 
compounds.[11] We have chosen an indium powder reduction method for this 
transformation due to the inflammable nature, easy handling and non-toxic properties. 
Recently, we have developed a reduction method for the synthesis of 2-amino-1,1’-
biphenyls 8.4 from 2-nitro-1,1’-biphenyls 8.3 using an indium powder.[12] The method 
required only simple filtration to remove the residue of the metal since the quantitative 
conversion yield of desired amine compounds were obtained in almost all the cases. 
The method is suitable for selective reduction of nitro compound in presence of 
several other reducible groups. In our synthetic route, the Boscalid® intermediate 4’-
chloro-2-nitro-1,1’-biphenyl 8.3 was reduced to 4’-chloro-2-amino-1,1’-biphenyl 
compound 8.4 (88% isolated yield) using indium powder as the reductant in sealed 
tube for 3 hours at 120oC. In view of the industrial application of Boscalid® 8.8, we 
have developed a novel and efficient method for the reduction of nitro to amino 
compound using the NaBH4 and cobalt sulfate heptahydrate as the reductant system. 
Previously there are some existed methods for the reduction of different functionalities 
using the NaBH4 in presence of various additives. [13] We focused mainly to reduce the 
nitro group into amino group. The developed method is very rapid under thermal 
heating and about 10 min reaction time the reaction has been completed and afforded 
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an excellent yield of the corresponding amine compound. We used this method to 
synthesize the intermediate and obtained 95% isolated yield of 4’-chloro-2-
aminobiphenyl 8.4. Due to the high rate and good selectivity of the method, we wanted 
to elaborate the reduction step using different functionalities, which has been discussed 
in Chapter 9. 
8.2.3 Amide bond formation (Step 3) 
 
The final step of the synthesis is the amide bond formation between the amine with 
either acid or acid chloride. Amide bond formation is well known reaction in organic 
synthesis.[14] Several synthetic methods has been described earlier for this formation. 
For our target molecule, we have developed a two different method for amide bond 
formation. Method 1 involves the coupling between the synthesized amine (via two 
steps) with the 2-chloro-nicotinyl chloride 8.6 (synthesized from 2-chloro-nicotinic 
acid 8.5 using SOCl2) in the presence of trimethylamine as base in short time (10 min) 
afforded Boscalid® 8.8 in 92% yield. (Scheme 8.2). 






Method 2 describes the coupling of the amine 8.4 with less reactive 2-chloronicotinic 
acid 8.5 in the presence of thionyl chloride and pyridine, a stable intermediate 
sulfinylaniline was formed in situ during the reaction [15] and simultaneously react with 
the acid compound to obtain the target Boscalid® compound. (Scheme 8.3). 
 







In summary, we have developed a synthetic route to minimize the reaction times and 
reduced temperatures in synthesis of Boscalid® in a reported industry method. Our 
methodology comprised a much higher reaction rate in all the three synthetic steps and 
provided excellent outcomes of the reaction. We are presently exploiting the batch 
process method into continuous flow process for the industrial application, which is 










[1]  (a) C. L. Xiao and R. J. Boal, Plant Dis. 2009, 93, 185–189. (b) W. Krämer, U. Schirmer, P. 
Jeschke, M. Witschel, Modern Crop Protection Compounds, Herbicides, Vol. 1. Wiley-VCH, 
2011. (c) K.-H. Kuck, U. Gisi, Modern Crop Protection Compounds, Vol. 2, (Eds.: W. Krämer, 
U. Schrimer), Wiley-VCH, Weinheim, 2007, pp 415–432. b) F. Earley, Modern Crop Protection 
Compounds, Vol. 2, (Eds.: W. Krämer, U. Schrimer), Wiley-VCH, Weinheim, 2007, 433–538.  
[2]  United States Environmental Protection Agency: Pesticide Fact Sheet Boscalid®, 2006. 
[3]  C. Torborg, M. Beller, Adv. Synth. Catal. 2009, 351, 3027-3043. 
[4]  (a) K. Eicken, (BASF AG, Ludwigshafen), 1992, Patent EO05450992A2. (b) K. Eicken, N. 
Goetz, A. Harreus, E. Ammermann, G. Lorenz, H. Rang, (BASF AG, Ludwigshafen), 1993, 
Patent EP0545099. (c) K. Eicken, H. Rang, A. Harreus, N. Goetz, E. Ammermann, G. Lorenz, S. 
Strathmann (BASF, Ludwigshafen), 1997, Patent DE19531813. (d) K. Eicken, M. Rack, F. 
Wetterich, E. Ammermann, G. Lorenz, S. Strathmann (BASF AG, Ludwigshafen), 1999, Patent 
DE9735224. (e) K. Eicken, M. Rack, F. Wetterich, E. Ammermann, G. Hardt, M. Rack, P. 
Schäfer (BASF AG, Ludwigshafen), 1997, Patent WO9733846. (f) S. Engel, T. Oberding (BASF 
AG, Ludwigshafen), 2006, Patent WO2006092429. 
[5]  (a) T. N. Glasnov and C. O. Kappe, Adv. Synth. Catal. 2010, 352, 3089–3097. (b) G. P.Chiusoli 
and P. M. Maitlis, the Royal Society of Chemistry, 2008. (c)  I. Volovych, M. Neumann, M. 
Schmidt, G. Buchner, J. –Y. Yang, J. Wӧlk, T. Sottmann, R. Strey, R. Schomäcker, M. Schwarze, 
RSC Adv. 2016, 6, 58279–58287. 
[6]  (a) N. Miyaura, A. Suzuki, Chem. Commun. 1979, 866-867. (b) N. Miyaura, A. Suzuki, Chem. 
Rev. 1995, 95, 2457-2483. 
[7]  R. Rodríguez González, L. Liguori, A. Martinez Carrillo, H.-R. Bjørsvik, J. Org. Chem. 2005, 70, 
9591–9594. 
[8]  V. Elumalai, A. H. Sandtorv, H.-R. Bjørsvik, Eur. J. Org. Chem. 2016, 1344-1354. 
[9]  (a) W. C. P. Tsang, N. Zheng, S. L. Buchwald, J. Am. Chem. Soc. 2005, 127, 14560–14561. (b) 
W. C. P. Tsang, R. H. Mundey, G. rasche, N. Zheng, S. L. Buchwald, J. Org. Chem. 2008, 73, 
7603–7610. (c) A. P. Antonchick, R. Samanta, K. Kulikov, J. Lategahn,  Angew. Chem. Int. Ed. 
2011, 50, 8605–8608. (d) A. W. Freeman, M. Urvoy, M. E. Criswell, J. Org. Chem. 2005, 70, 
5014–5019. (e) H. Peng, X. Chen, Y.Chen, Q. He, Y. Xie, C. Yang, Tetrahedron. 2011, 67, 
5725–5731. (f) H.-R. Bjørsvik, V. Elumalai, Eur. J. Org. Chem. 2016, 5474-5479. 
[10]  L. Liguori, H. –R. Bjørsvik, Org. Process Res. Dev. 2011, 15, 997-1009. 
[11]  (a) P. M. G. Bavin, Org. Synth. 1973, 5, 30. (b) C. F. H. Allen, J. VanAllan, Org. Synth. 1955, 3, 
63. (c) R. J. Rahaim, R. E. Maleeka, Org. Lett. 2005, 7, 5087–5090. (d) B. A. Fox, T. L. Threlfall, 
Org. Synth. 1973, 5, 346-351. (e) A. Albert, W. H. J. Linnel, Chem. Soc. 1936, 1614-1619. (f)  F. 
D. Bellamy,  K. Ou, Tetrahedron Lett. 1984, 25, 839–842. (g) M. Somei, K. Kato, S. Inoue, 
Chem. Pharm. Bull. 1980, 28, 2515–2518. (h)  B. Raju,  R. Ragul,  B. N. Sivasankar, Indian J. 
Chem. 2009, 48, 1315–1318. (i) M. K. Basu, Tetrahedron Lett. 2000, 41, 5603–5606. (j) C. T. 
Redemann, C. E. Redemann, Org. Synth. 1955, 3, 69-70. 
[12]  V. Elumalai, H.-R. Bjørsvik, Tetrahedron Lett. 2016, 57, 1224–1226. 
[13]  (a) S. Yoo, S. Lee, Synlett. 1990, 419-420. (b) H.N. Borah, D. Prajapati, J. S. Sandhu, J. Chem. 
Res. S. 1994, 228-229. (c)  K. Yanada, H. yamaguchi, H. Meguri, S. Uchida, J. Chem.Soc. Chem. 
Commun. 1986, 1655-1656. (d) S. Gohain, D. Prajapati, J. S. Sandhu, Chem. Lett. 1995, 725-726. 
[14]  C. -A. G. N. Montalbetti, V. Falque, Tetrahedron. 2005, 61, 10827–10852. 







Reduction reactions are of paramount importance in organic synthesis. In particular, 
reduction of nitro compounds into corresponding amines are one of the essential 
synthetic transformations used heavily in synthetic organic chemistry.[1]Aromatic 
amines are an important starting materials and extensively used as key intermediates 
for the production of various chemical substances such as agrochemicals, dye stuffs, 
drugs, polymers and pigments. [2] Furthermore, aromatic amines might be easily 
converted into different groups such as H, OH, F, Cl, Br, I, etc by means of the 
diazotization reactions.[3]  
Numerous synthetic methods were previously reported for direct conversion of nitro to 
amino groups. The catalytic hydrogenation [4] involving palladium on carbon with 
hydrogen gas is one of the most commonly used method in industry and no side 
products are formed except water.  However, these existing methods suffers from 
number of limitations involving using expensive and highly flammable nature of the 
reagents. Moreover, this method also suffers in reducing the selectivity in the presence 
of other functional groups and required high purity of the substrates in order to 
facilitate the reduction reaction. In this viewpoint a new facile, chemo selective and 
sustainable reduction method is a subject of interest and still highly demanded.  
In order to implement our process leading to boscalid (Chapter 8), we needed a 
reduction method that could be implemented as a continuous flow operation. Recently, 
we have developed and improved a method for reduction of nitro group into 
corresponding amine using indium powder.[5] However, indium method is partially not 
suitable to our current flow reactor process due to the solubility and difficult to feed 
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the substrate into the reactor.[6] Therefore, it is required a suitable method to solve 
these type of problems.  
In the past decades, metal hydrides are considered valuable reagents in modern organic 
synthesis.[7] Among the metal hydrides, NaBH4 is one of the most frequently used 
hydride due to its mild conditions, and inexpensive reagent brings innovative changes 
in reduction of different functional groups, more commonly, aldehydes, [8] and 
ketones, [9]. Moreover, the functional groups such as nitro (-NO2), carboxylic acid (-
COOH), ester (-CO2R), nitriles (-CN) and amides (-CONH2) are more resistant 
towards NaBH4 reduction. It is well known that using NaBH4 alone, the reducing 
power is rather limited. However, the reducing power is drastically enhanced when 
combined with metal halides. Reduction of nitro and several other functional groups 
have been reduced by using NaBH4 in the presence of  various transition metals and 
other additives, for example CoCl2,[10] NiCl2,[11] CuCl2,[12] SnCl2,[13] BiCl3,[14] ZrCl4,[15] 
SbF3,[16] CuSO4,[17] Raney nickel,[18] and charcoal.[19] 
The approach using sodium borohydride combined with transition metals have 
attracted our attention. Herein, we have described a simple and efficient reduction 
method using readily available NaBH4 and cobalt sulfate heptahydrate for the 
reduction of several functional groups. The developed method enables the workup 
process easier and afforded a high yield of the desired product by simple filtration. In 
addition, the rate of the reaction enriched considerably to reduce groups such as nitro, 
nitrile, and azide. The method has been elaborated extensively in our group and 
examined the reduction of several aromatic and aliphatic alkene and alkyne 
compounds under slightly different reaction conditions. Overall, the method is suitable 






9.2 Results and discussion 
 
We set out to investigate the NaBH4/CoII reduction system using cobalt (II) 
heptasulfate and NaBH4. CoSO4.7H2O is readily available and cheap material 
compared to other cobalt counter ions. Based on the previous study with NaBH4/cobalt 
chloride,[10a] attempted a reduction reaction of compound 1 with 5 equivalents of 
NaBH4 and 2 equivalents of cobalt sulfate, afforded a quantitative yield of the desired 
amine compound in 10 minutes. Despite of its frequent use for reduction of various 
functionality using these combinations of NaBH4 and cobalt source,[10] the nature of the 
reducing species in these reaction mixtures remains unclear.  For example, observed a 
black granular precipitate (Co2B) when mixing NaBH4 and cobalt sulfate in ethanol as 
a solvent, it is an exothermic reaction evolving hydrogen gas steadily during the 
reaction. Cobalt boride is a cheap inorganic material and has been considered as 
an effective hydrogenation catalyst in organic synthesis and useful for 
hydrogen storage in fuel cell technologies.[20]  
The mechanism of the reaction is somewhat not clearly understood based on the 
previous work.[10c] We supposed that the cobalt boride was formed in situ with the 
reaction mixture of NaBH4 and Cobalt source. The cobalt boride act as a true catalyst 
in the reaction mixture and coordinating with the functional group that need to reduce 
and activating them towards the reduction reaction. A large excess of NaBH4 was 
required to carry out the reduction reaction. It reacted with the alcoholic solvent and 
cobalt borides further accelerated to the decomposition of NaBH4.  
We examined the reaction rate using reduced amount of NaBH4 and catalytic amount 
of cobalt source. It gave only trace amount of the amine product 9.2 (entry 2), 
increased amount of NaBH4 (4 equiv) and catalytic amount of cobalt afforded only 
23% yield. Additional trials with stoichiometric amount, gave almost quantitative 
conversion yield. (entry 5) Only negligible amount (1%) of hydrodechlorinated 
compound was observed. The optimized condition was developed for the reduction of 
nitro to amino compounds (entry 5) and shown in Table 9.1.  
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Table 9.1. Optimization of reduction of NO2 group using NaBH4/Co system[a]   
 
 
In addition, reduction of nitro benzene with recycled cobalt boride (Co2B) was also 
performed to study the reaction rate compared with cobalt sulfate. The method works 
very well in a small-scale (0.5 mmol) and afforded 90% conversion yield of azoxy 
product 9.4, (Scheme 9.1).  The results of the reaction was encouraged further to 
explore with recycled catalyst (cobalt boride) in order to scale up the reaction. When 
we scaled up to ten times (5 mmol), the reaction rate becomes slower and gave only 
23% yield after 10 minutes reaction time. Prolonged the reaction period (up to 1 hour) 
did not improve the yield. To conclude with this viewpoint, the cobalt boride is not 
suitable catalyst with large-scale reduction of nitro compound. It might be due to the 
presence of impurities formed in the reaction and stability of the catalyst. However, it 






Scheme 9.1 Attempt to reduction using recycled cobalt boride 
 
 
Furthermore, needed to explore the reduction reaction using NaBH4 in the presence of 
several other cobalt counter ions. The reaction rate with counter ions such as, sulfate, 
chloride, nitrate and acetate were tested. The method works almost similar in all the 
cases except the cobalt sulfate that afforded nearly quantitative yield. Moreover, the 
cobalt sulfate is much cheaper than the other counter ions. The list of reaction study is 
shown in Table 9.2. 





In addition to this screening (Table 9.2), the reduction method was established with 
several protic solvents under three different reaction times (Table 9.3). The solvent 
ethanol, methanol are suitable for the transformation of 2-nitrobiphenyl 9.6 to 2-
aminobiphenyl 9.7 with complete conversion after 10 minutes (entry 1& 2, Table 9.3). 
The method was failed in propanol and butanol as solvent due to the poor solubility of 
substrates. Then adding catalytic amount (20 mol%) of phase transfer catalyst (TBAB) 
to the reaction mixture (entry 3 & 4, Table 9.3) resulted quantitative conversion of 
nitrobiphenyl compound 9.6. However, the desired product 9.7 was obtained in low 
yield with additional side products (9.8 & 9.9).  






9.3 Scope and limitation 
 
Using this optimized procedure (Table 9.1), several functional groups such as NO2, 
CN, and N3 were examined. The scope and limitation of the method was shown in 
Scheme 9.2. The reduction of nitro biphenyl and highly congested nitro compound 
afforded excellent yield of corresponding amino compounds (9.11a-9.11c, Scheme 
9.2). The method is compatible with both electron withdrawing and donating groups. 
Reduction of nitro compound in the presence of bromo and chloro substituents is 
compatible with this method and obtained the amine compound (9.11e) in excellent 
yield. In case with reduction of nitrobenzene and chloronitrobenzene, mainly observed 
the azoxy benzene instead of the desired amine compound under the optimized 
conditions (9.11g & 9.11h). This is due to the reductive coupling of nitrobenzene in 
aqueous medium and evidenced by previous published results.[21] However, increased 
amount of NaBH4 (5 equiv) gave the amine only with chloronitrobenzene (9.11f).  
Reduction of dinitro compounds is also challenging with this method. We have tested 
with different dinitro compound with the same conditions as nitro reduction. However, 
it gave only approximately 50 % of the desired diamine compound (9.11j & 9.11l, 
Scheme 9.2). Increased amount of NaBH4 (8 equiv.) didn’t improve the yield of 
desired product instead some unidentified compounds were obtained. Synthesis of 
secondary amines is challenging reaction using the reduction of nitrile compounds. 
With our method, benzonitrile was reduced and afforded secondary amine in 91% 
yield (9.11m). Further scope of the method was unsuccessful with chloro and hydroxyl 
substituents in the para position, no reaction was occurred (9.11n & 9.11p). However, 
the method work with nitro group in ortho position, it reduced the nitrile into primary 
amine and partially reduced the nitro group into nitrozo group evidenced by HR-MS 
analysis (9.11o). Additionally, it was also selectively reduced the nitro to amine and 
ketone into secondary alcohol in presence of nitriles (9.11q & 9.11r). It also reduced 












In summary, we have developed a rapid and efficient method for the reduction of 
reducible groups, NO2, CN and N3. This method well tolerated with various functional 
groups and afforded medium to excellent yield. Moreover, the method is compatible 
for selective reduction in presence of halogen and nitriles. We believe that the reported 
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Summary and Outlook 
10.1 Summary 
In this dissertation, we have addressed the synthetic strategies and novel 
methodologies to the functionalization of some of the heterocyclic compounds. The 
main contribution of my project involved in total synthesis of natural product, 
carbazomycin G. Several novel synthetic methods have been presented in this thesis 
for the synthesis of intermediates to achieve the natural product. In particular, the 
carbazole framework is the fundamental structural unit of the target molecule. A new 
approach was designed for the synthesis of carbazole framework through three 
synthetic steps such as Suzuki cross coupling for the synthesis of 2-nitrobiphenyls 
followed by reduction of nitro into amine and finally the intramolecular C-H activation 
and subsequent C-N bond formation of 2-aminobiphenyl leading to carbaozle moiety. 
We have developed and optimized a highly efficient Pd-catalyzed Suzuki cross 
coupling method for the synthesis of unsymmetrical 2-nitrobiphenyls using highly 
crowed chloroarenes as challenging coupling partner, which is summarized in chapter 
3 (Paper I). Based on the scope and utility, the developed method could be suitable as 
a general synthetic protocol for the synthesis of 2-nitrobiphenyls. The reaction 
optimization study was elaborated in chapter 2 and discussed mainly the importance 
and various application of the statistical experimental design and multivariate 
modeling in synthetic organic chemistry.  
The Suzuki cross coupling protocol have attracted our attention and utilized in 
synthesis of 2, 2’-dinitrobiphenyls, an important intermediate for the preparation of 
both the symmetrically and unsymmetrically substituted benzo[c]cinnolines. The 
synthesis of benzo[c]cinnolines and different scope of the method were described in 
chapter 7 (Paper IV) 
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Furthermore, two different reduction methods were disclosed in this thesis. Indium 
powder reduction method described in chapter 4 (Paper II) for converting mainly the 
various substituted 2-nitrobiphenyls into 2-aminobiphenyls. The method shown very 
simple workup procedure and selective reduction afforded excellent yield of the target 
product. Another method involved the cobalt catalyzed NaBH4 reduction reported in 
chapter 9 for the reduction of numerous functional groups for example, nitro, nitrile, 
and azide. The method displayed a high reaction rate and broad scope of the reaction 
was investigated. 
In chapter 5 (Paper III), we have reported a direct ring closing method for the synthesis 
of carbazole using 2-aminobiphenyls. The method involves combined C-H activation 
and C-N bond formation using Palladium catalyst. The developed method was suitable 
for the synthesis of various substituted carbazoles on both the rings. Moreover, the 
method could also appropriate for the synthesis of N-acetyl carbazoles from 
corresponding 2-acetaminobiphenyls. We have utilized this methodology for the 
synthesis of natural product carbazomycin G, discussed in chapter 6. Our methodology 
contains distinct novel synthetic intermediates and substantial transition metal 
catalyzed reactions were utilized.  
Additionally, an improved 3-step synthesis of Boscalid® was discussed in chapter 8. 
We have used our synthetic methodology (from chapter 3 and chapter 9) for the 
synthesis of intermediates towards the Boscalid® synthesis. The final step involves the 
amidation using amine and acid or acid chloride. We have developed one pot reaction 
for amidation via sulfinylaniline intermediate using acid and amine in the presence of 
thionyl chloride. 
To conclude, the project has been described in a well-connected arrangement. The 2-
nitrobiphenyl via Suzuki coupling is the central structural moiety. The developed 
methodology of the project can be used for variety of applications including in natural 






There are significant numbers of experiments; thoughts and adaptations in related to 
this dissertation have been left for future work due to the inadequate time period to 
carry out. Future work might involve in study of reaction mechanisms of particular 
reactions and trying various methods with new approaches. First, it could be 
interesting to try optimized Suzuki cross coupling method (Chapter 3) using 
heterocyclic substrates as coupling partners to synthesize the heterocyclic compounds. 
Many natural products contain heterocyclic core moieties and they are invaluable 
sources for medicinal chemistry. In addition, it could also be useful to try to develop 
and optimize the Suzuki coupling with deactivated boronic acid for the synthesis of 
various important intermediates as only few particular examples have been examined 
with deactivated boronic acid. Further developments in this area could be beneficial. 
The other attention could be the study on mechanism of reduction using NaBH4/CoII 
system in chapter 9. The mechanism of this reaction is still unclear with the reported 
methods. Additional improvements with the previous methods could be valuable. 
Moreover, the direct ring closing method for the synthesis of carbazole is highly 
important in organic synthesis for the variety of natural products and several other 
drug candidates. The method is not very suitable with the substrates bearing easily 
oxidizable functional groups, gave only low yield under the oxidative condition with 
strong oxidant hydrogen peroxide. Further developments with different approaches 
could be useful with this method. Several novel intermediates were synthesized in the 
total synthesis of carbazomcyin G (Chapter 6). The intermediates are of particular 
interest and tested the cytotoxic effect with HL-60 and MOLM-13 leukemia cells. 
Further activity analysis is in progress. 
Furthermore, we have utilized the amidation method for the synthesis of Boscalid® via 
sulfiniyaniline intermediate in chapter 8. The methods worked very well in one pot 
reaction with less reactive acid as a substrate. Further analysis of the reaction 
mechanism of the amidation would be highly desirable and could be useful method for 
synthesis of numerous substituted amides. 
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The research results presented in chapter 6 about the carbazomycin G synthesis, 
chapter 8 about a new industrial synthesis of the agrochemical Boscalid®, and chapter 
9 that concern a new efficient high rate reduction method based on the sodium 
borohydride reduction of Co2+ forming in-situ hydrogen and the nanoparticle material 
Co2B, are currently under preparation as manuscripts and will be submitted for 
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Abstract: A simple and efficient method for Suzuki cross-cou-
pling of highly substituted and congested 1-chloro-2-nitrobenz-
ene with phenylboronic acid was developed, investigated, and
optimized. The reaction conditions comprises a mixture of
MeOH and water (4:1) as the reaction medium, readily available
and cheap Pd(PPh3)4 as catalyst, sodium carbonate as base, and
Introduction
The biphenyl scaffold constitutes a fundamental structural moi-
ety for several application areas, which includes herbicides,[1]
fungicides[2] catalyst ligands,[3] liquid crystals,[4] active pharma-
ceutical ingredients, and drug candidates.[5] Moreover, 2-N-sub-
stituted biphenyls are of notable interest because such frame-
works can act as precursors for the essential 1H-carbazole
framework.[6]
Methods, such as the Ullmann,[7] Gomberg–Bachmann,[8]
and Suzuki cross-coupling reactions[9] are used for the prepara-
tion of biphenyls, of which the latter is the most efficient
method for the construction of C(sp2)–C(sp2) bonds in organic
synthesis and in the fine chemical industry.[10]
Freeman and collaborators[6d] disclosed in 2005 a method
for the synthesis of 2-nitrobiphenyls by using Pd(PPh3)4 as a
catalyst. In contrast to the method we disclose herein, their
method required long reaction times (up to 42 h) and a large
surplus of base to synthesize the target 2-nitrobiphenyls. Re-
cently, Gooßen and collaborators[11] disclosed a method for the
synthesis of 2-nitrobiphenyls by means of a decarboxylative Hi-
yama coupling reaction, which uses a trimetallic Pd/Cu/Ag cata-
lytic system at high temperatures. However, the Suzuki cross-
coupling reaction has emerged as the method with the most
attractive features for the purpose of preparation of biphenyls,
which includes mild reaction conditions, tolerance of water,
generally high functional group tolerance, and high selectivity
and yields.
Originally, the Suzuki cross-coupling reaction was performed
by reacting organic boronic acids with bromo- and iodoarenes
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microwave heating, which affords a fast reaction rate with good
outcomes. The procedure was proven to have high functional
group tolerance with phenylboronic acid and for 1-chloro-2-
nitrobenzene and thus is a general method for the synthesis of
2-nitrobiphenyl. The target scaffold, 2-nitrobiphenyls, was pro-
duced in excellent yields with excellent selectivities in all cases.
in the presence of a base and Pd(PPh3)4 as catalyst.[12] However,
because the C–Cl bond is less activated towards oxidative addi-
tion, a general application of chlorobenzenes as one of the re-
action partners in the Suzuki cross-coupling reaction has been
a long-standing and challenging task for the Suzuki cross-cou-
pling method. Although some of the first examples to involve
chloro-arenes[13] as reaction partners in this cross-coupling re-
action were disclosed about forty years ago, further significant
advances were not revealed until various palladium complexes
were introduced as catalysts to facilitate the Suzuki cross-cou-
pling reaction.[14] Even if simple catalysts, such as Pd(OAc)2 have
been shown to operate to some extent with chlorobenzenes in
the Suzuki cross-coupling reaction,[15] the greatest successes
were obtained when ingenious and dedicated ligands[16] were
installed on Pd to form the catalyst. In this context, particularly
complex elaborated phosphorus ligand have been devised, syn-
thesized, and used for the purpose.[17] These ligands have,
among other features, increased electron density around the
Pd center, which helps to facilitate the C–Cl oxidative cleavage
and assist cross-coupling,[3a,18–23] but due to their high degree
of elaboration, such ligands are expensive and not achievable
for larger scale reactions.
Results and Discussion
For our project, we needed access to unusually congested bi-
phenyl 5 (Scheme 1), which we devised as a key intermediate
in a new total synthesis for the carbazole alkaloids carbazomy-
cin G and H.[24]
One of the key steps in this synthesis was devised and devel-
oped in our group several years ago, namely a Suzuki cross-
coupling reaction[25] that was needed to join congested 1-iodo-
2-nitrobenzene (3I) and phenylboronic acid. An accompanying
scope and limitation study revealed that the method operated
to provide 2-nitrobiphenyls in high yields by reacting 1-iodo-2-
Full Paper
Scheme 1. Chlorination or iodination followed by Suzuki coupling reaction
steps that lead to 3,5-dimethoxy-4-methyl-6-nitro-1,1′-biphenyl-2-ol.
nitrobenzenes with phenylboronic acids by using Pd(PPh3)4 as
catalyst, with any of the solvent pairs, dimethylformamide/wa-
ter, acetone/water, methanol/water, or methanol, as reaction
medium. To implement the cross-coupling step for congested
1-iodo-2-nitrobenzene (3I), which we attempted by means of
an iodination method disclosed by Crich and collaborators.[26]
This method afforded 3I but only in a low yield (≈ 30 %). Never-
theless, a much larger problem arose, because we were not able
to reproduce the iodination step 1 → 3I in accordance with this
method (Scheme 1, Method A). We assumed the obstacle in
this process to be due to the iodine purity. We were about to
abandon the outlined strategy to lead to 1H-carbazole scaffold
through the 2-nitro-1,1′-biphenyl, at which point we discovered
a halogenating method suitable for various N-heterocycles.[27]
These results made us wonder whether this method could op-
erate for the iodination 1 → 3I with N,N′-diiodo-5,5-dimethyl-
hydantoin as iodination reagent (similar to Scheme 1,
Method B), however, iodination trials failed. Subsequently, we
attempted to perform bromination with the corresponding
N,N′-dibromo-5,5-dimethylhydantoin, however, this also did not
work. Attempts with N,N′-dichloro-5,5-dimethylhydantoin (DCH)
2Cl reacted smoothly to provide chlorinated benzene 3Cl
(Scheme 1, Method B) in quantitative yield. With chlorinated
product 3Cl in hand, we wanted to establish a Suzuki cross-
coupling reaction 3Cl + 4 → 5. We attempted our previously
disclosed Suzuki cross-coupling method developed for iodo-
benzenes,[25] which successfully afforded target molecule 3,5-
dimethoxy-4-methyl-6-nitro-1,1′-biphenyl-2-ol (5), but only in
low yield (≈ 30 %). This encouraging result prompted us to per-
form a systematic optimization by means of statistical experi-
mental design,[28] multivariate regression analysis,[29,30] and re-
sponse surface methodology.[31] In this context, we assumed
that the reaction temperature (z1), the reaction time (z2), the
quantity of base (z3), and the amount of catalyst (z4) were the
variables that affected the performance of the reaction in terms
of yield and selectivity. By using the experimental variables
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z1–z4 a statistical experimental design 2k + c = 24 + 2 = 18 was
created, which is listed in standard order in Table 1, but it was
performed in random order in the laboratory.
Table 1. Statistical experimental design used for the investigation and optimi-
zation of the Suzuki cross-coupling with Pd(PPh3)4 as catalyst.
Experimental variables and selected levels
Experimental variables –1 (L) 0 +1 (H)
z1 Reaction temperature [°C] 90 100 110
z2 Reaction time [min] 45 60 75
z3 Quantity Na2CO3 [g] 0.15 0.19 0.23
z4 Loading Pd(PPh3)4 [mmol] 0.022 0.0435 0.065
Experimental design: 2k + c, k = 4, c = 2 ⇒ 24 + 2 = 18
#[a] Experimental variables[b] Response[c]
z1 [°C] z2 [min] z3 [g] z4 [mmol] y [%]
1 90 45 0.15 0.022 8
2 110 45 0.15 0.022 44
3 90 75 0.15 0.022 15
4 110 75 0.15 0.022 35
5 90 45 0.23 0.022 25
6 110 45 0.23 0.022 39
7 90 75 0.23 0.022 29
8 110 75 0.23 0.022 43
9 90 45 0.15 0.065 22
10 110 45 0.15 0.065 30
11 90 75 0.15 0.065 27
12 110 75 0.15 0.065 32
13 90 45 0.23 0.065 16
14 110 45 0.23 0.065 29
15 90 75 0.23 0.065 20
16 110 75 0.23 0.065 39
17 100 60 0.19 0.0435 19
18 100 60 0.19 0.0435 21
Opt.[d] 120 30 0.10 0.025 53
[a] The experiments were carried out in a random order. [b] 2-Chloro-4,6-
dimethoxy-5-methyl-3-nitrophenol (3Cl; 0.21 g, 0.85 mmol) was used as a
substrate in all of the experiments. [c] Measured response from each experi-
ment y = GC–MS measured yield of target product 3,5-dimethoxy-4-methyl-
6-nitro-1,1′-biphenyl-2-ol (5). [d] Optimized conditions expressed in coded
format: reaction temperature (x1) = +2, reaction time (x2) = –2, quantity of
base (x3) ≈ –2, and Pd-catalyst loading (x4) ≈ –1.
The results of the experiments were evaluated by analyzing
the post-reaction mixture by means of GC–MS, the results of
which are given in the right hand column of Table 1.
Modeling
To facilitate the estimation of the model terms, the experimen-
tal variables z1–z4 were scaled in accordance with Equation (1)
that produced design matrix D in the scaled variables x1–x4,
which were then used to produce model matrix M by using
Equation (2). In these equations, zk is the experimental variable
k expressed in real units and variable xk is the identical variable
provided in scaled units. zk,L and zk,H are the selected low (L)
and high (H) experimental values expressed in the real units of
the experimental variable zk. The selected levels (L, 0, H) are
provided in the upper part of Table 1. The scaling by means of
Equation (1) gives all the experimental variables low values




Multiple linear regression,[29] Equation (3), was used to esti-
mate the model shown in Equation (4) by means of MATLAB[32]
computer software and in-house coded routines that previously




The estimated regression coefficients were analyzed with a
cumulative normal distribution plot (Figure 1), which suggest
Figure 2. iso-Contour projection of the response surface prepared for predictive purposes. The iso-contour lines created by the model Equation (4) display
the predicted yield (y) of target molecule 2-nitrobiphenyl 7. How to read the graphic: the outer horizontal frame line shows the variation in the quantity of
the sodium carbonate (x3), and the vertical frame line displays the effect of the reaction time (x2). Each variable has five discrete levels [–2 –1 0 +1 +2]. The
25 subplots within the outer frame lines show the iso-contour lines projections of the response surfaces when the two experimental variables — reaction
temperature (x1) and quantity of Pd catalyst (x4) — are continuously varied within a range that corresponds to [–2 +2].
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that the regression coefficients 1, 2, 3 (positive signs) and 4
(negative sign) should be included in the model. Moreover, the
interaction terms 14 and 34 (negative signs) and 134 (positive
sign) might also be included. The final multivariate model, see
Equation (5), was subsequently used to produce the iso-contour
response surface projections of the Suzuki cross-coupling reac-
tion (Figure 2).
Figure 1. Cumulative normal distribution plot and regression coefficient spec-
trum estimated for the Suzuki cross-coupling reaction: 3Cl + 4 → 5.
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(5)
The plots within Figure 2 were subsequently used to predict
the conditions of a higher yielding procedure for the Suzuki
cross-coupling reaction. The optimized conditions were taken
Table 2. Library for the investigation of the scope and limitation of the Pd(PPh3)4-catalysed Suzuki cross-coupling reaction that involves 1-chloro-2-nitroben-
zenes (3) and phenylboronic acids (4) as reaction partners.
[a] Conversion yield based on GC/isolated yield after column chromatography; n.d.: not detected. [b] The isolated product in this reaction was the 2-
nitrobiphenyl that resulted from a dehydrodebromination reaction.
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from the sub plot found in the lower left-hand corner of the
Figure 2.
The model predicts that a low quantity of base (z3; 0.10 g),
short reaction time (z2; 30 min), high reaction temperature (z1;
120 °C), and low Pd-catalyst loading (z4; 0.022 mmol) are opti-
mal.
These selections were made to simultaneously obtain opti-
mized yields and to minimize inputs (that is amounts of rea-
Full Paper
gents and Pd catalyst, and shorten reaction times). This was
possible to achieve by means of the sub-plot in the lower left
corner of Figure 2. This sub-plot predicts a yield of ≥ 50 %.
The predicted reaction conditions were used in following-
up experiments to achieve a maximum yield of 53 % of target
molecule 5. This result corresponds to an increased yield of (53
– 32) 21 %-point and is a relative improvement of > 65 % by
using only a simple Pd(PPh3)4 as catalyst in the Suzuki cross-
coupling reaction.
Owing to the good result we attained with congested
chloroarene 3Cl, we were eager to explore whether the devel-
oped and optimized reaction conditions could operate as a
general method for the coupling of 1-chloro-2-nitrobenzenes
and phenylboronic acids with Pd(PPh3)4 as the only catalyst.
Investigation of the Scope and Limitation of the Method
A test library (Table 2) composed of 18 various combinations
of phenylboronic acids and 1-chloro-2-nitrobenzenes with a
Table 3. Library for the investigation of the scope and limitation of the Pd(PPh3)4-catalysed Suzuki cross-coupling reaction that involves 1-bromo-2-nitro-
benzenes (6) and phenylboronic acids (4) as reaction partners.
[a] Conversion yield based on GC/Isolated yield after column chromatography; n.d.: not detected.
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variety of electron-donating and electron-withdrawing func-
tional groups was outlined and tested by means of the
established procedure for the 3Cl + 4 → 5 cross-coupling reac-
tion.
The only change to the method made was to reduce quan-
tity of phenylboronic acid used (2.3 equiv. → 1.5 equiv.). As
Table 2 reveals, the developed method proceeds with excellent
yields in most cases and demonstrates high functional group
tolerance. In addition to these advantages, the method takes
place at a significantly faster rate than previously published
methods that involve chlorobenzenes. Furthermore, the
method was also investigated by using a similar library that
contained bromobenzenes in place of chlorobenzenes as the
coupling partner to phenylboronic acid. A library composed of
13 entries (Table 3) of 1-bromo-2-nitrobenzenes and phenyl-
boronic acids was explored to evaluate the scope and limita-




In summary, we have designed, developed, and optimized a
fast and efficient Suzuki cross-coupling reaction for the synthe-
sis of 2-nitro-1,1′-biphenyls in high to excellent yield by using
1-chloro-2-nitrobenzenes and phenylboronic acids as reaction
partners. The method demonstrates high functional group tol-
erance with both 1-chloro-2-nitrobenzenes and the phenyl-
boronic acids. The method was originally developed to couple
a highly congested halo-arene with phenylboronic acid. In con-
trast to previously disclosed studies that relate to chloro-
benzenes as a reactant in the Suzuki cross-coupling reaction,
we utilized cheap, simple, and commonly exploited catalyst tet-
rakis(triphenylphosphine)-palladium(0). This was made possible
by fine-tuning the experimental conditions assisted by multi-
variate design and modeling to inform a fast, selective, and
high-yielding cross-coupling method. This study demonstrates
how multivariate design and modeling might be used in explor-
ative synthesis to develop new catalyzed synthetic methods
and, as in this case, replace the need for dedicated and sophisti-
cated catalyst ligands.
Experimental Section
Experimental Details: All reagents and solvents were purchased
from commercial sources and used as received. Melting points were
determined in open capillaries. Reagent grade chemicals were pur-
chased from commercial sources and used without further purifica-
tion. All reaction mixtures and column eluents were monitored by
TLC (TLC plates Merck Kieselgel 60 F254). The TLC plates were ob-
served under UV light at λ = 254 nm and λ = 365 nm. IR spectra
were recorded as KBr discs with a Shimadzu FTIR-8300 spectropho-
tometer, and 1H and 13C NMR spectra were recorded with Bruker
AV 400 MHz and 500 MHz instruments. High-resolution mass spec-
tra (HRMS) were performed with a Q-TOF Micro YA263 instrument.
General Methods: GC analyses were performed with a capillary gas
chromatograph equipped with a fused silica column (l25 m,
0.20 mm i.d.,0.33 mm film thickness) at a helium pressure of
200 kPa, split less/split injector and flame ionization detector. Mass
spectra were obtained with a GC–MS instrument, with a gas chro-
matograph equipped with a fused silica column (l30 m, 0.25 mm
i.d., 0.25 mm film thickness) and helium as the carrier gas. DART-
mass spectra were obtained by using PEG as an internal standard
in positive ionization mode with a TOF mass analyzer. 1H and 13C
NMR spectra were recorded at ambient temperature at a frequency
of 400 and 100 MHz, respectively.
The chemical shifts are reported in ppm relative to residual CHCl3
for proton (δ = 7.26 ppm) and CDCl3 for carbon (δ = 77.0 ppm)
with tetramethylsilane as an external reference. Flash chromatogra-
phy was performed by using the indicated solvent system and silica
gel (230–400 mesh). All reagents used were commercially available
from Aldrich Chemical Co. For new compounds HRMS data were
also recorded.
The microwave-assisted experiments were performed by means of
a Biotage Initiator Sixty EXP Microwave System, that operates at 0–
400 W at 2.45 GHz, in the temperature range of 40–250 °C, a pres-
sure range of 0–20 bar (2 MPa, 290 psi), and with reactor vial vol-
umes of 0.2–20 mL.
General Procedure for the Suzuki Cross-Coupling Reaction: Into
a microwave vial, 1-chloro (or bromo)-2-nitrobenzene (1 mmol),
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phenylboronic acid (1.5 mmol), Na2CO3 (1.1 mmol), tetrabutylam-
monium bromide (TBAB; 0.08 mmol), and Pd(PPh3)4 (0.026 mmol,
2.6 mol-%) were added. The vial was sealed and argon was carefully
flushed through the septa before a mixture of MeOH (4 mL) and
water (1 mL) was added. The vial was submerged in the microwave
cavity for 30 min at 120 °C. The post-reaction mixture was cooled
to room temperature, and methanol was removed under reduced
pressure. The reaction mixture was diluted with diethyl ether
(30 mL) and washed with water (40 mL). The aqueous phase was
extracted with diethyl ether (2 × 50 mL) and the organic phases
were combined and dried with Na2SO4. The drying agent was fil-
tered off and the crude product purified by flash chromatography
[ethyl acetate/hexane (mixture of isomers)] to afford 2-nitrobiphen-
yls.
Suzuki Cross-Coupling Reaction with Chlorobenzenes
2,4-Dimethoxy-3-methyl-5-nitrophenol (1) [136763-93-3]: A so-
lution of conc. HCl (13 mL) in MeOH (25 mL) was added to 2,4-
dimethoxy-3-methyl-5-nitrophenyl acetate (1.9 g, 7.45 mmol) at
0 °C. The reaction mixture was stirred for 1 h at 70 °C at reflux
temperatures. After cooling to r.t. the solvent was removed under
reduced pressure. The crude product was diluted with water
(50 mL) and extracted with EtOAc (2 × 50 mL). The organic layers
were combined and dried with Na2SO4 to afford the title compound
as an orange solid (1.40 g, 88 %), m.p. 53–55 °C. Rf = 0.65 (EtOAc/
hexane, 40:60). 1H NMR (400 MHz, CDCl3): δ = 7.29 (s, 1 H), 5.56 (s,
1 H), 3.79 (s, 6 H), 2.23 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
149.9, 146.4, 145, 140.2, 127.4, 109.3, 62.1, 61.1, 10 ppm. MS (EI):
m/z (%) = 213 (100) [M+], 183 (7), 166 (53), 152 (21), 137 (40), 125
(40), 122 (26), 77 (30), 53 (45). IR: ν̃ = 3404, 3083, 2929, 2846,
1500 cm–1.
2-Chloro 4,6-dimethoxy-5-methyl-3-nitrophenol (3Cl): To a solu-
tion of 2,4-dimethoxy-3-methyl-5-nitrophenol (0.311 g, 0.145 mmol)
in EtOH (15 mL), DCH (146 mg, 0.0741 mmol) was added followed
by conc. H2SO4 dropwise (≈ 24 drops) with good stirring. After the
addition was completed, the reaction mixture was quenched with
NaOH (4.1 M, 5 mL). A heavy red precipitation was observed during
the addition of NaOH, which was neutralized with acetic acid (pH
≈ 4), and the resulting mixture was diluted with water (25 mL) and
extracted with diethyl ether (3 × 40 mL). The organic layers were
combined and dried with Na2SO4. The crude product was isolated
by flash chromatography (CH2Cl2/hexane, 40:60) to afford the title
compound as pale yellow crystals (0.34 g, 95 %), m.p. 118.5 °C. Rf =
0.29 (CH2Cl2/hexane, 60:40). 1H NMR (400 MHz, CDCl3): δ = 5.91 (s,
1 H), 3.87 (s, 3 H), 3.80 (s, 3 H), 2.26 (s, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 147.5, 144.0, 142.7, 125.6, 109.3, 62.9, 61.0, 9.9 ppm. MS
(EI): m/z (%) = 247 (100) [M+], 217 (5), 213 (16), 186 (25), 171 (27),
138 (26), 108 (20), 83 (22), 77 (48), 67 (32). HRMS (EI): calcd. for
C9H10ClNO5 247.0248; found 247.0248. IR: ν̃ = 3406, 3083, 2970,
2929, 2846, 1500, 1108 cm–1.
2-Iodo 4,6-dimethoxy-5-methyl-3-nitrophenol (3I): A solution of
KI (0.332 g, 2 mmol) and iodine (0.295 g, 1.16 mmol) in H2O (1 mL)
was added dropwise to an aqueous solution of BuNH2 (20 %;
1.5 mL) and acetic acid 2,4-dimethoxy-3-methyl-5-nitrophenyl (4;
0.170 g, 0.67 mmol), for 1–2 min at room temperature. The resulting
dark mixture was stirred for 30 min at room temperature, and then
poured into CH2Cl2 (50 mL). The organic layer was washed with
aqueous sodium thiosulfate (10 %; 30 mL), dried with anhydrous
Na2SO4, and filtered. After removal of the solvent in vacuo, the final
crude (0.100 g) contained 5 as major product in 32 % yield (81 %
purity), and 2,4-dimethoxy-3-methyl-5-nitrophenol as a major impu-
rity. C9H10NO5I MW 339.09. 1H NMR (200 MHz, CDCl3): δ = 3.85 [s,
3 H, -OMe], 3.79 [s, 3 H, -OMe], 2.26 [s, 3 H, -Me] ppm. 13C NMR
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(200 MHz, CDCl3): δ = 146.7, 146.0, 144.3, 127.0, 71.1, 62.9, 61.1,
10.1 ppm. MS: m/z (%) = 339 (100), 324 (3), 278 (14), 263 (19), 248
(6), 235 (6), 207 (8), 179 (14), 167 (19), 151 (13), 136 (22), 123 (15),
108 (39), 93 (13), 79 (38), 67 (47), 53 (40), 43 (16).
3,5-Dimethoxy-4-methyl-6-nitrobiphenyl-2-ol (5): In a micro-
wave tube, 2-chloro-4,6-dimethoxy-5-methyl-3-nitrophenol (6;
0.21 g, 0.85 mmol), phenyl boronic acid (0.24 g, 1.97 mmol), Na2CO3
(0.10 g, 0.94 mmol), TBAB (0.021 g, 0.065 mmol) and Pd(PPh3)4
(0.025 g, 0.022 mmol) were added. The reaction mixture was care-
fully flushed with argon before adding a mixture of MeOH (4 mL)
and water (1 mL), The tube was sealed and placed into the micro-
wave cavity for 30 min at 120 °C. Then the reaction mixture was
washed with water (40 mL) and extracted with diethyl ether (2 ×
25 mL). The organic extracts were combined and dried with Na2SO4.
The crude product was isolated by flash chromatography (CH2Cl2/
hexane, 15:85) to afford the title compound as a white powder
(0.125 g, 51 %), m.p. 102.5 °C. Rf = 0.49 (CH2Cl2/hexane, 60:40). 1H
NMR (400 MHz, CDCl3): δ = 7.34–7.45 (m, 5 H), 5.57 (s, 1 H), 3.88 (s,
3 H), 3.83 (s, 3 H), 2.33 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
147.2, 143.2, 142.9, 130.8, 129.4, 128.9, 128.8, 125.6, 119.4, 62.8, 61.0,
10.0 ppm. MS (EI): m/z (%) = 289 (100) [M+], 272 (7), 246 (20), 207
(24), 199 (13), 169 (13), 141 (20), 129 (40), 115 (33), 102 (12), 83 (23),
77 (20). HRMS (ESI): calcd. for C15H15NO5 [M + Na+] 312.0848; found
312.0846. IR: ν̃ = 3481, 2927, 2850, 1530, 1370 cm–1.
4′-Chloro-2-nitro-1,1′-biphenyl (5a) [6271-80-3]: 1-Chloro-2-
nitrobenzene (0.25 g, 1.59 mmol), 4-chlorophenylboronic acid
(0.373 g, 2.39 mmol), Na2CO3 (0.185 g, 1.75 mmol), TBAB (0.041 g,
0.13 mmol), and Pd(PPh3)4 (0.048 g, 0.042 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 5:95) as a
yellow crystalline solid (0.315 g, 85 %), m.p. 59 °C. Rf = 0.58 (EtOAc/
hexane, 20:80). 1H NMR (400 MHz, CDCl3): δ = 7.79–7.82 (dd, J =
1.2, 8 Hz, 1 H), 7.53–7.57 (td, J = 1.2, 7.6 Hz, 1 H), 7.41–7.45 (td, J =
1.2, 8 Hz, 1 H), 7.31–7.34 (m, 3 H), 7.16–7.19 (m, 2 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 149.1, 135.9, 135.2, 134.5, 132.5, 131.9, 129.3,
128.9, 128.6, 124.3 ppm. MS (EI): m/z (%) = 237.2 (1), 236.1 (8), 233.3
(99) [M+], 215.9 (42), 198 (48), 168.3 (98), 149.9 (100), 139.2 (98),
115.1 (94), 97.7 (35), 74.23 (99), 62.3 (87). IR: ν̃ = 1521, 1347,
827 cm–1. The recorded spectroscopic data were in accordance with
the literature.[34]
4′-Ethyl-2-nitro-1,1′-biphenyl (5b) [166589-62-4]: 1-Chloro-2-
nitrobenzene (0.25 g, 1.59 mmol), 4-ethylphenylboronic acid
(0.358 g, 2.39 mmol), Na2CO3 (0.185 g, 1.75 mmol), TBAB (0.041 g,
0.127 mmol), and Pd(PPh3)4 (0.048 g, 0.042 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 5:95) as a
yellow liquid (0.301 g, 84 %). Rf = 0.66 (EtOAc/hexane, 20:80). 1H
NMR (400 MHz, CDCl3): δ = 7.72–7.75 (dd, J = 1.2, 7.2 Hz, 1 H), 7.49–
7.53 (td, J = 1.2, 7.6 Hz, 1 H), 7.35–7.39 (m, 2 H), 7.15–7.19 (m, 4 H),
2.62 (q, J = 7.6 Hz, 2 H), 1.19 (t, J = 7.6 Hz, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 147.8, 134.7, 133, 130.6, 130.4, 126.7, 126.3,
126.2, 122.7, 122.4, 27, 13.7 ppm. MS (EI): m/z (%) = 228.2 (4), 227
(35) [M+], 210 (19), 198 (27), 181.9 (54), 164.9 (100), 151.6 (61), 129.1
(21), 115 (27), 88.8 (16), 82 (33), 76 (20). IR: ν̃ = 2964, 1521,
1351 cm–1.
2-Methoxy-2′-nitro-1,1′-biphenyl (5c) [6460-92-0]: 1-Chloro-2-
nitrobenzene (0.25 g, 1.59 mmol), 2-methoxyphenylboronic acid
(0.362 g, 2.38 mmol), Na2CO3 (0.185 g, 1.75 mmol), TBAB (0.041 g,
0.13 mmol), and Pd(PPh3)4 (0.048 g, 0.042 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 10:90) as a
pale green solid (0.264 g, 73 %), m.p. 78.9 °C. Rf = 0.53 (EtOAc/
hexane, 20:80). 1H NMR (400 MHz, CDCl3): δ = 7.92–7.94 (dd, J =
1.2, 8 Hz, 1 H), 7.63–7.66 (td, J = 1.2, 7.6 Hz, 1 H), 7.45–7.49 (td, J =
1.6, 8 Hz, 1 H), 7.37–7.43 (m, 4 H), 7.31–7.33 (dd, J = 1.6, 7.2 Hz, 1
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H), 7.01–7.11 (td, J = 1.2, 7.6 Hz, 1 H), 6.90–6.93 (dd, J = 0.8, 8.4 Hz,
1 H), 3.71 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 155.8, 149.7,
133.1, 132.8, 132.5, 129.8, 129.7, 128, 127, 123.9, 121.2, 110.6,
55.2 ppm. MS (EI): m/z (%) = 231.2 (3), 230.2 (25), 229 (98) [M+],
197.9 (47), 184 (33), 170 (82), 168 (99), 152 (50), 139 (100), 115 (86),
89 (26), 77 (35), 63 (45). IR: ν̃ = 2950, 1500, 1355 cm–1. The recorded
spectroscopic data were in accordance with the literature.[35]
2-Methyl-2′-nitro-1,1′-biphenyl (5d) [67992-12-5]: 1-Chloro-2-
nitrobenzene (0.25 g, 1.59 mmol), 2-methylphenylboronic acid
(0.324 g, 2.38 mmol), Na2CO3 (0.185 g, 1.75 mmol), TBAB (0.041 g,
0.127 mmol), and Pd(PPh3)4 (0.048 g, 0.042 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 5:95) as a
yellow liquid (0.3112 g, 92 %). Rf = 0.53 (EtOAc/hexane, 20:80). 1H
NMR (400 MHz, CDCl3): δ = 7.90–7.93 (dd, J = 1.2, 8.4 Hz, 1 H), 7.53–
7.58 (td, J = 1.2, 7.6 Hz, 1 H), 7.42–7.46 (td, J = 1.6, 8 Hz, 1 H), 7.24–
7.27 (dd, J = 1.6, 8 Hz, 1 H), 7.13–7.23 (m, 3 H), 7.01–7.03 (dd, J =
0.8, 7.6 Hz, 1 H), 2.03 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
149.1, 137.5, 136.5, 135.6, 132.6, 132.2, 130, 128.3, 128.2, 125.8,
124.1, 19.9 ppm. MS (EI): m/z (%) = 214.2 (2), 213 (15) [M+], 195.9
(48), 166.1 (64), 164.9 (100), 151.6 (39), 139 (19), 115 (28), 88.9 (12),
82.2 (43), 63 (18). IR: ν̃ = 3062, 2360, 2342, 1521, 1346 cm–1. The
recorded spectroscopic data were in accordance with the litera-
ture.[25]
4-Methyl-2-nitro-1,1′-biphenyl (5e) [39554-87-5]: 4-Chloro-3-
nitrotoluene (0.25 g, 1.46 mmol), phenylboronic acid (0.267 g,
2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.12 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 10:90) as a
pale orange liquid (0.239 g, 77 %). Rf = 0.63(EtOAc/hexane, 20:80).
1H NMR (400 MHz, CDCl3): δ = 7.67 (s, 1 H), 7.39–7.44 (m, 4 H), 7.30–
7.34 (m, 3 H), 2.47 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
149.1, 138.7, 137.4, 133.5, 133.1, 131.8, 128.7, 128, 127.9, 124.4,
20.9 ppm. MS (EI): m/z (%) = 214.2 (7), 212.8 (52) [M+], 184.5 (81),
164 (98), 151.4 (100), 127.1 (99), 1149 (52), 90.7 (31), 88.8 (41), 82
(68), 76.5 (71). IR: ν̃ = 3028, 1523, 1351 cm–1. The recorded spectro-
scopic data were in accordance with the literature.[36]
4′-Chloro-4-methyl-2-nitro-1,1′-biphenyl (5f): 4-Chloro-3-nitro-
toluene (0.25 g, 1.46 mmol), 4-chlorophenylboronic acid (0.342 g,
2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.12 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 10:90) as a
yellow liquid (0.291 g, 80 %). Rf = 0.63 (EtOAc/hexane, 20:80). 1H
NMR (400 MHz, CDCl3): δ = 7.69 (s, 1 H), 7.41–7.44 (dd, J = 1.2, 8 Hz,
1 H), 7.37–7.40 (m, 2 H), 7.28 (d, J = 7.6 Hz, 1 H), 7.21–7.24 (m, 2 H),
2.47 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 148.9, 139.2, 136,
134.2, 133.3, 132.4, 131.6, 129.3, 128.9, 124.6, 20.9 ppm. HRMS (EI):
calcd. for C13H10ClNO2 247.0400; found 247.0400. IR: ν̃ = 2924, 1525,
1347, 817 cm–1.
4′-Ethyl-4-methyl-2-nitro-1,1′-biphenyl (5g): 4-Chloro-3-nitrotol-
uene (0.25 g, 1.46 mmol), 4-ethylphenylboronic acid (0.328 g,
2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.12 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 10:90) as a
yellow solid (0.327 g, 93 %), m.p. 53.6 °C. Rf = 0.73(EtOAc/hexane,
20:80). 1H NMR (400 MHz, CDCl3): δ = 7.68 (s, 1 H), 7.44–746 (dd,
J = 1.2, 8 Hz, 1 H), 7.36–7.38 (d, J = 8 Hz, 1 H), 7.26–7.31 (m, 4 H),
2.74 (q, J = 7.6 Hz, 2 H), 2.51 (s, 3 H), 1.32 (t, J = 7.6 Hz, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 149.2, 144.2, 138.4, 134.6, 133.4,
133, 131.7, 128.2, 127.9, 124.3, 28.6, 20.9, 15.4 ppm. HRMS (ESI):
calcd. for C15H15NO2Na [M + Na+] 264.1000; found 260.1001. IR: ν̃ =
2969, 2932, 1525, 1354 cm–1.
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2′,4-Dimethyl-2-nitro-1,1′-biphenyl (5h): 4-Chloro-3-nitrotoluene
(0.25 g, 1.46 mmol), 2-methylphenylboronic acid (0.298 g,
2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.12 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 10:90) as a
yellow liquid (0.280 g, 85 %). Rf = 0.71 (EtOAc/hexane, 20:80). 1H
NMR (400 MHz, CDCl3): δ = 7.73 (s, 1 H), 7.35–7.37 (dd, J = 1.2,
7.2 Hz, 1 H), 7.12–7.22 (m, 4 H), 7.00–7.01 (dd, J = 1.2, 8.4 Hz, 1 H),
2.41 (s, 3 H), 2.02 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 148.9,
138.7, 137.5, 135.8, 133.6, 133.4, 132, 129.9, 128.4, 128, 125.7, 124.4,
21, 19.9 ppm. HRMS (ESI): calcd. for C14H13NO2Na [M + Na+]
250.0844; found 250.0845. IR: ν̃ = 2923, 1524, 1349 cm–1.
2′-Methoxy-4-methyl-2-nitro-1,1′-biphenyl (5i): 4-Chloro-3-nitro-
toluene (0.25 g, 1.46 mmol), 2-methoxyphenylboronic acid (0.333 g,
2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g, 0.12 mmol)
and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title compound was iso-
lated by chromatography (EtOAc/hexane, 10:90) as a pale-yellow
solid (0.265 g, 75 %), m.p. 101 °C. Rf = 0.61 (EtOAc/hexane, 20:80).
1H NMR (400 MHz, CDCl3): δ = 7.75 (s, 1 H), 7.43–7.45 (dd, J = 0.8,
7.6 Hz, 1 H), 7.35–7.39 (td, J = 1.6, 8 Hz, 1 H), 7.28–7.31 (m, 2 H),
7.05–7.09 (td, J = 1.2, 7.6 Hz, 1 H), 6.90 (d, J = 8 Hz, 1 H), 3.70 (s, 3
H), 2.46 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 155.9, 149.5,
138.5, 133.5, 132.3, 130.1, 129.7, 129.6, 127, 124.3, 121.2, 110.6, 55.2,
20.9 ppm. HRMS (ESI): calcd. for C14H13NO3Na [M + Na+] 266.0793;
found 266.0795. IR: ν̃ = 2963, 2835, 1501, 1356 cm–1.
(2-Nitro-1,1′-biphenyl-4-yl)(phenyl)methanone (5j) [857493-17-
5]: 4-Chloro-3-nitrobenzophenone (0.25 g, 0.96 mmol), phenyl-
boronic acid (0.176 g, 1.44 mmol), Na2CO3 (0.112 g, 1.06 mmol),
TBAB (0.025 g, 0.08 mmol), and Pd(PPh3)4 (0.029 g, 0.025 mmol).
The title compound was isolated by chromatography (EtOAc/hex-
ane, 10:90) as a pale yellow crystalline solid (0.260 g, 89 %), m.p.
115.8 °C. Rf = 0.61 (EtOAc/hexane, 20:80). 1H NMR (400 MHz, CDCl3):
δ = 8.26 (d, J = 1.6 Hz, 1 H), 8.05–8.07 (dd, J = 2, 8 Hz, 1 H), 7.84–
7.86 (dd, J = 0.8, 8 Hz, 2 H), 7.64–7.68 (m, 1 H), 7.53–7.61 (m, 3 H),
7.45–7.48 (m, 3 H), 7.36–7.39 (m, 2 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 193.9, 149.1, 139.8, 137.5, 136.4, 136.4, 133.3, 133.2,
132.2, 130, 128.9, 128.8, 127.8, 125.6 ppm. MS (EI): m/z (%) = 304.3
(1), 302.9 (9) [M+], 274.8 (28), 258 (6), 225.9 (7), 207 (9), 197.9 (6),
170 (16), 150.6 (22), 138.9 (8), 105 (98), 78.3 (5), 76.9 (100), 62.7 (5),
50.9 (17). IR: ν̃ = 1661, 1515, 1360 cm–1. The recorded spectroscopic
data were in accordance with the literature.[6d]
2-Nitro-1,1′-biphenyl-4-carboxylic Acid (5k) [99847-12-8]: 4-
Chloro-3-nitrobenzoic acid (0.25 g, 1.24 mmol), phenylboronic acid
(0.226 g, 1.85 mmol), Na2CO3 (0.145 g, 1.37 mmol), TBAB (0.032 g,
0.10 mmol), and Pd(PPh3)4 (0.037 g, 0.032 mmol) were added. The
reaction mixture was carefully flushed with argon before adding a
mixture of MeOH (4 mL) and water (1 mL). The tube was sealed
and placed into the microwave cavity for 30 min at 120 °C. After
this time, the reaction mixture was cooled to room temp. and the
solvent was removed under reduced pressure. Then the reaction
mixture was washed with water (40 mL) and acidified with HCl (1 N,
pH = 1–2) and filtered. The obtained solid contains both acid com-
pound and biphenyl (impurity). Water (5 mL) was added to the
flask, which contained the obtained solid. The solid was basified
with NaOH (4 M; pH = 10–12) and extracted with CH2Cl2 (2 × 40 mL).
The aqueous layer was then acidified with HCl (1 N; pH = 1–2) and
filtered to afford compound 5k as a pale yellow solid (0.215 g,
72 %), m.p. 189.9 °C. 1H NMR (400 MHz, CDCl3): δ = 8.58 (d, J =
1.6 Hz, 1 H), 8.33–8.36 (dd, J = 1.6, 8.0 Hz, 1 H), 7.61 (d, J = 8.0 Hz,
1 H), 7.45–7.49 (m, 3 H), 7.35–7.37 (m, 2 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 169.5, 149.4, 141.3, 136.2, 133.4, 132.5, 129.5, 129.1, 129,
127.7, 125.9 ppm. HRMS (ESI–): calcd for C13H8NO4 [M+ – H]
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242.0453; found 242.0455. IR: ν̃ = 2515, 1693, 1537, 1350 cm–1. The
recorded spectroscopic data were in accordance with the litera-
ture.[6d]
2′-Nitro-1,1′-biphenyl-4-carbaldehyde (5l) [169188-17-4]: 1-
Chloro-2-nitrobenzene (0.25 g, 1.59 mmol), 4-formylphenylboronic
acid (0.358 g, 2.39 mmol), Na2CO3 (0.185 g, 1.75 mmol), TBAB
(0.041 g, 0.127 mmol), and Pd(PPh3)4 (0.048 g, 0.042 mmol). The
title compound was isolated by chromatography (CH2Cl2/hexane,
50:50) as yellow crystals (0.287 g, 80 %), m.p. 102.3 °C. Rf = 0.33
(CH2Cl2/hexane, 50:50). 1H NMR (400 MHz, CDCl3): δ = 10.01 (s, 1
H), 7.93–7.96 (m, 3 H), 7.66–7.70 (td, J = 1.2, 7.2 Hz, 1 H), 7.54–7.58
(td, J = 1.2, 8 Hz, 1 H), 7.48–7.50 (dd, J = 1.6, 6.4 Hz, 2 H), 7.44–7.46
(dd, J = 1.6, 8 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 191.8,
148.8, 143.8, 135.8, 135.4, 132.9, 131.7, 130, 129.1, 128.7, 124.5 ppm.
MS (EI): m/z (%) = 226.7 (95) [M+], 210 (62), 198.6 (100), 168.5 (99),
150.1 (100), 113.8 (99), 101.2 (92), 74.3 (99). IR: ν̃ = 2859, 1693, 1505,
1351 cm–1.
4′-Methyl-2′-nitro-1,1′-biphenyl-4-carbaldehyde (5m): 4-Chloro-
3-nitrotoluene (0.25 g, 1.46 mmol), 4-formylphenylboronic acid
(0.328 g, 2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.117 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (CH2Cl2/hexane, 40:60) as
yellow crystals (0.309 g, 88 %), m.p. 106 °C. Rf = 0.29 (CH2Cl2/hexane,
50:50). 1H NMR (400 MHz, CDCl3): δ = 10.05 (s, 1 H), 7.91–7.93 (m,
2 H), 7.76 (s, 1 H), 7.45–7.48 (m, 3 H), 7.32 (d, J = 8 Hz, 1 H), 2.49 (s,
3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 191.8, 148.6, 143.9, 139.8,
135.7, 133.5, 132.5, 131.5, 129.8, 128.7, 124.9, 21 ppm. HRMS (ESI):
calcd. for C14H11NO3Na (MeOH) [M + Na+] 296.0899; found
296.0899. IR: ν̃ = 2854, 2750, 1696, 1521, 1351 cm–1.
4′-Methyl-2′-nitro-1,1′-biphenyl-4-ol (5n) [1620094-10-1]: 4-
Chloro-3-nitrotoluene (0.25 g, 1.46 mmol), 4-hydroxyphenylboronic
acid (0.302 g, 2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB
(0.038 g, 0.117 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The
title compound was isolated by chromatography (CH2Cl2/hexane,
80:20) as a dark yellow liquid (0.208 g, 62 %). Rf = 0.26 (CH2Cl2/
hexane, 90:10). 1H NMR (400 MHz, CDCl3): δ = 7.61 (s, 1 H), 7.38–
7.40 (dd, J = 0.8, 8 Hz, 1 H), 7.30 (d, J = 7.6 Hz, 1 H), 7.15–7.19 (m,
2 H), 6.84–6.88 (m, 2 H), 5.52 (s, 1 H), 2.45 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 155.7, 149.2, 138.3, 133, 131.7, 129.6, 129.3,
124.3, 115.7, 20.8 ppm. MS (EI): 231.2 (1), 230.2 (10), 228.9 (100)
[M+], 212 (26), 196 (8), 183.9 (57), 167.9 (35), 151.7 (49), 127.4 (56),
114.9 (32), 77 (22), 75.6 (30). IR: ν̃ = 3284, 1701, 1520, 1355 cm–1.
4-Methyl-2-nitro-4′-vinyl-1,1′-biphenyl (5o): 4-Chloro-3-nitrotolu-
ene (0.25 g, 1.46 mmol), 4-vinylphenylboronic acid (0.324 g,
2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.117 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (CH2Cl2/hexane, 40:60) as
yellow crystals (0.265 g, 76 %), m.p. 73.6 °C. Rf = 0.69 (CH2Cl2/hex-
ane, 50:50). 1H NMR (400 MHz, CDCl3): δ = 7.58 (s, 1 H), 7.32–7.38
(m, 3 H), 7.24 (d, J = 8 Hz, 1 H), 7.17–7.20 (m, 2 H), 6.63–6.70 (m, 1
H), 5.69–5.74 (dd, J = 0.4, 17.6 Hz, 1 H), 5.20–5.23 (m, 1 H), 2.38 (s,
3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 149.1, 138.7, 137.3, 136.8,
136.2, 133.1, 133.1, 131.6, 128.1, 126.5, 124.5, 114.6, 20.9 ppm.
HRMS (ESI): calcd. for C15H13NO2Na [M + Na+] 262.0844; found
262.0845. IR: ν̃ = 3064, 1514, 1359 cm–1.
4′-Methyl-2′-nitro-1,1′-biphenyl-2-carbonitrile (5p): 4-Chloro-3-
nitrotoluene (0.25 g, 1.46 mmol), 2-cyanophenylboronic acid
(0.322 g, 2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB (0.038 g,
0.117 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The title com-
pound was isolated by chromatography (CH2Cl2/hexane, 50:50) as
pale-yellow crystals (0.110 g, 32 %), m.p. 97.6 °C. Rf = 0.39 (CH2Cl2/
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hexane, 50:50). 1H NMR (400 MHz, CDCl3): δ = 7.96 (s, 1 H), 7.74–
7.77 (dd, J = 1.2, 8 Hz, 1 H), 7.61–7.65 (td, J = 1.6, 8 Hz, 1 H), 7.48–
7.54 (m, 2 H), 7.31–7.34 (m, 2 H), 2.52 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 148, 142.2, 140.7, 134.1, 132.9, 132.7, 132,
130.5, 129, 128.3, 125.4, 117.6, 112.3, 21.1 ppm. HRMS (ESI): calcd.
for C14H10N2O2Na [M + Na+] 261.0640; found 261.0641. IR: ν̃ = 2919,
2360, 2340, 2233, 1519, 1351 cm–1.
N,N-4′-Trimethyl-2′-nitro-1,1′-biphenyl-4-amine (5q): 4-Chloro-3-
nitrotoluene (0.25 g, 1.46 mmol), 4-(dimethylamino)phenylboronic
acid (0.361 g, 2.19 mmol), Na2CO3 (0.170 g, 1.60 mmol), TBAB
(0.038 g, 0.117 mmol), and Pd(PPh3)4 (0.044 g, 0.038 mmol). The
title compound was isolated by chromatography (CH2Cl2/hexane,
30:70) as dark orange crystals (0.201 g, 53 %), m.p. 136 °C. Rf = 0.24
(CH2Cl2/hexane, 30:70). 1H NMR (400 MHz, CDCl3): δ = 7.57 (s, 1 H),
7.31–7.38 (m, 2 H), 7.17–7.21 (m, 2 H), 6.76 (d, J = 8.8 Hz, 2 H), 2.99
(s, 6 H), 2.43 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 150.1,
149.2, 137.4, 133.4, 132.8, 131.6, 128.7, 124.8, 124.3, 112.5, 40.5,
20.8 ppm. HRMS (ESI): calcd. for C15H17N2O2H [M + H+] 257.1290;
found 257.1291. IR: ν̃ = 2880, 2811, 1610, 1521, 1361 cm–1.
Suzuki Cross-Coupling Reaction with Bromobenzenes
4′-Chloro-4-methoxy-2-nitro-1,1′-biphenyl (5r) [41734-95-6]: 1-
Bromo-4-methoxy-2-nitrobenzene (0.25 g, 1.08 mmol), (4-chloro-
phenyl)boronic acid (0.253 g, 1.62 mmol), Na2CO3 (0.126 g,
1.19 mmol), TBAB (0.028 g, 0.087 mmol), and Pd(PPh3)4 (0.032 g,
0.028 mmol). The title compound was isolated by chromatography
(EtOAc/hexane, 10:90) as a yellow solid (0.275 g, 95 %), m.p. 77.8 °C.
Rf = 0.40 (EtOAc/hexane, 10:90). 1H NMR (500 MHz, CDCl3): δ = 7.38–
7.39 (m, 2 H), 7.36 (s, 1 H), 7.30 (d, J = 8.5 Hz, 1 H), 7.20–7.21 (m, 2
H), 7.14–7.16 (dd, J = 2.5, 8.5 Hz,1 H), 3.90 (s, 3 H) ppm. 13C NMR
(125 MHz, CDCl3): δ = 159.4, 149.5, 135.9, 134.0, 132.7, 129.4, 128.8,
127.5, 118.8, 109.2, 56.0 ppm. MS (EI): m/z (%) = 265 (38), 263 (87)
[M+], 246 (15), 228 (28), 200 (36), 182 (45), 170 (37), 139 (100), 113
(14), 75 (13), 69 (31). IR: ν̃ = 3084, 3017, 2983, 2942, 2841, 1529,
1358, 817 cm–1.
4-Methoxy-2-nitro-1,1′-biphenyl (5s) [16098-16-1]: 1-Bromo-4-
methoxy-2-nitrobenzene (0.25 g, 1.08 mmol), phenylboronic acid
(0.198 g, 1.62 mmol), Na2CO3 (0.126 g, 1.19 mmol), TBAB (0.028 g,
0.087 mmol), and Pd(PPh3)4 (0.032 g, 0.028 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 5:95) as
dark yellow crystals (0.223 g, 90 %), m.p. 72.1 °C. Rf = 0.45 (EtOAc/
hexane, 10:90). 1H NMR (500 MHz, CDCl3): δ = 7.37–7.42 (m, 4 H),
7.34 (d, J = 8.5, 7.6 Hz, 1 H), 7.27–7.29 (m, 2 H), 7.14–7.16 (dd, J =
2.5, 8.5 Hz,1 H), 3.90 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ =
159.1, 149.7, 137.3, 132.8, 128.7, 128.6, 128.0, 127.9, 118.7, 109.0,
55.9 ppm. MS (EI): m/z (%) = 229 (85) [M+], 212 (58), 201 (34), 184
(53), 168 (74), 139 (100), 128 (78), 102 (23), 63 (36). IR: ν̃ = 2917,
2849, 1526, 1346 cm–1.
2′-Chloro-4-methyl-2-nitro-1,1′-biphenyl (5t): 1-Bromo-4-methyl-
2-nitrobenzene (0.25 g, 1.16 mmol), (2-chlorophenyl)boronic acid
(0.272 g, 1.74 mmol), Na2CO3 (0.135 g, 1.27 mmol), TBAB (0.030 g,
0.09 mmol), and Pd(PPh3)4 (0.035 g, 0.030 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 5:95) as
light brown crystals (0.256 g, 90 %), m.p. 72.6 °C. Rf = 0.55 (EtOAc/
hexane, 10:90). 1H NMR (500 MHz, CDCl3): δ = 7.91 (s, 1 H), 7.47–
7.49 (dd, J = 0.5, 7.5 Hz, 1 H), 7.44–7.45 (m, 1 H), 7.32–7.34 (m, 2 H),
7.24–7.26 (m, 2 H), 2.50 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 148.4, 139.6, 137.2, 133.7, 132.9, 132.2, 131.5, 130.0, 129.4, 129.3,
126.9, 124.8, 21.0 ppm. HRMS (DART): calcd. for C13H1135ClNO2 [M
+ H+] 248.0478; found 248.0478, calcd. for C13H1137ClNO2 250.0478;
found 248.0449 IR: ν̃ = 3057, 2922, 1522, 1352, 754 cm–1.
3′-Methoxy-4-methyl-2-nitro-1,1′-biphenyl (5u) [943620-21-1]:
1-Bromo-4-methyl-2-nitrobenzene (0.25 g, 1.16 mmol), (3-methoxy-
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phenyl)boronic acid (0.264 g, 1.74 mmol), Na2CO3 (0.135 g,
1.27 mmol), TBAB (0.030 g, 0.09 mmol), and Pd(PPh3)4 (0.035 g,
0.030 mmol). The title compound was isolated by chromatography
(EtOAc/hexane, 5:95) as a yellow liquid (0.255 g, 90 %). Rf = 0.48
(EtOAc/hexane, 10:90). 1H NMR (500 MHz, CDCl3): δ = 7.64 (s, 1 H),
7.40–7.41 (dd, J = 1, 8 Hz, 1 H), 7.30–7.33 (m, 2 H), 6.91–6.93 (m, 1
H), 6.86–6.88 (dd, J = 1, 7.5 Hz, 1 H), 6.83–6.84 (m, 1 H), 3.81 (s, 3
H), 2.46 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 159.7, 149.2,
138.8, 138.7, 133.3, 133.0, 131.6, 129.7, 124.3, 120.3, 113.7, 113.5,
55.3, 20.9 ppm. MS (EI): m/z (%) = 243 (73) [M+], 215 (65), 184 (41),
172 (54), 152 (100), 144 (55), 115 (52), 76 (28), 63 (33), 55 (66). IR:
ν̃ = 2938, 2836, 1525, 1355 cm–1.
4,4′-Dichloro-2-nitro-1,1′-biphenyl (5v) [192942-45-3]: 1-Bromo-
4-chloro-2-nitrobenzene (0.25 g, 1.06 mmol), (4-chlorophenyl)-
boronic acid (0.249 g, 1.59 mmol), Na2CO3 (0.124 g, 1.17 mmol),
TBAB (0.027 g, 0.084 mmol), and Pd(PPh3)4 (0.032 g, 0.028 mmol).
The title compound was isolated by chromatography (EtOAc/hex-
ane, 5:95) as a yellow solid (0.232 g, 82 %), m.p. 87.1 °C. Rf = 0.56
(EtOAc/hexane, 10:90). 1H NMR (500 MHz, CDCl3): δ = 7.88 (d, J =
2.5 Hz, 1 H), 7.59–7.61 (dd, J = 2, 8.5 Hz, 1 H), 7.39–7.41 (dd, J = 2,
6.5 Hz, 2 H), 7.36 (d, J = 8 Hz, 1 H), 7.21–7.22 (dd, J = 2, 6.5 Hz, 2
H) ppm. 13C NMR (125 MHz, CDCl3): δ = 149.3, 134.9, 134.8, 134.4,
133.7, 132.9, 132.6, 129.2, 129.1, 124.4 ppm. MS (EI): m/z (%) = 269
(28), 267 (43) [M+], 232 (31), 204 (54), 186 (100), 176 (43), 150 (89),
139 (51), 93 (45), 75 (94). IR: ν̃ = 3091, 1518, 13548, 815 cm–1.
4-Chloro-2-nitro-1,1′-biphenyl (5w) [29608-78-4]: 1-Bromo-4-
chloro-2-nitrobenzene (0.25 g, 1.06 mmol), phenylboronic acid
(0.194 g, 1.59 mmol), Na2CO3 (0.124 g, 1.17 mmol), TBAB (0.027 g,
0.084 mmol), and Pd(PPh3)4 (0.032 g, 0.028 mmol). The title com-
pound was isolated by chromatography (EtOAc/hexane, 5:95) as a
yellow liquid (0.220 g, 89 %). Rf = 0.69(EtOAc/hexane, 10:90). 1H
NMR (500 MHz, CDCl3): δ = 7.85 (d, J = 2 Hz, 1 H), 7.58–7.60 (dd,
J = 2.5, 8.5 Hz, 1 H), 7.38–7.43 (m, 4 H), 7.28–7.29 (m, 2 H) ppm. 13C
NMR (125 MHz, CDCl3): δ = 149.5, 136.3, 134.8, 133.0, 132.4, 129.2,
128.8, 128.6, 127.8, 124.2 ppm. MS (EI): m/z (%) = 235 (10), 233 (30)
[M+], 216 (40), 205 (48), 188 (26), 168 (52), 152 (100), 115 (60), 75
(56), 63 (40). IR: ν̃ = 3063, 3028, 1529, 1349, 773 cm–1.
1-(2-Nitro-1,1′-biphenyl-4-yl)ethan-1-one (5x) [42771-77-7]: 1-
(4-bromo-3-nitrophenyl)ethan-1-one (0.25 g, 1.02 mmol), phenyl-
boronic acid (0.187 g, 1.59 mmol), Na2CO3 (0.119 g, 1.12 mmol),
TBAB (0.026 g, 0.080 mmol), and Pd(PPh3)4 (0.031 g, 0.027 mmol).
The title compound was isolated by chromatography (EtOAc/hex-
ane, 10:90) as a yellow solid (0.246 g, 83 %), m.p. 106.7 °C. Rf =
0.17(EtOAc/hexane, 10:90). 1H NMR (500 MHz, CDCl3): δ = 8.39 (d,
J = 1.5 Hz, 1 H), 8.17–8.19 (dd, J = 2, 8 Hz, 1 H), 7.57 (d, J = 8 Hz, 1
H), 7.44–7.46 (m, 3 H), 7.32–7.34 (m, 2 H), 2.68 (s, 3 H) ppm. 13C
NMR (125 MHz, CDCl3): δ = 195.4, 149.5, 140.4, 136.8, 136.3, 132.5,
131.4, 129.0, 128.9, 127.7, 124.0, 26.7 ppm. MS (EI): m/z (%) = 241
(31) [M+], 224 (35), 213 (54), 198 (39), 170 (46), 151 (100), 142 (47),
139 (35), 115 (33), 76 (25), 63 (31). IR: ν̃ = 3095, 1683, 1519,
1352 cm–1. The recorded spectroscopic data were in accordance
with the previously disclosed 1H NMR spectroscopic data.[6d]
1-(4′-Chloro-2-nitro-1,1′-biphenyl-4-yl)ethan-1-one (5y) [52806-
84-5]: 1-(4-Bromo-3-nitrophenyl)ethan-1-one (0.25 g, 1.02 mmol),
(4-chlorophenyl)boronic acid (0.239 g, 1.59 mmol), Na2CO3 (0.119 g,
1.12 mmol), TBAB (0.026 g, 0.080 mmol) and Pd(PPh3)4 (0.031 g,
0.027 mmol). The title compound was isolated by chromatography
(EtOAc/hexane, 10:90) as a yellow solid (0.220 g, 80 %), m.p.
101.3 °C. Rf = 0.14(EtOAc/hexane, 10:90). 1H NMR (500 MHz, CDCl3):
δ = 8.42 (d, J = 2 Hz, 1 H), 8.18–8.20 (dd, J = 1.5, 8 Hz, 1 H), 7.54
(d, J = 8 Hz, 1 H), 7.43–7.44 (dd, J = 1.5, 6.5 Hz, 2 H), 7.26–7.28 (dd,
J = 1.5, 6.5 Hz, 2 H), 2.69 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3):
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δ = 195.2, 149.3, 139.2, 137.1, 135.3, 134.8, 132.4, 131.5, 129.2, 129.1,
124.1, 26.7 ppm. MS (EI): m/z (%) = 277 (36), 275 (94) [M+], 260 (47),
240 (69), 214 (48), 186 (72), 179 (91), 170 (58), 151 (100), 139 (55),
75 (98). IR: ν̃ = 3073, 1698, 1521, 1350, 817 cm–1.
1-(2′-Methyl-2-nitro-1,1′-biphenyl-4-yl)ethan-1-one (5z): 1-(4-
Bromo-3-nitrophenyl)ethan-1-one (0.25 g, 1.02 mmol), 2-methyl-
phenylboronic acid (0.208 g, 1.53 mmol), Na2CO3 (0.119 g,
1.12 mmol), TBAB (0.026 g, 0.080 mmol), and Pd(PPh3)4 (0.031 g,
0.027 mmol). The title compound was isolated by chromatography
(EtOAc/hexane, 15:85) as a yellow solid (0.216 g, 83 %), m.p. 59.5 °C.
Rf = 0.22(EtOAc/hexane, 10:90). 1H NMR (400 MHz, CDCl3): δ = 8.46
(d, J = 2 Hz, 1 H), 8.12–8.15 (dd, J = 2, 10 Hz, 1 H), 7.40 (d, J =
9.5 Hz, 1 H), 7.16–7.28 (m, 3 H), 7.00–7.02 (dd, J = 1, 9.5 Hz, 1 H),
2.64 (s, 3 H), 2.03 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 195.5,
149.3, 140.9, 137.0, 136.5, 135.3, 132.9, 131.6, 130.2 128.7, 127.9,
125.9, 124.0, 26.7, 19.9 ppm. HRMS (DART): calcd. for C15H14NO3
[M + H+] 256.0974; found 256.0974. IR: ν̃ = 2923, 1689, 1529,
1351 cm–1.
1-(2′-Methoxy-2-nitro-1,1′-biphenyl-4-yl)ethan-1-one (5æ): 1-(4-
Bromo-3-nitrophenyl)ethan-1-one (0.25 g, 1.02 mmol), (2-methoxy-
phenyl)boronic acid (0.232 g, 1.53 mmol), Na2CO3 (0.119 g,
1.12 mmol), TBAB (0.026 g, 0.080 mmol), and Pd(PPh3)4 (0.031 g,
0.027 mmol). The title compound was isolated by chromatography
(EtOAc/hexane, 15:85) as a yellow solid (0.216 g, 83 %), m.p.
113.1 °C. Rf = 0.14(EtOAc/hexane, 10:90). 1H NMR (400 MHz, CDCl3):
δ = 8.40 (d, J = 2 Hz, 1 H), 8.12–8.14 (dd, J = 2, 10 Hz, 1 H), 7.46 (d,
J = 10 Hz, 1 H), 7.33–7.37 (m, 1 H), 7.25–7.27 (dd, J = 2, 9 Hz, 1 H),
7.02–7.06 (td, J = 1, 9.5 Hz, 1 H), 6.85 (d, J = 10 Hz, 1 H), 3.63 (s, 3
H), 2.61 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 195.7, 155.7,
149.8, 137.5, 136.6, 133.0, 131.8, 130.6, 129.6, 126.0, 123.8, 121.4,
110.7, 55.2, 26.7 ppm. HRMS (DART): calcd. for C15H14NO4 [M + H+]
272.0923; found 272.0923. IR: ν̃ = 2910, 1689, 1537, 1363 cm–1.
1-(4′-Ethyl-2-nitro-1,1′-biphenyl-4-yl)ethan-1-one (5ø): 1-(4-
Bromo-3-nitrophenyl)ethan-1-one (0.25 g, 1.02 mmol), (4-ethyl-
phenyl)boronic acid (0.229 g, 1.53 mmol), Na2CO3 (0.119 g,
1.12 mmol), TBAB (0.026 g, 0.080 mmol), and Pd(PPh3)4 (0.031 g,
0.027 mmol). The title compound was isolated by chromatography
(EtOAc/hexane, 10:90) as yellow crystals (0.205 g, 75 %), m.p.
79.3 °C. Rf = 0.19(EtOAc/hexane, 10:90). 1H NMR (500 MHz, CDCl3):
δ = 8.36 (d, J = 1.5 Hz, 1 H), 8.15–8.17 (dd, J = 1.5, 8 Hz, 1 H), 7.57
(d, J = 8 Hz, 1 H), 7.25–7.29 (m, 4 H), 2.71 (q, J = 7.5 Hz, 2 H), 2.67
(s, 3 H), 1.28 (t, J = 8 Hz, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ =
195.4, 149.5, 145.3, 140.4, 136.5, 133.5, 132.4, 131.3, 128.5, 127.7,
123.9, 28.6, 26.7, 15.3 ppm. HRMS (DART): calcd. for C16H16NO3 [M
+ H+] 270.1130; found 270.1130. IR: ν̃ = 2965, 2929, 2870, 1689,
1532, 1356 cm–1.
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a b s t r a c t
An improved and simplified In-based protocol for the reduction of 2-nitro-1,10-biphenyls to the corre-
sponding 2-amino-1,10-biphenyls is disclosed. The method utilizes only a stoichiometric quantity of
indium powder as the reducing reagent along with a stoichiometric quantity of ammonium chloride.
The work-up is very simple, it requires only a simple filtration of the post-reaction mixture whereupon
the reaction medium is removed under reduced pressure. The method was also proven to operate with a
variety of functional groups to provide high to excellent yields of the target 2-amino-1,10-biphenyls. A
proposal for a reaction mechanism is also provided.
 2016 Elsevier Ltd. All rights reserved.
Introduction
For a project dedicated to the synthesis of the 1H-carbazole
scaffold, we have previously disclosed a highly efficient method
for the synthesis of 2-nitro-1,10-biphenyls by means of the Suzuki
cross coupling reaction (Scheme 1).1 For the subsequent step,
which encompasses reduction of the 2-nitro-1,10-biphenyl inter-
mediate to the corresponding 2-amino-1,10-biphenyl, we were
searching for a reliable, simple, and efficient reduction method.
To approach the target 1H-carbazole frameworks, we planned to
use the combined C–H functionalization and C–N bond formation
as disclosed by Buchwald and collaborators,2 or the newly reported
iridium(III) catalyzed intramolecular C–H amination method by
Miura and collaborator.3
Numerous methods exist for the Ph—NO2? Ph—NH2 transfor-
mation, including catalytic hydrogenation with Pd/C4 or Raney
nickel,5 Pd catalyzed reduction using silicon hydride as the reduc-
ing agent,6 and the Bechamp reduction that involves treatment of
the nitroaromatic with iron and hydrochloric acid.7
Additionally, protocols encompassing either SnCl2,
9 TiCl3,
10 Zn,11
Sm,12 or sodium dithionite (Na2S2O4)
13 as reducing agents consti-
tute functioning methods developed for the nitroarene to aniline
transformation. A method disclosed by Moody and collaborators14
attracted our attention due to its simplicity involving the treatment
of nitroarene with elemental In in an ammonium chloride solution.
Results and discussion
In order to utilize the Moody method,14 a highly diluted sub-
strate mixture in ethanol should be treated with a large excess of
indium powder and a saturated solution of aqueous ammonium
chloride for a long reaction time, up to 72 h. We began to investi-
gate this method with our substrate 2-nitro-1,10-biphenyl, trials
that proved to function perfectly well. Chromatographic analysis
of the post-reaction mixture revealed full conversion of the sub-
strate to the desired 2-amino-1,10-biphenyl (Scheme 2, entry 1).
However, the subsequent workup procedure required several steps
including filtration, pH adjustment, extraction, solvent removal,
and finally column chromatography, which only provided a low
isolated yield (41%) of our target 2-amino-1,10-biphenyl.
It turned out that the work-up procedure resulted in decompo-
sition or other loss of the target reduction product and in some
occasions we also observed ring closure to give the 1H-carbazole
frameworks, but only in small quantities. Although, with consider-
able challenges to implement this reduction method, we found
http://dx.doi.org/10.1016/j.tetlet.2016.02.007
0040-4039/ 2016 Elsevier Ltd. All rights reserved.
⇑ Corresponding author. Tel.: +47 55 58 34 52; fax: +47 55 58 94 90.















Scheme 1. Outline for the synthesis of 2-amino-1,10-biphenyls,8 a key intermediate
for the synthesis of 1H-carbazoles.
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that it looked attractive due to its simplicity, which spurred us to
explore, adapt, and simplify the Moody method for our amino-
biphenyl application.
To the best of our knowledge, the In reduction method has not
been thoroughly investigated from a mechanistic point of view.
Nevertheless, for us it was reasonable to draw a parallel to the
Zn powder reduction method, which would require two or three
equivalents of In for each nitro group depending on the final oxida-
tion state of the oxidized indium.
Therefore, we reduced the amount of indium, 7? 3.5 equiv, an
alteration that still provided quantitative yields (measured with
GC) of the 2-amino-biphenyl. Further lowering the quantity of In
to only 2 equiv afforded a yield of 87% (GC). This experiment was
repeated with prolonged reaction time, 150 min (Scheme 2, entry
4), which successfully provided the target molecule in quantitative
yields (GC). The achieved results suggested a mechanism where In
ends up at an oxidation state of +3, see our proposal for a mecha-
nism in Scheme 3. During this experimentation we also observed
that the particle size of the indium powder was important in rela-
tion to the reaction rate and overall performance of the reaction.
For the reduction experiments, we utilized a freshly opened con-
tainer of indium powder (100 mesh, 99.99%) to achieve a quantita-
tive conversion in almost all trials. However, the reactivity of the
indium as a reductant was observed to be impaired even at few
days of storage when stored under a normal atmosphere at room
temperature, which we believe is due to surface oxidation.
A scope and limitation of the reduction method was evaluated
by means of a small library of various substituted 2-nitro-1,10-
biphenyls (Table 1). Unfortunately, the hitherto developed method
was revealed to operate in low to medium yields only.
These results (Table 1) encouraged us to further explore the
experimental variables with the goal to improve the outcome.
The reaction temperature was raised (78?120 C) and for this pur-
pose the reaction was conducted in a sealed tube reactor. The sol-
vent (EtOH) volume was lowered (10?4 mL) and a lowered
quantity of ammonium chloride was utilized [16 mmol
(0.85 g)15? 1.03 mmol (0.055 g)]. These conditions were explored
with a library composed of fifteen 2-nitro-1,10-biphenyls (Table 2).
The results show that the method provides high to excellent yields
in all cases and displays a good functional group tolerance. The
achieved results also suggest that the developed method is consis-
tent with the proposed mechanism resulting in an oxidation of In
to In+2 and thus requiring 3 equiv of elemental In.
NO2 NH2
In, t , reflux (78 oC)














a Yield based on GC


































































Scheme 3. Mechanism proposal for the In promoted reduction of the Ar-NO2 group.
Table 1
Introductory exploration of an improved procedure for the reduction of 2-nitro-1,10-
biphenyl to 2-amino-1,10-biphenyl
R2R1
aq. sat NH4Cl, EtOH
NH2
In (2 equiv.), 3 h, Reflux (78 oC)
R2R1
NO2












































a Yield based on GC (isolated yield after column chromatography).
b Additional In powder (2 equiv) and aq satd NH4CI (3 mL) was added after 3 h in
an attempt to attain higher conversion and yield.
Table 2
Exploration of the scope and limitation of the In promoted reduction of 2-nitro-1,10-
biphenyl to 2-amino-1,10-biphenyl8
R2R1




In (3 equiv.), 3 h, 120 oC
R2R1
NO2
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Advantages of the improved indium reduction method com-
prise a considerably simplified work-up and high purity of target
product. When the reduction was completed at 3 h, ethyl acetate
was added to the post reaction mixture and the solid inorganics
could be filtered off. The resulting filtrate was dried over Na2SO4
and the solvent was removed under reduced pressure using a
rotary evaporator. The target 2-amino-1,1-biphenyls were isolated
in yields in the range of 69–96%.
Conclusions
In conclusion, we have explored and improved a method suit-
able for the preparation of 2-amino-1,10-biphenyls by reduction
of the corresponding 2-nitro-1,10-biphenyls. A stoichiometric
quantity of indium powder (3 In: 1 substrate) with ethanol as
the reaction medium was revealed to be necessary. The lowered
reduction reagent loading gives rise to a simple work-up, namely
only filtration of the post reaction mixture followed by evaporation
of the solvent. This is in contrast to previous methods, which
required column chromatography for purification of the reaction
product. Furthermore, the method displays a high functional group
tolerance to provide high to excellent yields, demonstrated with a
series of 2-nitro-1,10-biphenyls. A proposal for a reaction mecha-
nism is described based on analogy with the Zn reduction and
experimental observations, namely the required quantities of the
elemental In as reduction reagent.
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b Product was not isolated, measured by GC.






















































































































and  flame  ionization  detector.  Mass  spectra  were  obtained  on  a  GC‐MS  instrument,  using  a  gas 
chromatograph equipped with fused silica column (l30 m, 0.25 mm i.d., 0.25mm film thickness) and 













MHz, CDCl3): δ= 143.3,  139.1,  138.5,  136.5,  136.3,  130.3,  129.3,  126.6,  124.6,  119.7,  116.3,  113.8, 




2‐nitro‐[1,1'‐biphenyl]‐4‐carboxylic  acid  (0.125  g,  0.515 mmol),  NH4Cl  (0.055  g,  1.03 mmol)  and 
indium powder (0.178 g, 1.55 mmol) .The title compound was obtained as a yellow liquid (0.082 g, 
75%). Rf = 0.17 [(EtOAc:Hx, 30:70)]; 1HNMR (500 MHz, CDCl3): δ=  7.56 (d, J= 7.5 Hz, 1H), 7.44‐7.51 
(m,  5H),  7.37‐7.41  (m,  1H),  7.21  (d,  J=  7.5  Hz,  1H);  13C‐NMR  (125 MHz,  CDCl3);  δ=  171.9,  143.7, 








(m, 2H), 6.81‐6.84  (td,  J= 1 Hz, 7.5Hz, 1H), 6.75‐6.77  (dd,  J= 1 Hz, 8 Hz, 1H);  13C‐NMR (125 MHz, 

















































4'‐chloro‐4‐methoxy‐2‐nitro‐1,1'‐biphenyl  (0.225  g,  0.86 mmol),  NH4Cl  (0.091  g,  1.72 mmol)  and 
indium powder  (0.296  g,  2.58 mmol)    .The  title  compound was  obtained  as  a  dark  yellow  liquid 
(0.191g, 96%); Rf = 0.63 [(EtOAc:Hx, 30:70)]; 1HNMR (500 MHz, CDCl3): δ=  7.35‐7.38 (m, 4H), 7.0 
(d,  J= 8.5 Hz, 1H), 6.39‐6.41 (dd,  J= 2.5Hz, 8 Hz, 1H), 6.30 (d,  J= 2.5Hz, 1H), 3.79 (s, 3H); 13C‐NMR 
(125 MHz, CDCl3): δ= 160.3, 144.6, 137.8, 132.7, 131.3, 130.6, 128.9, 119.5, 104.5, 101.2, 55.2; HR‐




4‐methoxy‐2‐nitro‐1,1'‐biphenyl  (0.217  g,  0.95  mmol),  NH4Cl  (0.101  g,  1.90  mmol)  and  indium 






















130.3,  129.5,  128.2,  126.3,  118.6,  114.2,  26.7,  19.6;  HR‐MS  (DART):  (M+H)+:  Calcd  for  C15H16NO 








1Hz,  8 Hz,  1H),  3.56  (s,  br,  2H);  13C‐NMR  (125 MHz, CDCl3): δ= 143.5,  138.0,  133.1,  130.5,  130.4, 
129.0, 128.9, 126.4, 118.8, 115.8; HR‐MS (DART):  (M+H)+: Calcd  for C12H1135ClN 204.0580; Found 




1‐(4'‐chloro‐2‐nitro‐[1,1'‐biphenyl]‐4‐yl)ethan‐1‐one  (0.21  g,  0.76  mmol),  NH4Cl  (0.081  g,  1.53 
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Synthesis of the Carbazole Scaffold Directly from
2-Aminobiphenyl by Means of Tandem C–H Activation
and C–N Bond Formation
Hans-René Bjørsvik*[a] and Vijayaragavan Elumalai[a]
Abstract: An efficient method for the synthesis of the carbaz-
ole scaffold was designed and investigated. The method was
developed to produce substituted carbazoles by an intramolec-
ular combination of a free amine group and an arene. The steps
of the method involved tandem Pd-catalyzed C–H activation
and intramolecular C–N bond formation. The method showed
Introduction
The carbazole framework constitutes an essential kernel of nu-
merous indispensable applications in society and industry.
Therefore, considerable effort has been devoted to the develop-
ment of efficient methods exploitable for the synthesis of such
molecular motifs.[1] A decade ago, Buchwald and collabora-
tors[2] disclosed seminal work that described an attractive strat-
egy and methodology that permitted the synthesis of the carb-
azole framework through tandem C–H activation and C–N bond
formation (Scheme 1, path a). This strategy involved 2-N-acet-
ylaminobiphenyl 2 as the substrate, and it was exposed to C–H
activation at the 2′-position assisted by a PdII moiety coordi-
nated to the 2-N-acetylamino group. The subsequent step re-
sulted in C–N bond formation that afforded the carbazole scaf-
fold concomitant with the release of Pd0. Pd0 was oxidized to
PdII by O2, which allowed recycling of Pd as the catalyst
(Scheme 2). The major drawbacks of this method[2] comprise a
rather long reaction time and the need for a protecting or auxil-
iary group attached to the 2-amino group, provoked by the
fact that the oxidative conditions can also support the parasite
oxidation reaction 1 → 5.
During the last decade, a few more methods based on tan-
dem C–H activation and C–N bond formation have been re-
vealed.
Gaunt and collaborators[3] disclosed a process that also in-
volved Pd(OAc)2 as the catalyst, but with the hypervalent iodine
compound phenyliodosyl diacetate in DMF as the reoxidant for
the palladium catalyst (Scheme 1, path b). An important im-
provement offered by this method is the low reaction tempera-
[a] Department of Chemistry, University of Bergen,
Allégaten 41, 5007 Bergen, Norway
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good functional group tolerance, and substituent(s) could be
on either of the two rings or on both of the two rings of the
2-aminobiphenyl substrate. After ring closure, the reduced Pd
catalyst was oxidized to PdII by hydrogen peroxide. The novel
method was also demonstrated to operate excellently with the
corresponding 2-N-acetylaminobiphenyls.
Scheme 1. Intramolecular C–H activation and C–N bond formation resulting
in the carbazole framework. Cu(OTf)2 = copper(II) trifluoromethanesulfonate,
2-Py = 2-pyridyl, Cp* = pentamethylcyclopentadienyl, PivOH = pivalic acid,
NMP = 1-methylpyrrolidin-2-one, IMes = 1,3-bis(2,4,6-trimethylphenyl)imid-
azol-2-ylidene.
ture (20 °C), although the method is still saddled with draw-
backs, namely, the need of a protecting or auxiliary group and
the production of stoichiometric quantities of the reduced oxid-
ant as a byproduct.
Satoh, Miura, and collaborators[4] communicated lately a
method that encompassed an IrIII/Cu-based catalytic system
with air as the terminal oxidant (Scheme 1, path e). To date,
this method is the only intramolecular amination method allow-
ing the preparation of the carbazole scaffold from unprotected
2-aminobiphenyl, but this protocol requires an expensive Ir-
based catalyst along with several other additives to operate the
ring-closing reaction. Two other methods involving copper as
the catalyst were disclosed by Chang and collaborators[5a] and
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Scheme 2. Reaction mechanism proposed for tandem Pd-catalyzed C–H activation and C–N bond formation resulting in the carbazole scaffold by using 2-
aminobiphenyl as the substrate.
Hirano, Miura, and collaborators[5b] (Scheme 1, paths c and d).
Both of these methods also require supporting/auxiliary groups
installed on the amino group and stoichiometric quantities of
oxidants, PhI(OAc)2, and MnO2.
Results and Discussion
For a project in progress in our group dedicated to a novel total
synthesis of the natural products carbazomycins G and H,[6] sev-
eral new methods were needed: preparation of the functional-
ized benzene moieties[7] needed for the 2-aminobiphenyl pre-
cursor, Suzuki cross-coupling methods suitable for the prepara-
tion of 2-nitrobiphenyls,[8] and an efficient method for reduc-
tion of the nitro group.[9] Moreover, we aimed to utilize the
C–H activation and intramolecular C–N formation strategy dis-
closed by Buchwald and collaborators.[2] Thus, we initiated the
use of the Buchwald protocol in attempts to accomplish the
intramolecular amidation with biphenyl 2a (Scheme 3).
Scheme 3. Intramolecular C–H activation and C–N formation leading to carb-
azole precursor 3a (29 %) for carbazomycin G (R = H) and carbazomycin H
(R = OCH3).
However, probably because of the highly congested substi-
tution pattern of the A ring combined with the acetyl group
attached to the 2-amino group, the ring-closing reaction af-
forded target carbazole 3a in a yield of only 29 %. This some-
what disappointing result spurred us to undertake further in-
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vestigations of the ring-closing protocol. Even though the
amino group can be oxidized to the nitro group under various
conditions,[10] we wanted to investigate the ring closure by us-
ing the nonprotected 2-aminobiphenyl framework. 2-Nitrobi-
phenyl (5) might be the product of a parasite reaction occurring
under the oxidative conditions used in the Pd-catalyzed intra-
molecular amination. Indeed, we observed this oxidation prod-
uct as soon as unprotected 2-aminobiphenyl (1) was used as
the substrate (Table 1).
Alteration of the reaction time, reaction temperature, and
the composition of the catalytic system was revealed to affect
Table 1. Screening experiments for the ring closing of 2-aminobiphenyl to
achieve the carbazole scaffold.[a]
Entry Catalyst/Ligand t Measured response[b] [%]
[min] Conv. y4 y5 y2
1 Pd(OAc)2 90 93 39 26 20
2 Pd(OAc)2 60 86 48 30 nd
3 Pd(OAc)2 20 67 30 10 24
4 Pd(OAc)2/IMes·HCl 20 84 45 18 15
5 Pd(tfa)2 20 77 49 9 16
6 Pd(tfa)2/IMes·HCl 20 83 43 15 21
7[c] Pd(OAc)2/IMes·HCl 10 97 67 2 28
[a] Reaction conditions: A reactor tube was charged with a solution of 2-
aminobiphenyl (1; 84.5 mg, 0.5 mmol) in glacial acetic acid (5 mL), Pd(OAc)2
(5.6 mg, 0.025 mmol, 5 mol-%) or Pd(TFA)2 (8.3 mg, 0.025 mmol, 5 mol-%),
IMes·HCl (8.5 mg, 0.025 mmol) if specified, and H2O2 (35 %, 0.128 mL,
1.45 mmol), and the tube was immersed into the cavity of a microwave oven
for the specified time at T = 90 °C. tfa = trifluoroacetic acid. [b] The reaction
was monitored by means of GC–MS; Conv. = conversion of 1. Yields (y) of
compound 4 and 5 were corrected by using the following response factors:
2-aminobiphenyl (1), rf1 = 1.00; carbazole, rf4 = 1.00; 2-nitrobiphenyl, rf5 =
1.29. The selectivities and yields of compounds 2 and 5 are uncorrected with
response factor. nd = not detected. [c] Pd(OAc)2 (22.4 mg, 0.100 mmol,
20 mol-%) was used.
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not only the yield of target carbazole 4 but also the distribution
of side products 2 and 5. Evidently, the N-heterocyclic carbene
ligand IMes with Pd(OAc)2 operated reasonably well as the cata-
lyst for the ring-closing reaction. Moreover, the reaction time
also appeared to be of paramount importance. The reaction
trial of entry 7 (Table 1) was used as a basis in an attempt to
discover a higher yielding protocol. A series of experiments with
various Pd loadings (5–20 mol-%) were conducted and moni-
tored over a period of 20 min. Alteration of the Pd loading
revealed a great effect on the outcome of the reaction (Fig-
ure 1a). Moreover, after a reaction time of 10–15 min, the target
molecule started to depredate concomitantly as parasite prod-
ucts 2 and 5 were produced.
Further optimization of the method was conducted by
means of systematic variation (in a grid pattern) of the reaction
temperature and time (Figure 1b).
High-yielding conditions were located at a reaction time of
15–20 min with a temperature of 120–130 °C. The so-far-opti-
mized protocol (Figure 1a,b) was then repeated under various
Pd loadings (5–20 %, Figure 1c). A high conversion (≥97 %) of
the 2-aminobiphenyl (1) substrate was achieved for all of these
experiments. If the Pd loading was <20 mol %, oxidation of the
amino group to the nitro group occurred. In fact, as much as
23 % of 2-nitrobiphenyl (5) was formed by using 5 mol % Pd,
and 5 was formed in only about 2 % yield with a Pd loading of
15 mol %. With a Pd loading of 20 mol %, the carbazole scaffold
was obtained in 97 % yield.
A scope and limitations study of our new method was then
undertaken by means of examining a series of substituted 2-
aminobiphenyls (Table 2). Overall, the method tolerated both
Figure 1. (a) Reaction profiles showing the outcomes of 4, 5, and 2 at various Pd loadings. To a solution of 2-aminobiphenyl (84.5 mg, 0.5 mmol) in glacial
acetic acid (5 mL) was added Pd(OAc)2 (5–20 mol-%), IMes·HCl (8.5 mg, 0.025 mmol), and H2O2 (35 %, 0.128 mL, 1.45 mmol) to perform the above reactions
under microwave irradiation for 15–20 min at 90 °C. (b) Screening of the reaction time (5–20 min) vs. reaction temperature (90–130 °C) revealed optimized
conditions at higher temperatures and longer reaction times. (c) Variation (5–20 %) of the catalyst loading (using 20 min and 120 °C) afforded a high
conversion (≥97 %) of 2-aminobiphenyl (1) with 4 and 5 as reaction products.
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electron-withdrawing and electron-donating groups to afford
the target carbazole scaffolds in moderate to excellent yields.
However, a few exceptions were observed: 2′-methoxy-2-
aminobiphenyl and 3′-methoxy-2-aminobiphenyl afforded
yields of around 10 % only (Table 2, entries 6 and 7) and 4′-
methoxy-2-aminobiphenyl provided a moderate yield (Table 2,
entry 8). These observations might be due to the inductive ef-
fect of the methoxy substituent that would disrupt the interme-
diate, but the oxidative conditions present for the catalytic cycle
might also give rise to oxidation of the aromatic kernel into a
demethoxylated quinoid framework,[11] which could be fol-
lowed by additional degradation reactions. Moreover, as ex-
pected, the method did not operate with substrates that con-
tained a free hydroxy group; nevertheless, by means of stan-
dard protection (tert-butyldimethylsilyl chloride) of the hydroxy
group, a high yield of the target carbazole was obtained
(Table 2, entry 15).
The method was also explored with 2-N-acetylaminobiphen-
yls as substrates (Table 3). In this context, minor alterations to
the experimental conditions were found to be beneficial,
namely, a lower Pd loading (5 mol-%) and an extended reaction
time (3 h). Under these conditions with 3′-methoxy-2-N-acet-
ylaminobiphenyl and 4′-methoxy-2-N-acetylaminobiphenyl, the
corresponding carbazoles were achieved in high yields (Table 3,
entries 7 and 8). However, the 2′-methoxy-substituted substrate
provided a low yield (25 %) only. The 3′-methoxy-substituted
substrate (Table 3, entry 7) provided two regioisomers, namely,
1-(3-methoxy-9H-carbazol-9-yl)ethan-1-one (3g, major) and 1-
(2-methoxy-9H-carbazol-9-yl)ethan-1-one (minor). The methyl-
ated substrates (Table 3, entries 3 and 4) provided low to mod-
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Table 2. Scope of the reaction by using 2-aminobiphenyls 1 as the substrate.
[a] y = conversion yield based on GC, yi = yield of isolated product after
column chromatography (silica gel), na = not analyzed on GC. [b] An addi-
tional experiment by using 20 mol-% IMes was also conducted. The outcome
was similar to that obtained in the experiment for which 5 mol-% IMes was
used. [c] An experiment without the tert-butyldimethylsilyl (TBS) protecting
group installed did not afford the target carbazole.
erate yields; this applied also to a substrate with a strong elec-
tron-withdrawing group (Table 3, entry 2). The observed results
are consistent with previous observations.[2]
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Table 3. Scope of the reaction by using 2-N-acetylaminobiphenyl (2) as the
substrate.
[a] y = conversion yield based on GC, yi = yield of isolated product after
column chromatography (silica gel), ni = not isolated. [b] In addition to major
product 3g, a minor quantity (12 %) of the 5′-methoxy derivative was ob-
tained.
Electrophilic substitution on the carbazole scaffold normally
occurs at the 3- and 6-positions. However, our new method
allowed functionalization in the 2- and 4-positions, which might
be valuable for the synthesis of natural products that contain
the carbazole scaffold.
As an ultimate test of the new protocol, we attempted to
perform the transformation 2a → 3a previously performed with
the Buchwald method[2] (Scheme 2). Only a minor change to
the conditions of our new method was needed: whereas 3 h
Communication
afforded the product in 37 % yield, a reaction time of 5 h pro-
vided the product in an excellent yield of 94 %. The conditions
and results are summarized in Scheme 4.
Scheme 4. Intramolecular C–H activation and C–N formation leading to carb-
azole 3a (94 %) as a precursor of carbazomycin G. µW = microwave.
Conclusion
In summary, we developed a new, highly efficient and high-rate
method for the synthesis of the carbazole framework by means
of Pd-catalyzed tandem C–H activation and intramolecular C–N
bond formation by using the 2-aminobiphenyl scaffold as the
substrate. In general, the method tolerated both electron-with-
drawing and electron-donating groups on one or both of the
two aromatic rings of the substrate. Even substrates labile for
oxidation such as aromatics that contained hydroxy and/or the
methoxy groups could be converted into their corresponding
carbazoles. However, if the 2-aminobiphenyl scaffold was sub-
stituted with a methoxy group, an acetyl group needed to be
introduced on the 2-amino group as an auxiliary group. Free
hydroxy groups needed protection.
Experimental Section
General Methods: All reagents and solvents were purchased from
commercial sources and were used as received. Melting points were
determined in open capillaries. Reagent-grade chemicals were pur-
chased from commercial sources and were used without further
purification. All reactions and column eluates were monitored by
TLC (TLC plates Merck Kieselgel 60 F254). The TLC plates were ob-
served under UV light at λ = 254 and 365 nm. IR spectra were
recorded as KBr discs with a Shimadzu FTIR-8300 spectrophotome-
ter, and 1H NMR and 13C NMR spectra were recorded with Bruker
AV 400 MHz and 500 MHz instruments. High-resolution mass spec-
tra (HRMS) were performed with a Q-TOF Micro YA263 instrument.
GC analyses were performed with a capillary gas chromatograph
equipped with a fused silica column (l25 m, 0.20 mm i.d., 0.33 mm
film thickness) at a helium pressure of 200 kPa, split less/split in-
jector and flame ionization detector. Mass spectra were obtained
with a GC–MS instrument, with a gas chromatograph equipped
with a fused silica column (l30 m, 0.25 mm i.d., 0.25 mm film thick-
ness) and helium as the carrier gas. DART mass spectra were ob-
tained by using PEG as an internal standard in positive ionization
mode with a TOF mass analyzer. 1H NMR and 13C NMR spectra were
recorded at ambient temperature at frequencies of 400/500 and
100/125 MHz, respectively. The chemical shifts are reported in ppm
relative to residual CHCl3 for 1H (δ = 7.26 ppm) and CDCl3 for 13C
(δ = 77.0 ppm) and residual DMSO for 1H (δ = 2.50 ppm) and
[D6]DMSO for 13C (δ = 39 ppm) with tetramethylsilane as an exter-
nal reference. Flash chromatography was performed by using the
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indicated solvent system and silica gel (230–400 mesh). All reagents
used were commercially available from Aldrich Chemical Co. For
new compounds, HRMS data were also recorded. The microwave-
assisted experiments were performed by means of a Biotage Initia-
tor Sixty EXP Microwave System that operated at 0–400 W and
2.45 GHz in the temperature range of 40 to 250 °C, a pressure range
of 0 to 20 bar (2 MPa, 290 psi), with reactor vial volumes of 0.2 to
20 mL.
General Procedure for 2-Aminobiphenyl Derivatives 1–1o: 2-
Nitrobiphenyl (1 mmol, 0.2 g) was dissolved in EtOH (4 mL) and
transferred to a tube reactor. Then, a mixture of NH4Cl (2 mmol,
0.107 g) in H2O (1.2 mL) and indium powder (3 mmol, 0.344 g,
99.99 % 100 mesh, used preferably a freshly opened bottle or stored
under an atmosphere of argon) were added, whereupon a magnetic
stirrer bar was transferred to the tube. The tube was then sealed,
and the mixture was stirred and heated at 120 °C for 3 h. The
mixture was cooled to room temperature and diluted with ethyl
acetate (30 mL). The resulting mixture was filtered through a pad
of Celite to remove the catalyst. Another portion (20 mL) of ethyl
acetate was used to wash through the filter pad. The resulting trans-
parent organic phase was dried with Na2SO4, filtered, and concen-
trated under reduced pressure to obtain the 2-aminobiphenyl com-
pound.
2′-Methyl-[1,1′-biphenyl]-2-amine (1c): 2′-Methyl-2-nitro-1,1′-bi-
phenyl (0.324 g, 1.52 mmol), NH4Cl (0.161 g, 3.04 mmol), and in-
dium powder (0.523 g, 4.56 mmol). The title compound was ob-
tained as a yellow liquid (0.259 g, 93 %). Rf = 0.66 (hexanes/EtOAc,
80:20). 1H NMR (500 MHz, CDCl3): δ = 7.17–7.22 (m, 3 H), 7.12–7.14
(m, 1 H), 7.08–7.11 (td, J = 1.5, 7.5 Hz, 1 H), 6.93–6.95 (dd, J = 1,
7 Hz, 1 H), 6.72–6.75 (td, J = 1, 7 Hz, 1 H), 6.68–6.70 (dd, J = 1, 8 Hz,
1 H), 2.10 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 143.6, 138.6,
137.0, 130.3, 130.1, 130.0, 128.4, 127.7, 127.5, 126.2, 118.3, 115.1,
19.7 ppm. IR: ν̃ = 3465, 3375, 3018, 2921, 1612, 1480, 1447,
1296 cm–1. HRMS (DART): calcd. for C13H13N [M + H]+ 184.1126;
found 184.1127.
General Procedure for 2-Acetaminobiphenyl Derivatives 2–2h:
Acetyl chloride (0.04 mL, 0.62 mmol) was added dropwise to a solu-
tion of 2-aminobiphenyl (0.1 g, 0.59 mmol) and triethylamine
(0.09 mL, 0.65 mmol) in anhydrous dichloromethane (10 mL) at 0 °C.
The mixture was stirred at room temperature for 1 h. Then, the
solvent was evaporated under reduced pressure. The residue was
dissolved in ether (20 mL) and washed with water (20 mL). The
organic phase was dried with Na2SO4, filtered, and concentrated
under reduced pressure obtain the N-acetylated compound.
N-([1,1′-Biphenyl]-2-yl) Acetamide: 2′-Amino-[1,1′-biphenyl] (1a)
(0.10 g, 0.59 mmol), acetyl chloride (0.04 mL, 0.62 mmol), and trieth-
ylamine (0.09 mL, 0.65 mmol). The title compound was obtained as
a pale-white solid (0.115 g, 93 %). M.p. 119.8–120 °C. Rf = 0.24 (hex-
anes/EtOAc, 80:20). 1H NMR (500 MHz, CDCl3): δ = 8.26 (d, J = 8.5 Hz,
1 H), 7.49 (t, J = 7 Hz, 2 H), 7.38 (m, 3 H), 7.24 (d, J = 7 Hz, 1 H),
7.18 (d, J = 7.5 Hz, 1 H), 2.02 (s, 3 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 168.3, 138.2, 134.7, 132.2, 130.1 129.2, 129.1, 128.4, 128.0, 124.4,
121.7, 24.6 ppm. IR: ν̃ = 3286, 3027, 1658, 1531, 1433, 1301 cm–1.
HRMS (ESI): calcd. for C14H13NNaO [M + Na]+ 234.0895; found
234.0896;
General Procedure for Carbazole Derivatives 4–4o: In a micro-
wave tube, 2-aminobiphenyl (84.5 mg, 0.5 mmol) was dissolved in
glacial acetic acid (5 mL) and then Pd(OAc)2 (22.5 mg, 0.1 mmol),
IMes·HCl (8.5 mg, 0.025 mmol), and H2O2 (35 %, 0.128 mL,
1.45 mmol) were added. The vial was sealed, whereupon a magnetic
stirrer bar was transferred to the tube. The tube was submerged in
Communication
the microwave cavity for 20 min at 120 °C. Then, the acetic acid
solvent was removed under reduced pressure. The crude product
was dissolved in EtOAc (25 mL) and washed with water (20 mL).
The aqueous phase was extracted with EtOAc (2 × 20 mL). The com-
bined organic layer was washed with aqueous NaHCO3 (20 mL). The
organic layer was filtered through a pad of Celite and dried with
Na2SO4. The solvent was evaporated under reduced pressure. The
crude product was purified by column chromatography (silica gel;
hexanes/EtOAc, gradient 90:10 to 50:50) to obtain the target com-
pound.
9H-Carbazole (4): 2-Amino-1,1′-biphenyl (1a; 0.085 g, 0.50 mmol),
Pd(OAc)2 (22.4 mg, 0.1 mmol), IMes·HCl (8.5 mg, 0.05 mmol), and
H2O2 (35 %, 0.128 mL, 1.45 mmol). The title compound was ob-
tained as a pale-brown solid (0.070 g, 84 %). M.p. 242–243 °C. Rf =
0.49 (hexanes/EtOAc, 80:20). 1H NMR (400 MHz, CDCl3): δ = 8.09 (d,
J = 8 Hz, 2 H), 7.42–7.47 (m, 4 H), 7.22–7.26 (m, 2 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 139.5, 125.8, 123.4, 120.3, 119.4, 110.6 ppm.
IR: ν̃ = 3415, 3050, 1599, 1449, 1325, 722 cm–1. HRMS (DART): calcd.
for C12H10N [M + H]+ 168.0813; found 168.0814.
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General Procedure 2-aminobiphenyl derivatives 
Experimental Details: All reagents and solvents were purchased from commercial sources and used as 
received. Melting points were determined in open capillaries. Reagent grade chemicals were purchased from 
commercial sources and used without further purification. All reaction mixtures and column eluents were 
monitored by TLC (TLC plates Merck Kieselgel 60 F254). The TLC plates were observed under UV light at λ = 
254 nm and λ = 365 nm. IR spectra were recorded as KBr discs with a Shimadzu FTIR-8300 spectrophotometer, 
and 1H and 13C NMR spectra were recorded with Bruker AV 400 MHz and 500 MHz instruments. High-
resolution mass spectra (HRMS) were performed with a Q-TOF Micro YA263 instrument. 
 
General Methods: GC analyses were performed with a capillary gas chromatograph equipped with a fused 
silica column (l25 m, 0.20 mm i.d., 0.33 mm film thickness) at a helium pressure of 200 kPa, split less/split 
injector and flame ionization detector. Mass spectra were obtained with a GC–MS instrument, with a gas 
chromatograph equipped with a fused silica column (l30 m, 0.25 mm i.d., 0.25 mm film thickness) and helium as 
the carrier gas. DARTmass spectra were obtained by using PEG as an internal standard in positive ionization 
mode with a TOF mass analyzer. 1H and 13CNMR spectra were recorded at ambient temperature at a frequency 
of 400, 500 MHz and 100, 125 MHz respectively. The chemical shifts are reported in ppm relative to residual 
CDCl3 for proton (δ = 7.26 ppm) and CDCl3 for carbon (δ = 77.0 ppm) and DMSO-d6 for proton (δ = 2.50 ppm) 
and carbon (δ = 39 ppm) with tetramethylsilane as an external reference. Flash chromatography was performed 
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by using the indicated solvent system and silica gel (230–400 mesh). All reagents used were commercially 
available from Aldrich Chemical Co. For new compounds HRMS data were also recorded. 
 
The microwave-assisted experiments were performed by means of a Biotage Initiator Sixty EXP Microwave 
System, that operates at 0–400 W at 2.45 GHz, in the temperature range of 40–250 °C, a pressure range of 0–20 
bar (2 MPa, 290 psi), and with reactor vial volumes of 0.2–20 mL. 
 
2-aminobiphenyl derivatives: 
General Procedure. 2-Nitrobiphenyl (1 mmol, 0.2 g) was dissolved in EtOH (4 mL) and transferred to a tube 
reactor. Then, a mixture of NH4Cl (2 mmol, 0.107 g) in H2O (1.2 mL) and indium powder (3 mmol, 0.344 g, 
99.99% 100 mesh, use preferably a freshly opened bottle or stored under Ar) were added whereupon a magnetic 
stirrer bar was transferred to the tube. The tube was then sealed and the reaction mixture was stirred and heated 
at 120 °C for 3 h. The reaction mixture was cooled to room temperature and diluted with ethyl acetate (30 mL). 
The resulting mixture was filtered through a pad of celite to remove the catalyst. Another portion (20 mL) of 
ethyl acetate was used to wash through the filter pad. The resulting transparent organic phase was dried over 
Na2SO4, filtered and the solvent was removed under reduced pressure using a rotary evaporator to obtain the 2-
aminobiphenyl compound. 
 
2'-(trifluoromethyl)-[1, 1’-biphenyl]-2-amine (1b) [438-84-6] 
2-nitro-2'-(trifluoromethyl)-1,1'-biphenyl (0.283 g, 1.06 mmol), NH4Cl (0.112 g, 2.11 mmol) and indium powder 
(0.365 g, 3.22 mmol) .The title compound was obtained as a yellow liquid (0.236 g, 94%).; Rf = 0.81 
[(Hx:EtOAc, 50:50)]; 1H-NMR (500 MHz, CDCl3): !=  7.80 (d, J= 8 Hz, 1H), 7.59-7.62 (td, J= 0.5 Hz, 7.5 Hz, 
1H), 7.50 (t, J= 7.5 Hz, 1H), 7.38 (d, J= 8 Hz, 1H), 7.19-7.22 (td, J= 1.5 Hz, 7.5 Hz, 1H), 7.03 (d, J= 7.5 Hz, 
1H), 6.80-6.83 (td, J= 1 Hz, 7.5 Hz, 1H), 6.77-6.78 (dd, J= 1 Hz, 8 Hz, 1H), 3.34 (s, br, 2H); 13C-NMR (125 
MHz, CDCl3): != 143.7, 138.0, 137.9, 132.5, 132.0, 130.3, 129.1, 127.9, 126.6(q, CF3), 125.0, 124.9,  117.9, 
115.3 ; HR-MS (DART): (M+H)+: Calcd for C13H11F3N 238.0844; Found 238.0845); IR (cm-1): 3462, 3399, 
3360, 3340, 1616, 1452, 1312, 1106. 
2'-methyl-[1, 1’-biphenyl]-2-amine (1c) [1203-41-4] 
4'-methyl-2-nitro-1, 1’-biphenyl (0.324 g, 1.52 mmol), NH4Cl (0.161 g, 3.04 mmol) and indium powder (0.523 
g, 4.56 mmol). The title compound was obtained as a yellow liquid (0.259 g, 93%): Rf = 0.66 [(Hx:EtOAc, 
80:20)]; 1H-NMR (500 MHz, CDCl3): !=  7.17-7.22 (m, 3H), 7.12-7.14(m, 1H), 7.08-7.11 (td, J= 1.5 Hz, 7.5 
Hz, 1H), 6.93-6.95 (dd, J= 1.5 Hz, 7 Hz, 1H), 6.72-6.75 (td, J= 1 Hz, 7 Hz, 1H), 6.68-6.70 (dd, J= 1 Hz, 8 Hz, 
1H), 2.10 (s, 3H),; 13C-NMR (125 MHz, CDCl3): != 143.6, 138.6, 137.0, 130.3, 130.1, 130.0, 128.4, 127.7, 
127.5, 126.2, 118.3, 115.1, 19.7; HR-MS (DART): (M+H)+: Calcd for C13H13N 184.1126; Found 184.1127); IR 
(cm-1): 3465, 3375, 3018, 2921, 1612, 1480, 1447, 1296. 
4’-methyl-[1, 1’-biphenyl]-2-amine (1d) [1204-43-9] 
4’-methyl-2'-nitro-1,1'-biphenyl (0.235 g, 1.10 mmol), NH4Cl (0.117 g, 2.20 mmol) and indium powder (0.379 
g, 3.30 mmol) .The title compound obtained as an orange liquid (0.192 g, 96%); Rf = 0.61[(Hx:EtOAc, 80:20)]; 
1H-NMR (500 MHz, CDCl3): != 7.27 (d, J= 8.5 Hz, 2H), 7.17 (d, J= 8 Hz, 2H), 7.03-7.08 (dddd, J= 1.5 Hz, 7.5 
Hz, 2H), 6.72-6.75 (td, J= 1.5 Hz, 7.5 Hz, 1H), 6.67-6.69 (dd, J= 1 Hz, 8 Hz, 1H), 2.32 (s, 3H); 13C-NMR (125 
MHz, CDCl3): != 143.5, 136.9, 136.5, 130.5, 129.5, 129.0, 128.3, 127.7, 118.7, 115.6, 21.2; HR-MS (DART): 
(M+H)+: Calcd for C13H13N 184.1126; Found 184.1128); IR (cm-1): 3455, 3368, 3021, 2919, 1613, 1488, 1449, 
1293. 
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 4'-ethyl-[1, 1’-biphenyl]-2-amine (1e) [55258-95-2] 
4'-ethyl-2-nitro-1,1'-biphenyl (0.300 g, 1.32 mmol), NH4Cl (0.140 g, 2.64 mmol) and indium powder (0.455 g, 
3.96 mmol)  .The title compound was obtained as an orange liquid (0.240 g, 92%); Rf = 0.63 [(Hx:EtOAc, 
80:20)]; 1H-NMR (500 MHz, CDCl3): !=  7.37-7.39 (m, 2H), 7.28-7.30 (dd, J= 2 Hz, 7.5 Hz, 2H), 7.13-7.17 (m, 
2H), 6.81-6.85 (td, J= 1Hz, 7.5 Hz, 1H), 6.77-6.78 (dd, J= 1Hz, 8 Hz, 1H), 2.71 (q, J= 8 Hz, 2H), 1.30 (t, J= 
7.5Hz, 3H); 13C-NMR (125 MHz, CDCl3): != 143.5, 143.2, 136.8, 130.5, 129.0, 128.3, 127.7, 118.7, 115.6, 
28.6, 15.5; HR-MS (DART): (M+H)+: Calcd for C14H15N 198.1283; Found 198.1284);  IR (cm-1): 3460, 3370, 
3022, 2963, 2929, 2871, 1613, 1488, 1452, 1295. 
2’-methoxy-[1, 1’-biphenyl]-2-amine (1f) [1206-76-4] 
2’-methoxy-2-nitro-1, 1’-biphenyl (0.284 g, 1.24 mmol), NH4Cl (0.131 g, 2.47 mmol) and indium powder (0.427 
g, 3.72 mmol) .The title compound was obtained as a pale-brown liquid (0.238 g, 96%). Rf = 0.40 [(Hx:EtOAc, 
80:20)]; 1HNMR (500 MHz, CDCl3): != 7.26-7.29 (td, J= 1.5 Hz, 8 Hz, 1H), 7.17-7.19 (dd, J= 2 Hz, 7.5 Hz, 
1H), 7.08-7.11 (td, J= 1.5 Hz, 8 Hz, 1H), 7.02-7.04 (dd, J= 1.5 Hz, 7.5 Hz, 1H), 6.95-6.98 (td, J= 1 Hz, 7.5 Hz, 
1H), 6.92 (d, J= 8.5 Hz, 1H), 6.74-6.77 (td, J= 1 Hz, 7.5 Hz, 1H), 6.69-6.71 (dd, J= 1Hz, 8Hz, 1H), 3.73 (s, 3H); 
13C-NMR (125 MHz, CDCl3): != 156.7, 144.3, 131.8, 131.1, 129.0, 128.5, 128.3, 125.1, 121.2, 118.5, 115.7, 
111.3, 55.7; HR-MS (DART): (M+H)+: Calcd for C13H14NO 200.1077; Found 200.1077); IR (cm-1): 3449, 3368, 
3021, 2934, 2834, 1615, 1483, 1449, 1229. 
3’-methoxy-[1, 1’-biphenyl]-2-amine (1g) [38089-02-0] 
3’-methoxy-2-nitro-1,1'-biphenyl  (0.329 g, 1.44 mmol), NH4Cl (0.153 g, 2.88 mmol) and indium powder (0.496 
g, 4.32 mmol)  .The title compound was obtained as a pale-yellow liquid (0.250 g, 87%); Rf = 0.48 [(Hx:EtOAc, 
80:20)]; 1H-NMR (500 MHz, CDCl3): != 7.36 (t, J= 8 Hz, 1H), 7.14-7.18 (m, 2H), 7.04-7.06 (dt, J= 1.5 Hz, 7.5 
Hz, 1H), 7.00-7.01 (m, 1H), 6.89-6.91 (dddd, J= 1 Hz, 2.5 Hz, 1H), 6.82-6.85 (td, J= 1 Hz, 7.5 Hz, 1H), 6.77-
6.79 (dd, J= 1 Hz, 8 Hz, 1H), 3.84 (s, 3H); 13C-NMR (125 MHz, CDCl3): != 159.9, 143.3, 140.9, 130.3, 129.8, 
128.6, 127.6, 121.4, 118.6, 115.7, 114.5, 112.9, 55.3; HR-MS (DART): (M+H)+: Calcd for C13H14NO 200.1077; 
Found 200.1077); IR (cm-1): 3412, 3340, 3010, 2961, 2933, 2835, 1605, 1568, 1475, 1421, 1291, 1206, 1048. 
4’-methoxy-[1, 1’-biphenyl]-2-amine (1h) (38089-03-1) 
4’-methoxy-2-nitro-1,1'-biphenyl  (0.284 g, 1.24 mmol), NH4Cl (0.131 g, 2.48 mmol) and indium powder (0.427 
g, 3.72 mmol)  .The title compound was obtained as an orange liquid (0.235 g, 95%); Rf = 0.40 [(Hx:EtOAc, 
80:20)]; 1H-NMR (500 MHz, CDCl3): != 7.38-7.40 (m, 2H), 7.11-7.16 (m, 2H), 6.97-7.00 (m, 2H), 6.81-6.84 
(td, J= 1.5 Hz, 7.5 Hz, 1H), 6.76-6.78 (dd, J= 1 Hz, 8 Hz, 1H), 3.86 (s, 3H); 13C-NMR (125 MHz, CDCl3): != 
158.8, 143.6, 131.8, 130.5, 130.2, 128.2, 127.4, 118.7, 115.6, 114.2, 55.3; HR-MS (DART): (M+H)+: Calcd for 
C13H14NO 200.1077; Found 200.1077); IR (cm-1): 3461, 3368, 3001, 2934, 2835, 1709, 1610, 1488, 1240, 1032. 
4'-chloro-[1, 1’-biphenyl]-2-amine (1i) [1204-44-0] 
4'-chloro-2-nitro-1, 1’-biphenyl (0.25 g, 1.07 mmol), NH4Cl (0.113 g, 2.13 mmol) and indium powder (0.369 g, 
3.21 mmol). The title compound was obtained as a light brown liquid (0.192 g, 88%). Rf = 0.63 [(Hx:EtOAc, 
70:30)]; 1H-NMR (500 MHz, CDCl3): !=  7.28-7.31 (m, 4H), 7.03-7.07 (td, J= 1.5Hz, 8 Hz, 1H), 6.97-6.99 (dd, 
J= 1.5Hz, 7.5 Hz, 1H), 6.70-6.73 (td, J= 1Hz, 7.5 Hz, 1H), 6.63-6.65 (dd, J= 1Hz, 8 Hz, 1H), 3.56 (s, br, 2H); 
13C-NMR (125 MHz, CDCl3): != 143.5, 138.0, 133.1, 130.5, 130.4, 129.0, 128.9, 126.4, 118.8, 115.8; HR-MS 
(DART): (M+H)+: Calcd for C12H1135ClN 204.0580; Found 204.0582); Calcd for C12H1137ClN 206.0551; Found 
206.0522); IR (cm-1): 3455, 3370, 3026 , 1614, 1480, 1291. 
2-amino-[1, 1’-biphenyl]-4-carboxylic acid (1j) [856797-75-6] 
2-nitro-[1, 1’-biphenyl]-4-carboxylic acid (0.125 g, 0.515 mmol), NH4Cl (0.055 g, 1.03 mmol) and indium 
powder (0.178 g, 1.55 mmol) .The title compound was obtained as yellow liquid (0.082 g, 75%). Rf = 0.17 
[(Hx:EtOAc, 70:30)]; 1H-NMR (500 MHz, CDCl3): !=  7.56 (d, J= 7.5 Hz, 1H), 7.44-7.51 (m, 5H), 7.37-7.41 
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(m, 1H), 7.21 (d, J= 7.5 Hz, 1H); 13C-NMR (125 MHz, CDCl3); != 171.9, 143.7, 138.5, 132.7, 130.6, 129.0, 
128.8, 127.9, 120.4, 116.9; HR-MS (DART): (M+H)+: Calcd for C13H12NO2 214.0868; Found 214.0869); IR 
(cm-1): 3482, 3387, 3025, 2526, 2359, 1677, 1408. 
1-(2-amino-4'-chloro-[1, 1’-biphenyl]-4-yl) ethan-1-one (1k) [52806-85-6] 
1-(4'-chloro-2-nitro-[1, 1’-biphenyl]-4-yl) ethan-1-one (0.21 g, 0.76 mmol), NH4Cl (0.081 g, 1.53 mmol) and 
indium powder (0.262 g, 2.28 mmol). The title compound was obtained as a yellow solid (0.17 g, 94%). Rf = 
0.32 [(Hx:EtOAc, 70:30)]; 1H-NMR (500 MHz, CDCl3): !=  7.34 (d, J= 2Hz, 2H), 7.32-7.33 (m, 1H), 7.30-7.31 
(m, 1H), 7.25-7.27 (m, 2H), 7.06 (d, J= 7.5 Hz, 1H), 3.74 (s, br, 2H), 2.48 (s, 3H) ; 13C-NMR (125 MHz, 
CDCl3): != 198.1, 143.8, 137.5, 136.9, 133.8, 130.5, 130.2, 129.4, 129.2, 118.9, 114.9, 26.7; HR-MS (DART): 
(M+H)+: Calcd for C14H1335ClNO 246.0686; Found 246.0688);   Calcd for C14H1337ClNO 248.0656; Found 
248.0668);   IR (cm-1): 3497, 3380, 3302 , 1672, 1420, 1290. 
1-(2-amino-2'-methyl-[1, 1’-biphenyl]-4-yl) ethan-1-one (1l) [NEW] 
1-(2'-methyl-2-nitro-[1, 1’-biphenyl]-4-yl) ethan-1-one (0.24 g, 0.94 mmol), NH4Cl (0.10 g, 1.89 mmol) and 
indium powder (0.324 g, 2.82 mmol). The title compound was obtained as a pale-yellow solid (0.19 g, 90%). Rf 
= 0.37 [(Hx:EtOAc, 70:30)]; 1H-NMR (500 MHz, CDCl3): !=  7.28-7.31 (m, 2H), 7.22-7.23 (m, 2H), 7.17-7.20 
(m, 1H), 7.09-7.10 (m, 1H), 7.02 (d, J= 8 Hz, 1H), 3.46 (s, br, 2H), 2.51 (s, 3H), 2.08 (s, 3H); 13C-NMR (125 
MHz, CDCl3): != 198.3, 144.1, 137.6, 137.4, 136.6, 132.3, 130.5, 130.3, 129.5, 128.2, 126.3, 118.6, 114.2, 26.7, 
19.6; HR-MS (DART): (M+H)+: Calcd for C15H16NO 226.1232; Found 226.1233);   IR (cm-1): 3482, 3453, 
3382, 3361, 2921, 1671, 1659, 1620, 1425, 1292. 
4'-chloro-4-methyl-[1, 1’-biphenyl]-2-amine (1m) [1555774-70-3] 
 4'-chloro-4-methyl-2-nitro-[1, 1’-biphenyl] (0.124 g, 0.50 mmol), NH4Cl (0.055 g, 1.00 mmol) and indium 
powder (0.172 g, 1.50 mmol) .The title compound was obtained as a dark brown liquid (0.102 g, 94%). Rf = 0.75 
[(Hx:EtOAc, 70:30)]; 1H-NMR (500 MHz, CDCl3): !=  7.37-7.41 (m, 4H), 6.98 (d, J= 7.5 Hz, 1H), 6.65 (d, J= 
7.5 Hz, 1H), 6.60 (s, 1H), 3.64 (s, br, 2H), 2.30 ( s, 3H); 13C-NMR (125 MHz, CDCl3); != 143.2, 138.8, 138.0, 
132.9, 130.5, 130.2, 128.9, 127.8, 119.8, 116.4, 21.2; HR-MS (DART): (M+H)+: Calcd for C13H1335ClN 
218.0737; Found 218.0738); Calcd for C13H1337ClN 220.0707; Found 220.0701); IR (cm-1): 3463,3377, 2917, 
1608, 1478, 1090, 803. 
2'-chloro-4-methyl-[1, 1’-biphenyl]-2-amine (1n) [1552980-85-4] 
2'-chloro-4-methyl-2-nitro-1, 1'-biphenyl (0.24 g, 0.97mmol), NH4Cl (0.103 g, 1.94 mmol) and indium powder 
(0.334 g, 2.90 mmol). The title compound was obtained as a brown liquid (0.20 g, 95%). Rf = 0.71 [(Hx:EtOAc, 
70:30)]; 1H-NMR (500 MHz, CDCl3): !=  7.48-7.50 (m,  1H), 7.29-7.33 (m, 3H), 6.94 (d, J= 7.5 Hz, 1H), 6.66 
(d, J= 7.5 Hz, 1H), 6.62 (s, 1H), 2.32 (s, 3H); 13C-NMR (125 MHz, CDCl3): != 143.6, 139.1, 138, 134.0, 132.1, 
130.3, 129.9, 128.9, 127.2, 122.7, 119.3, 116.2, 21.4: HR-MS (DART): (M+H)+: Calcd for C13H1335ClN 
218.0737; Found 218.0738); Calcd for C13H1337ClN 220.0707; Found 220.0655); IR (cm-1): 3458, 3374, 2918, 
1619, 1467, 1033. 
4'-((tert-butyldimethylsilyl) oxy)-4-methyl-[1, 1’-biphenyl]-2-amine (1o) [NEW] 
4'-((tert-butyldimethylsilyl) oxy)-4-methyl-2-nitro-[1, 1’-biphenyl] (0.365 g, 1.06 mmol), NH4Cl (0.113 g, 2.12 
mmol) and indium powder (0.365 g, 3.18 mmol) .The title compound was obtained as a yellow solid (0.312 g, 
94%). Rf = 0.69 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  7.29-7.30 (m, 2H), 7.09 (d, J= 7.5 Hz, 
1H), 6.89-6.91 (m, 2H), 6.63-6.65 (m, 1H), 6.60 (s, 1H), 2.30 (s, 3H), 1.01 (s, 9H), 0.24 (s, 6H); 13C-NMR (125 
MHz, CDCl3); != 154.7, 143.4, 138.0, 132.3, 130.4, .130.2 124.9, 120.3, 119.6, 116.2, 25.7, 21.2, 18.2, -4.4; 
MS(EI): m/z(%): 314.2(21), 313.1(89, M+), 257.2(42), 256.1(100), 240.1(24), 198.1(9), 182.1(21), 167.1(22), 
127.6(27), 75.1(30), 57.1(8); HR-MS (DART): (M+H)+: Calcd for C19H28NOSi 314.1940; Found 314.1942); IR 
(cm-1): 3447, 3363, 2929, 2857, 1601, 1495, 1252. 
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2-acetaminobiphenyl derivatives 
General procedure. To a solution of 2-aminobiphenyl (0.1 g, 0.59 mmol) and triethylamine (0.09 mL, 0.65 
mmol) in 10 mL anhydrous of dichloromethane at 0°C, acetyl chloride (0.04 mL, 0.62 mmol) was added 
dropwise. The mixture was stirred at room temperature for 1 h. After the reaction time, the solvent was 
evaporated under reduced pressure. The residue was dissolved in ether (20 ml) washed with water (20 ml). The 
organic phase was dried over Na2SO4, filtered and the solvent was removed under reduced pressure using a 
rotary evaporator to obtain the N-acetylated compound. 
N-([1, 1’-biphenyl]-2-yl) acetamide (2a) [2113-47-5] 
2'-amino-[1, 1'-biphenyl] (1a) (0.10 g, 0.59 mmol), Acetyl chloride (0.04 mL, 0.62 mmol) and Triethylamine 
(0.09 mL, 0.65 mmol). The title compound was obtained as a pale- white solid (0.115 g, 93%). mp 119.8-120 oC; 
Rf = 0.24 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.26 (d, J= 8.5 Hz, 1H), 7.49 (t, J= 7 Hz, 2H), 
7.38(m, 3H), 7.24 (d, J= 7 Hz, 1H), 7.18 (d, J= 7.5 Hz, 1H), 2.02 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 
168.3, 138.2, 134.7, 132.2, 130.1 129.2, 129.1, 128.4, 128.0, 124.4, 121.7, 24.6; HR-MS (ESI): (M+Na)+: Calcd 
for C14H13NNaO 234.0895; Found 234.0896); IR (cm-1): 3286, 3027, 1658, 1531, 1433, 1301. 
N-(2'-(trifluoromethyl)-[1, 1’-biphenyl]-2-yl)acetamide(2b) [869631-32-3] 
2'-trifluoromethyl-[1, 1’-biphenyl]-2-amine (1b) (0.105 g, 0.443 mmol), Acetyl chloride (0.03 mL, 0.46 mmol) 
and Triethylamine (0.07 mL, 0.48 mmol). The title compound was obtained as pale- yellow solid (0.122 g, 98%). 
mp 87.2-88.4 oC; Rf = 0.42 [(Hx:EtOAc, 50:50)]; 1H-NMR (500 MHz, CDCl3): !=  8.15 (d, J= 8Hz, 1H), 7.82 
(d, J= 7.5Hz, 1H), 7.63 (t, J= 7.5Hz, 1H), 7.56 (t, J= 7.5Hz, 1H), 7.40-7.43 (m, 1H), 7.32 (d, J= 7.5Hz, 1H), 7.16 
(m, 2H), 6.51 (s, br, 1H), 1.92 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 167.1, 135.5, 134.1, 131.2, 131.0 129.0, 
128.9, 128.1, 127.5, 125.6 (q, CF3), 122.9, 121.1, 23.3; HR-MS (DART): (M+H)+: Calcd for 
C15H16NO 280.0949; Found 280.0950); IR (cm-1): 3237, 3031, 1659, 1529, 1312, 1109. 
N-(2'-methyl-[1, 1’-biphenyl]-2-yl)acetamide (2c) [1616966-63-2] 
2'-methyl-[1, 1’-biphenyl]-2-amine (1c) (0.12 g, 0.66 mmol), Acetyl chloride (0.05 mL, 0.69 mmol) and 
Triethylamine (1.0 mL, 0.72 mmol). The title compound was obtained as pale- brown liquid (0.146 g, 94%). Rf = 
0.15 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.34 (d, J= 7.5 Hz, 1H), 7.36-7.39 (m, 1H), 7.32-
7.34 (m, 2H), 7.29-7.31 (m, 1H), 7.14-7.19 (m, 3H), 6.78 (s, br, 1H), 2.10 (s, 3H), 1.95 (s, 3H); 13C-NMR (125 
MHz, CDCl3); != 168.1, 137.0, 135.3, 130.6, 130.0 129.7, 128.5, 128.4 126.4, 125.5, 123.9, 120.7, 24.7, 19.7; 
MS(EI): m/z(%); 226.1(8), 225.1(70, M+), 184.1(12), 183.1(100), 168.1(48), 167.1(52), 166.1(50), 152.1(14), 
139(10), 115(11), 89.1(8), 63(6); HR-MS (DART): (M+H)+: Calcd for C15H16NO 226.1232; Found 226.1233); 
IR (cm-1): 3413, 3294, 3019, 2923, 1686, 1518, 1443, 1301, 1181. 
N-(4'-methyl-[1, 1’-biphenyl]-2-yl)acetamide (2d) [76472-82-7] 
4'-methyl-[1, 1’-biphenyl]-2-amine (1d) (0.085 g, 0.460 mmol), Acetyl chloride (0.03 mL, 0.48 mmol) and 
Triethylamine (0.07 mL, 0.50 mmol). The title compound was obtained as pale- brown liquid (0.094 g, 90%). Rf 
= 0.16 [(Hx:EtOAc, 80:20)]; MS(EI): m/z (%): 226.2(6), 225.1(39, M+), 184.2(14), 183.1(100), 182.1(40), 
168.1(23), 167.1(36), 153.1(5), 152.1(14), 139.1(6), 115.1(7), 77.1(6), 63.1(5);  
N-(4'-ethyl-[1, 1’-biphenyl]-2-yl)acetamide (2e) [NEW] 
4'-ethyl-[1, 1’-biphenyl]-2-amine (1e) (0.112 g, 0.570 mmol), Acetyl chloride (0.04 mL, 0.60 mmol) and 
Triethylamine (0.09 mL, 0.62 mmol). The title compound was obtained as pale- yellow oil (0.131 g, 96%). Rf = 
0.19 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.27 (d, J= 8 Hz, 1H), 7.35-7.37 (m, 1H), 7.28-7.34 
(m, 4H), 7.23 (d, J= 7 Hz, 1H), 7.16 (t, J= 7.5 Hz, 1H), 2.73 (q, J= 7.5 Hz, 2H), 2.03 (s, 3H), 1.31 (t, J= 7.5 Hz, 
3H); 13C-NMR (125 MHz, CDCl3); != 168.2, 144.1, 135.4, 134.8, 130.1, 129.2, 128.6, 128.4 128.2, 124.3, 
121.5, 28.6, 24.7, 15.4; HR-MS (DART): (M+H)+: Calcd for C16H18NO 240.1388; Found 240.1389);  
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N-(2'-methoxy-[1, 1’-biphenyl]-2-yl)acetamide (2f) [141540-23-0] 
2'-methoxy-[1, 1’-biphenyl]-2-amine (1f) (0.11 g, 0.55 mmol), Acetyl chloride (0.04 mL, 0.57 mmol) and 
Triethylamine (0.08 mL, 0.60 mmol). The title compound was obtained as pale- brown liquid (0.128 g, 96%). Rf 
= 0.31 [(Hx:EtOAc, 50:50)]; 1H-NMR (500 MHz, CDCl3): !=  8.28 (d, J= 8.5 Hz, 1H), 7.35-7.41 (m, 2H), 7.24 
(d, J= 7.5 Hz, 1H), 7.17 (t, J= 7.5 Hz, 1H),  6.94-6.97 (m, 2H), 6.90 (m, 1H), 3.84 (s, 3H), 2.03 (s, 3H); 13C-
NMR (125 MHz, CDCl3); != 168.2, 156.1, 135.5, 132.2, 130.9, 129.7, 128.3, 124.5 122.5, 121.7, 117.5, 110.6, 
55.9, 24.6; MS(EI): m/z(%): 241.1(22, M+), 199.1(21), 181.1(26), 168.1(100), 167.1(82), 166.1(16), 139.1(18), 
128.1(16), 115.1(10), 77.1(19), 51.1(24); HR-MS (DART): (M+H)+: Calcd for C15H16NO2 242.1181; Found 
242.1182); IR (cm-1): 3415, 3057, 2933, 2836, 1688, 1515, 1443, 1234, 1022. 
N-(3'-methoxy-[1, 1’-biphenyl]-2-yl)acetamide (2g) [94028-76-9] 
3'-methoxy-[1, 1’-biphenyl]-2-amine (1g) (0.115, 0.577 mmol), Acetyl chloride (0.043 mL, 0.605 mmol) and 
Triethylamine (0.088 mL, 0.632 mmol). The title compound was obtained as pale- brown liquid (0.137 g, 99%). 
Rf = 0.41 [(Hx:EtOAc, 50:50)]; 1H-NMR (500 MHz, CDCl3): !=  8.08 (d, J= 8.5 Hz, 1H), 7.38-7.41 (m, 2H), 
7.22-7.25 (m, 2H), 7.18 (t, J= 7.5 Hz, 1H), 7.09 (t, J= 7.5 Hz, 1H),  7.03-7.06 (m, 1H), , 3.83 (s, 3H), 1.99 (s, 
3H); HR-MS (DART): (M+H)+: Calcd for C15H16NO2 242.1181; Found 242.1182); IR (cm-1): 3306, 2930, 2836, 
1691, 1516, 1443, 1240, 1020. 
N-(4'-methoxy-[1, 1’-biphenyl]-2-yl)acetamide (2h) [1217-87-4] 
4'-methoxy-[1, 1’-biphenyl]-2-amine (1h) (0.112, 0.563 mmol), Acetyl chloride (0.042 mL, 0.586 mmol) and 
Triethylamine (0.087 mL, 0.623 mmol). The title compound was obtained as pale- yellow oil (0.135 g, 99%). Rf 
= 0.38 [(Hx:EtOAc, 50:50)]; 1H-NMR (500 MHz, CDCl3): !=  8.26 (d, J= 8 Hz, 1H), 7.33-7.36 (m, 1H), 7.28-
7.30 (m, 2H), 7.22 (d, J= 7 Hz, 1H), 7.15-7.17 (m, 1H), 7.01-7.02 (m, 2H), 3.87 (s. 3H), 2.03 (s, 3H); 13C-NMR 
(125 MHz, CDCl3); != 168.2, 159.4, 134.9, 130.4, 130.3, 130.1, 128.1, 124.3, 121.5, 114.5, 55.4, 24.7; MS(EI): 
m/z(%): 242.1(7), 241.1(41, M+), 200.1(15), 199.1(100), 184.1(33), 167.1(14), 154.1(30), 139.1(9), 128.1(22), 
127.1(17), 102.1(7), 77.1(11), 63.1(8); HR-MS (DART): (M+H)+: Calcd for C15H16NO2 242.1181; Found 
242.1181; IR (cm-1): 3350, 2932, 2838, 1689, 1512, 1240, 1032. 
N-acetyl Carbazole derivatives 
General procedure. In a microwave tube, 2-acetaminobiphenyl (106 mg, 0.51 mmol) dissolved in glacial acetic 
acid (5mL), Pd(OAc)2 (5.7 mg, 0.025 mmol), Imes.HCl (8.7 mg, 0.025 mmol) and H2O2 (35%, 0.130 mL, 1.48 
mmol) were added. The vial was sealed whereupon a magnetic stirrer bar was transferred to the tube. The tube 
was submerged in the microwave cavity for 3 h at 120oC. After the reaction time, the solvent acetic acid was 
removed under reduced pressure. The crude product was dissolved in EtOAc (25 mL) and washed with water (20 
mL). The aqueous phase was extracted with EtOAc (2×20 mL). The combined organic layer was washed with 
aqueous NaHCO3 (20 mL). The organic layer was filtered off and dried over Na2SO4. The solvent was 
evaporated under reduced pressure. The crude product was purified by silica gel chromatography using hexane 
(mixture of isomers) and ethyl acetate (gradient; 90:10 to 70:30) to obtain the N-acetyl Carbazole compound. 
1-(9H-carbazol-9-yl)	ethan-1-one	(3a)	[574-39-0]	
N-([1, 1'-biphenyl]-2-yl)acetamide (2a) (0.106 g, 0.50 mmol), Pd(OAc)2 (5.6 mg, 0.025 mmol), IMes.HCl (8.5 
mg, 0.025 mmol) and H2O2 (35%, 0.128 mL, 1.45 mmol). The title compound was obtained as a pale- yellow 
solid (0.090 g, 85%). mp 77.5-78.5 oC; Rf = 0.70 [(Hx:EtOAc, 70:30)]; 1H-NMR (500 MHz, CDCl3): !=  8.22 
(d, J= 8.5 Hz, 2H), 7.99-8.01 (m, 2H), 7.47-7.50 (m, 2H), 7.38-7.41 (td, J= 7.5 Hz, 1 Hz, 2H), 2.89 (s, 3H); 13C-
NMR (125 MHz, CDCl3); != 170.1, 138.7, 127.4, 126.4, 123.7, 119.9, 116.3, 27.8; MS(EI): m/z(%): 210.1(5), 
209.1(32, M+), 168.1(20), 167.1(100), 166.1(25), 140.1(11), 139.1(11), 138.1(3), 113.1(3), 89.1(2), 63.1(3); HR-
MS (DART): (M+H)+: Calcd for C14H12NO 210.0919; Found 210.0920; IR (cm-1): 3417, 3043, 2919, 1678, 
1444, 1367, 1297, 1014. 
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1-(4-(trifluoromethyl)-9H-carbazol-9-yl)	ethan-1-one	(3b)	[3932-32-9]	
N-(2'-(trifluoromethyl)-[1, 1'-biphenyl]-2-yl) acetamide (2b) (0.105 g, 0.376 mmol), Pd(OAc)2 (4.2 mg, 0.019 
mmol), IMes.HCl (8.5 mg, 0.019 mmol) and H2O2 (35%, 0.096 mL, 1.09 mmol). MS (EI): m/z (%): 278.1(2), 
277(12, M+), 258(1), 236.1(12), 235.1(100), 216.1(4), 185.1(7), 166.1(9), 139.1(4), 87(1), 75(1), 63(1) 
1-(4-methyl-9H-carbazol-9-yl)	ethan-1-one	(3c)	[1616966-64-3]	
N-(2'-methyl-[1, 1'-biphenyl]-2-yl)acetamide (2c) (0.140 g, 0.62 mmol), Pd(OAc)2 (7.0 mg, 0.031 mmol), 
IMes.HCl (11.0 mg, 0.031 mmol) and H2O2 (35%, 0.16 mL, 1.79 mmol). MS (EI): m/z (%): 224.2(4), 223.1(23, 
M+), 182.1(15), 181.1(100), 180.1(68), 179.1(8), 152.1(19), 127.1(5), 89.1(3), 77.1(7), 63.1(5). 
1-(2-methyl-9H-carbazol-9-yl)	ethan-1-one	(3d)	[433287-20-8]	
N-(4'-methyl-[1, 1'-biphenyl]-2-yl)acetamide (2d) (0.087 g, 0.390 mmol), Pd(OAc)2 (4.4 mg, 0.02 mmol), 
IMes.HCl (7.0 mg, 0.02 mmol) and H2O2 (35%, 0.10 mL, 1.11 mmol). The title compound was obtained as an 
orange liquid (0.040 g, 46%). Rf = 0.55 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.15 (d, J= 8.5 
Hz, 1H), 8.05 (s, 1H), 7.93-7.95 (m, 1H), 7.85 (d, J= 8 Hz, 1H), 7.42-7.45 (td, J= 1 Hz, 7 Hz, 1H), 7.34-7.37 (td, 
J= 1 Hz, 7.5 Hz, 1H), 7.20-7.21 (dd, J= 0.5, 8 Hz, 1H), 2.87 (s, 3H), 2.54 (s, 3H); 13C-NMR (125 MHz, CDCl3); 
!= 170.2, 139.1, 138.6, 137.6, 126.8, 126.6, 124.9, 124.0, 123.6, 119.6, 27.8, 22.4; MS(EI): m/z(%): 224.1(5), 
223.1(27, M+), 182.1(15), 181.1(100), 180.1(70), 179.1(8), 152.1(18), 151.1(8), 127.1(5), 77.1(6), 63.1(5); HR-
MS (DART): (M+H)+: Calcd for C15H14NO 224.1075; Found 224.1077.  
1-(2-ethyl-9H-carbazol-9-yl)	ethan-1-one	(3e)	[NEW]	
N-(4'-ethyl-[1, 1'-biphenyl]-2-yl) acetamide (2e) (0.058 g, 0.25 mmol), Pd(OAc)2 (2.8 mg, 0.012 mmol), 
IMes.HCl (4.2 mg, 0.012 mmol) and H2O2 (35%, 0.062 mL, 0.70 mmol). The title compound was obtained as 
pale- orange oil (0.047 g, 81%). Rf = 0.71 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.14 (d, J= 8 
Hz, 1H), 8.08 (s, 3H),  7.93-7.95 (m, 1H), 7.88 (d, J= 7.5 Hz, 1H), 7.41-7.45 (td, J= 1.5 Hz, 7.5 Hz, 1H), 7.34-
7.37 (td, J= 1 Hz, 7.5 Hz, 1H), 7.23-7.24 (dd, J= 1.5 Hz, 8 Hz, 1H), 2.87 (s, 3H), 2.82 (q, J= 7.5 Hz, 2H), 1.33 (t, 
J= 8 Hz, 3H); 13C-NMR (125 MHz, CDCl3); !=  170.2, 144.2, 139.1, 138.7, 126.8, 126.6, 124.3, 123.8, 123.6, 
119.6, 119.5, 116.1, 115.7 29.8, 27.8, 16.2; MS(EI): m/z(%): 238.2(4), 237.1(28, M+), 196.1(10), 195.1(65), 
181.1(14), 180.1(100), 179.1(13), 168.1(12), 152.1(13), 75(4), 63(5); HR-MS (DART): (M+H)+: Calcd for 
C16H16NO 238.1232; Found 238.1233; IR (cm-1): 2963, 2928, 2870, 1690, 1421, 1366, 1293, 1192. 
1-(4-methoxy-9H-carbazol-9-yl)	ethan-1-one	(3f)	[869631-38-9]	
N-(2'-methoxy-[1, 1'-biphenyl]-2-yl)acetamide (2f) (0.115 g, 0.477 mmol), Pd(OAc)2 (5.4 mg, 0.024 mmol), 
IMes.HCl (8.1 mg, 0.024 mmol) and H2O2 (35%, 0.120 mL, 1.38 mmol). MS (EI): m/z(%): 240.1(4), 239.1(41, 
M+), 198.1(13), 197.1(100), 182(41), 154.1(76), 153.1(27), 139.1(10), 128.1(17), 127.1(25), 126.1(18), 77(9). 
63(8). 
1-(3-methoxy-9H-carbazol-9-yl)	ethan-1-one	(3g)	[173312-32-8]	
N-(3'-methoxy-[1, 1'-biphenyl]-2-yl)acetamide (2g) (0.108 g, 0.448 mmol), Pd(OAc)2 (5.0 mg, 0.022 mmol), 
IMes.HCl (8.0 mg, 0.022 mmol) and H2O2 (35%, 0.11 mL, 1.29 mmol). The title compound was obtained as 
pale- yellow oil (0.065 g, 61%). Rf = 0.77 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.15 (t, J= 7.5 
Hz, 1H), 7.94 (d, J= 8 Hz, 1H), 7.47-7.49 (m, 1H), 7.43-7.45 (dd, J= 1 Hz, 7 Hz, 1H), 7.37 (t, J= 8 Hz, 2H), 
7.04-7.06 (dd, J= 3 Hz, 9 Hz, 1H), 3.93(s, 3H), 2.85 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 169.7, 156.5, 
139.1, 133.1, 127.4, 126.5, 123.5, 119.9, 117.3, 116.3, 114.9, 103.2, 55.8, 27.6; MS(EI): m/z(%): 240.1(4), 
239.1(33, M+), 198.1(11), 197.1(78), 183(13), 182(100), 154.1(36), 139(6), 128.1(15), 127.1(27), 126.1(20), 
101(7), 75(13), 51(8); HR-MS (DART): (M+H)+: Calcd for C15H14NO2 240.1025; Found 240.1024; IR (cm-1): 
3346, 2935, 2833, 1684, 1487, 1433, 1300, 1200, 1033. 
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1-(2-methoxy-9H-carbazol-9-yl)	ethan-1-one	(3h)	[92552-65-3]	
N-(4'-methoxy-[1, 1'-biphenyl]-2-yl) acetamide (2h) (0.115 g, 0.477 mmol), Pd(OAc)2 (5.4 mg, 0.024 mmol), 
IMes.HCl (8.1 mg, 0.024 mmol) and H2O2 (35%, 0.120 mL, 1.38 mmol). The title compound was obtained as 
pale- yellow solid (0.080 g, 70%). mp 108.7-109.9 oC; Rf = 0.83 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, 
CDCl3): !=  7.93 (d, J= 8.5 Hz, 1H), 7.77-7.80 (m, 2H), 7.73 (d, J= 8.5 Hz, 1H), 7.23-7.31 (m, 2H), 6.86-6.89 
(dd, J= 2.5 Hz, 8.5 Hz, 1H), 3.82 (s, 3H), 2.75 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 170.2, 159.8, 140.1, 
138.4, 126.7, 125.9, 123.7, 120.2, 119.7, 119.2, 115.7, 111.4, 102, 55.8, 27.7; MS(EI): m/z(%): 240.1(8), 
239(50, M+), 198.1(15), 197.1(100), 182(71), 155(8), 154.1(64), 153.1(36), 139(7), 128(17), 127.1(27), 126(20), 
101.1(7), 75912), 63(9); HR-MS (DART): (M+H)+: Calcd for C15H14NO2 240.1025; Found 240.1023; IR (cm-1): 
3386, 2925, 2838, 1693, 1461, 1432, 1038.  
Carbazole derivatives 
General procedure. In a microwave tube, 2-aminobiphenyl (84.5 mg, 0.5 mmol) was dissolved in glacial acetic 
acid (5mL), Pd(OAc)2 (22.5 mg, 0.1 mmol), IMes.HCl (8.5 mg, 0.025 mmol) and H2O2 (35%, 0.128 mL, 1.45 
mmol) were added. The vial was sealed whereupon a magnetic stirrer bar was transferred to the tube. The tube 
was submerged in the microwave cavity for 20 min at 120oC. After the reaction time, the solvent acetic acid was 
removed under reduced pressure. The crude product was dissolved in EtOAc (25 mL) and washed with water (20 
mL). The aqueous phase was extracted with EtOAc (2×20 mL). The combined organic layer was washed with 
aqueous NaHCO3 (20 mL). The organic layer was filtered off via pad of celite and dried over Na2SO4. The 
solvent was evaporated under reduced pressure. The crude product was purified by silica gel column 
chromatography using hexanes (mixture of isomers) and ethyl acetate (gradient; 90:10 to 50:50) to obtain the 
target compound. 
9H-carbazole	(4a)	[86-74-8]	
2-amino-1, 1’-biphenyl (1a) (0.085 g, 0.50 mmol), Pd(OAc)2 (22.4 mg, 0.1 mmol), IMes.HCl (8.5 mg, 0.05 
mmol) and H2O2 (35%, 0.128 mL, 1.45 mmol). The title compound was obtained as a pale- brown solid (0.070 
g, 84 %). mp 242-243 oC ;Rf = 0.49 [(Hx:EtOAc, 80:20)]; 1H-NMR (400 MHz, CDCl3): !=  8.09 (d, J= 8 Hz, 
2H), 7.42-7.47 (m, 4H), 7.22-7.26 (m, 2H); 13C-NMR (100 MHz, CDCl3); != 139.5, 125.8, 123.4, 120.3, 119.4, 
110.6; HR-MS (DART): (M+H)+: Calcd for C12H10N 168.0813; Found 168.0814; IR (cm-1): 3415, 3050, 1599, 
1449, 1325, 722. 
4-(trifluoromethyl)-9H-carbazole	(4b)	[2586-09-6]	
2'-(trifluoromethyl)-[1, 1'-biphenyl]-2-amine (1b) (0.100 g, 0.422 mmol), Pd(OAc)2 (19.0 mg, 0.084 mmol), 
IMes.HCl (7.2 mg, 0.021 mmol) and H2O2 (35%, 0.11 mL, 1.23 mmol). The title compound was obtained as a 
brown liquid (0.060 g, 60 %). Rf = 0.42 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.25 (d, J= 8 
Hz, 1H), 8.23 (s, br, 1H), 7.52 (d, J= 8.5 Hz, 1H), 7.47 (d, J= 7.5 Hz, 1H), 7.36-7.43 (m, 3H), 7.20-7.24 (td, J= 
1.5 Hz, 8 Hz, 1H); 13C-NMR (125 MHz, CDCl3); != 140.1, 139.8, 126.9, 126.0, 124.9, 123.8, 123.5 (q, J= 18 
Hz), 120.5, 120.3, 119.4, 117.1 (q, J= 22.5 Hz), 114.5, 110.8; MS(EI): m/z(%): 236.1(14), 235.1(100, M+), 
216(9), 185.1(12), 166.1(16), 139(11), 117.4(52), 107.7(12), 93(25), 69.1(12); HR-MS (DART): (M+H)+: Calcd 
for C13H9F3N 236.0687; Found 236.0686; IR (cm-1): 3415, 1327, 1293, 1112, 726.  
4-methyl-9H-carbazole	(4c)	[3770-48-7]	
2'-methyl-[1, 1'-biphenyl]-2-amine (1c) (0.12 g, 0.66 mmol), Pd(OAc)2 (30.0 mg, 0.13 mmol), IMes.HCl (11.0 
mg, 0.032 mmol) and H2O2 (35%, 0.17 mL, 1.91 mmol). The title compound was obtained as a pale- brown solid 
(0.097 g, 82 %). mp 126 oC ;Rf = 0.66 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.16-8.18 (dd, J= 
0.5 Hz, 8 Hz, 1H), 8.05(s, br, 1H), 7.41-7.43 (m, 2H), 7.30-7.33 (m, 1H), 7.25-7.28 (m, 2H), 7.00-7.02 (dd, J= 1 
Hz, 7 Hz, 1H), 2.88 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 139.5, 133.4, 125.7, 125.2, 124.0, 122.6, 121.9, 
121.0, 119.4, 110.4, 108.1, 20.8; MS(EI): m/z(%): 182.1(13), 181.1(100, M+), 180.1(80), 179.1(7), 152.1(17), 
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127.1(5), 90.5(34), 77.1(30), 63.1(10); HR-MS (DART): (M+H)+: Calcd for C13H12N 182.0970; Found 
182.0969; IR (cm-1): 3384, 3053, 2918, 2849, 1600, 1454, 1324. 
2-methyl-9H-carbazole	(4d)	[3652-91-3]	
4’-methyl-[1, 1'-biphenyl]-2-amine (1d) (0.086 g, 0.47 mmol), Pd(OAc)2 (22.4 mg, 0.09 mmol), IMes.HCl (8.0 
mg, 0.023 mmol) and H2O2 (35%, 0.120 mL, 1.35 mmol). The title compound was obtained as brown solid 
(0.060 g, 71 %). mp 233.5-234.4 oC; Rf = 0.58 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.03 (d, 
J= 8 Hz, 1H), 7.95 (d, J= 8 Hz, 1H), 7.38-7.40 (m, 2H), 7.23 (s, 1H), 7.20-7.22 (m, 1H), 7.06 (d, J= 8 Hz, 1H), 
2.53 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 140.0, 139.5, 136.0, 129.3, 129.2, 125.3, 123.5, 121.0, 120.0, 
119.3, 110.7, 110.5, 22.1; MS(EI): m/z(%): 182.1(16), 181.1(100, M+), 153.1(10), 152.1(25), 96.1(18), 
90.5(45), 77.1(54), 60.1(77); HR-MS (DART): (M+H)+: Calcd for C13H12N 182.0970; Found 182.0968; IR (cm-
1): 3397, 3049, 2916, 2852, 1607, 1460, 1326, 1243, 807, 726. 
2-ethyl-9H-carbazole	(4e)	[106551-62-6]	
4'-ethyl-[1, 1'-biphenyl]-2-amine (1e) (0.112 g, 0.569 mmol), Pd(OAc)2 (25.0 mg, 0.11 mmol), IMes.HCl (11.0 
mg, 0.029 mmol) and H2O2 (35%, 0.15 mL, 1.65 mmol). The title compound was obtained as brown solid (0.082 
g, 75 %). mp 222-224 oC ;Rf = 0.66 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.02-8.04 (dd, J= 
0.5 Hz, 7.5 Hz, 1H), 7.97 (d, J= 8 Hz, 1H), 7.38-7.42 (m, 2H), 7.28 (d, J= 8.5 Hz, 1H), 7.24 (s, 1H), 7.08-7.10 
(dd, J= 1.5 Hz, 8 Hz, 1H), 2.81(q, J= 7.5 Hz, 2H), 1.32 (t, J= 7.5 Hz, 3H) ; 13C-NMR (125 MHz, CDCl3); != 
142.6, 136.2, 132.1, 129.3, 128.2, 125.3, 121.4, 120.0, 119.9, 119.3, 110.5, 29.5, 16.1; MS(EI): m/z(%): 
195.1(52, M+), 180.1(100), 133(19), 96(58), 77(36), 60(57); HR-MS (DART): (M+H)+: Calcd for 
C14H14N 196.1126; Found 196.1128; IR (cm-1): 3396, 2960, 2927, 1654, 1461, 1247. 
4-methoxy-9H-carbazole	(4f)	[6933-50-2]	
2’-methoxy-[1, 1'-biphenyl]-2-amine (1f) (0.110 g, 0.55 mmol), Pd(OAc)2 (25.0 mg, 0.11 mmol), IMes.HCl (9.0 
mg, 0.028 mmol) and H2O2 (35%, 0.128 mL, 1.45 mmol). The title compound was obtained as a pale- brown 
solid (0.010 g, 9 %). mp 132-133 oC; Rf = 0.71 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.31 (d, 
J= 8 Hz, 1H), 8.07 (s, br, 1H), 7.36-7.40 (m, 2H), 7.33 (d, J= 8 Hz, 1H), 7.22-7.24 (m, 1H), 7.05 (d, J= 8 Hz, 
1H), 6.68 (d, J= 8 Hz, 1H), 4.08 (s. 3H); 13C-NMR (125 MHz, CDCl3); != 151.0, 133.4, 127.2, 125.6, 123.6, 
121.4, 119.7, 117.8, 114.4, 104.6, 98.2, 95.1, 50.2; MS(EI): m/z(%): 198.1(11), 197.1(84, M+), 182(37), 
155.1(11), 154(100), 128(24), 127(32), 126(17), 99(30), 77(29), 63.1(23); HR-MS (DART): (M+H)+: Calcd for 
C13H12NO 198.0919; Found 198.0920; IR (cm-1): 3401, 2956, 2919, 2850, 1718, 1455, 1261, 1101, 752. 
3-methoxy-9H-carbazole	(4g)	[18992-85-3]	
3’-methoxy-[1, 1'-biphenyl]-2-amine (1g) (0.115 g, 0.578 mmol), Pd(OAc)2 (26.0 mg, 0.116 mmol), IMes.HCl 
(10 mg, 0.029 mmol) and H2O2 (35%, 0.148 mL, 1.676 mmol). The title compound was obtained as brown solid 
(0.013 g, 10 %). mp 145-147 oC; Rf = 0.71 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  8.03 (d, J= 
7.5 Hz, 1H), 7.93 (s, br, 1H), 7.56 (m, 1H), 7.39-7.42 (m, 2H), 7.34(d, J= 8.5 Hz, 1H), 7.19-7.22 (m, 1H), 7.05-
7.08 (dd, J= 2.5 Hz, 9 Hz, 1H), 3.93 (s. 3H); 13C-NMR (125 MHz, CDCl3); != 153.9, 140.3, 134.4, 128.8, 125.8, 
123.8, 120.3, 119.1, 115.1, 111.3, 110.7, 103.2, 56.1; MS(EI): m/z(%): 197.1(79, M+), 182(100), 154(65), 
133(25), 128(31), 127(41), 96(63), 77(53), 51(52); HR-MS (DART): (M+H)+: Calcd for C13H12NO 198.0919; 
Found 198.0920; IR (cm-1): 3399, 2917, 2848, 1460, 1172, 1031, 817, 726. 
2-methoxy-9H-carbazole (4h) (6933-49-9) 
4’-methoxy-[1, 1'-biphenyl]-2-amine (1h) (0.112 g, 0.563 mmol), Pd(OAc)2 (25 mg, 0.11 mmol), IMes.HCl (9.6 
mg, 0.028 mmol) and H2O2 (35%, 0.14 mL, 1.61 mmol). The title compound was obtained as a pale- brown solid 
(0.045 g, 41 %). mp 236.5-237.5 oC; Rf = 0.72 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, DMSO-d6): != 11.1 
(s, 1H), 7.95-7.99 (m, 2H), 7.42 (d, J= 8.5 Hz, 1H), 7.27-7.30 (td, J= 1 Hz, 7 Hz, 1H), 7.09-7.12 (td, J= 1 Hz, 8 
Hz, 1H), 6.97 (d, J= 2.5 Hz, 1H), 6.76-6.78(dd, J= 2 Hz, 8.5 Hz, 1H) 3.83 (s, 3H);; 13C-NMR (125 MHz, 
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DMSO-d6); != 158.4, 141.0, 139.6, 124.1, 122.6, 120.9, 119.2, 118.5, 116.1, 110.6, 107.7, 94.4, 55.2; HR-MS 
(DART): (M+H)+: Calcd for C13H12NO 198.0919; Found 198.0919; IR (cm-1): 3386, 2930, 2837, 1602, 1511, 
1460, 1303, 1245, 1178, 1030. 
2-chloro-9H-carbazole	(4i)	[10537-08-3]	
4'-chloro-[1, 1'-biphenyl]-2-amine (1i) (0.13 g, 0.090 mmol), Pd(OAc)2 (29 mg, 0.129 mmol), IMes.HCl (11.0 
mg, 0.032 mmol) and H2O2 (35%, 0.160 mL, 1.85 mmol). The title compound was obtained as pale- brown solid 
(0.090 g, 70 %). mp 233.1-235 oC ;Rf = 0.61 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): != 7.92 (s, 
1H), 7.86 (d, J= 7.5 Hz, 1H), 7.80 (d, J= 8.5 Hz, 1H), 7.23-7.25 (m, 3H), 7.08-7.10 (m, 1H), 7.02-7.04 (dd, J= 
1.5 Hz, 8.0 Hz, 1H); 13C-NMR (125 MHz, DMSO-d6); != 140.3, 140.0, 129.9, 126.0, 121.8, 121.5, 121.3, 120.3, 
119.0, 118.6, 111.2, 110.6; MS(EI): m/z(%): 203(30), 201(100, M+), 167.1(6), 166.1(61), 140(20), 139(30), 
102(23), 101(65), 87.1(23), 83(62), 69.2(49), 63.1(30); HR-MS (EI): (M)+: Calcd for C12H835ClN 201.0345; 
Found 201.0348; Calcd for C12H837ClN 203.0316; Found 203.0323; IR (cm-1): 3413, 3061, 2952, 2853, 1595, 
1437, 1327, 1090, 812, 726. 
9H-carbazole-2-carboxylic	acid	(4j)	[51094-28-1]	
2-amino-[1, 1'-biphenyl]-4-carboxylic acid (1j) (0.11 g, 0.52 mmol), Pd(OAc)2 (23 mg, 0.102 mmol), IMes.HCl 
(9.0 mg, 0.026 mmol) and H2O2 (35%, 0.13 mL, 1.50 mmol). The title compound was obtained as a pale- white 
solid (0.082 g, 75 %). mp 316-318 oC; Rf = 0.63 [(Hx:EtOAc, 50:50)]; 1H-NMR (500 MHz, DMSO-d6): !=  
11.53 (s, 1H), 8.20 (t, J= 7.5 Hz, 2H), 8.11 (s, 1H), 7.77-7.79 (dd, J= 1 Hz, 8 Hz, 1H), 7.56 (d, J= 8 Hz, 1H), 
7.45-7.48 (td, J= 1 Hz, 7 Hz, 1H), 7.20-7.23 (td, J= 1 Hz, 8 Hz, 1H); 13C-NMR (125 MHz, DMSO-d6); != 
168.1,140.9, 139.0, 127.7, 126.8, 125.8, 121.6, 120.9, 119.8, 119.5, 119.0, 112.4, 111.3; HR-MS (DART): (M-
H)+: Calcd for C13H8NO2 210.0555; Found 210.0552; IR (cm-1): 3415, 3391, 2923, 1670, 1260, 1000. 
1-(7-chloro-9H-carbazol-2-yl)	ethan-1-one	(4k)	[NEW]	
1-(2-amino-4'-chloro-[1, 1'-biphenyl]-4-yl) ethan-1-one (1k) (0.125 g, 0.510 mmol), Pd(OAc)2 (23 mg, 0.102 
mmol), IMes.HCl (8.7 mg, 0.026 mmol) and H2O2 (35%, 0.130 mL, 1.47 mmol). The title compound was 
obtained as brown solid (0.090 g, 73 %). mp 218-220 oC; Rf = 0.69 [(EtOAc:Hx, 50:50)]; 1H-NMR (500 MHz, 
DMSO-d6): !=  11.67 (s, 1H), 8.21-8.25 (m, 2H), 8.11 (s, 1H), 7.81-7.83 (dd, J= 1.5 Hz, 8 Hz, 1H), 7.62 (d, J= 
2Hz, 1H), 7.22-7.24 (dd, J= 2 Hz, 8.5 Hz, 1H), 2.68 (s, 3H); 13C-NMR (125 MHz, DMSO-d6); != 197.8, 141.7, 
139.5, 134.4, 131.4, 125.5, 122.6, 120.5, 120.2, 119.4, 119.1, 111.6, 111.0, 26.9; MS(EI): m/z(%): 245(18), 
243(57, M+),  230(32), 228(100), 208(69), 200(82), 173(42), 164(56), 138(29), 114(47), 96(44), 86(60), 83(69), 
82(52), 63(50); HR-MS (DART): (M+H)+: Calcd for C14H1035Cl NO 243.0451; Found 243.0453, Calcd for 
C14H1037Cl NO 245.0451; Found 245.0454; IR (cm-1): 3307, 2962, 2919, 1660, 1621, 1429, 1250, 801. 
1-(5-methyl-9H-carbazol-2-yl)	ethan-1-one	(4l)	[NEW]	
1-(2-amino-2'-methyl-[1, 1'-biphenyl]-4-yl) ethan-1-one (1l) (0.095 g, 0.422 mmol), Pd(OAc)2 (19.0 mg, 0.085 
mmol), IMes.HCl (7.0 mg, 0.021 mmol) and H2O2 (35%, 0.11 mL, 1.23 mmol). The title compound was 
obtained as pale white solid (0.080 g, 85 %). mp 180-182 oC ;Rf = 0.70 [(Hx:EtOAc, 50:50)]; 1H-NMR (500 
MHz, CDCl3): !=  8.39 (s, br, 1H), 8.20 (d, J= 8 Hz, 1H), 8.09 (s, 1H), 7.85-7.87 (dd, J= 1.5 Hz, 8.5 Hz, 1H), 
7.37-7.40 (m, 1H), 7.33 (d, J= 8 Hz, 1H), 7.05 (d, J= 7 Hz, 1H), 2.90 (s, 3H), 2.72 (s, 3H) ; 13C-NMR (125 MHz, 
CDCl3); != 198.5, 141.2, 139.1, 134.3, 134.0, 127.9, 127.2, 122.2, 121.4, 121.2, 119.9, 110.6, 108.5, 27.0, 20.8; 
MS(EI): m/z(%): 223.1(61, M+), 208(100), 207(17), 180(68), 178(20), 152(32), 151(17), 127(16), 104(60), 
89.1(35), 77(67), 63(25); HR-MS (DART): (M+H)+: Calcd for C15H14NO 224.1075; Found 224.1077; IR (cm-1): 
3261, 2918, 2849, 1660, 1618, 1441, 1274, 1205. 
2-chloro-7-methyl-9H-carbazole	(4m)	[NEW]		
4'-chloro-4-methyl-[1, 1'-biphenyl]-2-amine (1m) (0.085 g, 0.391 mmol), Pd(OAc)2 (18.0 mg, 0.080 mmol), 
IMes.HCl (7.0 mg, 0.021 mmol) and H2O2 (35%, 0.10 mL, 1.14 mmol). The title compound was obtained as 
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yellow solid (0.065 g, 77 %). mp 85-87 oC ;Rf = 0.58 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, DMSO-d6): 
!=11.27 (s, 1H), 8.06 (d, J= 8.5 Hz, 1H), 7.98 (d, J= 8.0 Hz, 1H), 7.54 (m, 1H), 7.49 (s, 1H), 7.48 (m, 1H), 7.30 
(s, 1H), 2.47 (s, 3H); 13C-NMR (125 MHz, DMSO-d6); != 140.5, 140.3, 135.6, 131.2, 128.3, 121.1, 120.6, 
120.0, 119.5, 118.5, 111.1, 110.4, 21.6; MS(EI): m/z(%): 216(24), 215(71, M+), 214(38), 180.1(44), 179.1(22), 
151(20), 133(11), 107(15), 96(26), 90(81), 76(100), 75.1(61), 63(44), 57(39); HR-MS (EI): (M)+: Calcd for 
C13H1035ClN 215.0502; Found 215.0503; Calcd for C13H1037ClN 217.0472; Found 217.0564; IR (cm-1): 3406, 
2920, 2851, 1600, 1002, 798. 
5-chloro-2-methyl-9H-carbazole	(4n)	[NEW]	
2'-chloro-4-methyl-[1, 1'-biphenyl]-2-amine (1n) (0.089 g, 0.410 mmol), Pd(OAc)2 (18 mg, 0.08 mmol), 
IMes.HCl (7.0 mg, 0.021 mmol) and H2O2 (35%, 0.10 mL, 1.18 mmol). The title compound was obtained as 
orange solid (0.071 g, 81 %). mp 70-71 oC; Rf = 0.40 [(Hx:EtOAc, 80:20)]; 1H-NMR (500 MHz, CDCl3): !=  
8.35 (d, J= 8 Hz, 1H), 7.90 (s, 1H), 7.16-7.19 (m, 2H), 7.09-7.11 (m, 2H), 7.01-7.03 (dd, J= 0.5 Hz, 8 Hz, 1H), 
2.44 (s, 3H); 13C-NMR (125 MHz, CDCl3); != 140.5, 140.0, 136.7, 128.3, 125.6, 122.7, 121.4, 120.8, 120.1, 
120.0, 110.5, 108.8, 22.1; MS(EI): m/z(%):  217(31), 216(30), 215(100, M+), 180.1(44), 178(22), 152.1(20), 
108(17), 90(64), 89.1(92), 76(84), 75.1(45), 63(31); HR-MS (EI): (M)+: Calcd for C13H1035ClN 215.0502; Found 
215.0503; Calcd for C13H1037ClN 217.0472; Found 217.0507; IR (cm-1): 3384, 2917, 2850, 1609, 1432, 1317, 
808, 753. 
2-((tert-butyldimethylsilyl)	oxy)-7-methyl-9H-carbazole	(4o)	[NEW]	
4'-((tert-butyldimethylsilyl) oxy)-4-methyl-[1, 1’-biphenyl]-2-amine (1o) (0.070 g, 0.23 mmol), Pd(OAc)2 (10 
mg, 0.045 mmol), IMes.HCl (4 mg, 0.01 mmol) and H2O2 (35%, 0.06 mL, 0.64 mmol). MS(EI): m/z(%): 
312.1(9), 311.1(38, M+), 255.1(36), 254(100), 239(16), 226(23), 207(25), 196(12), 180(22), 152(14), 126.7(99), 
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HRMS (EI) of 2-chloro-9H-carbazole (4i) 
 
 













 HRMS (DART-) of 9H-carbazole-2-carboxylic acid (4j) 
 
 














HRMS (EI) of 1-(7-chloro-9H-carbazol-2-yl) ethan-1-one (4k) 
 
 














HRMS (DART+) of 1-(5-methyl-9H-carbazol-2-yl) ethan-1-one (4l) 
 
 














HRMS (EI) of 2-chloro-7-methyl-9H-carbazole (4m) 
 
 














HRMS (EI) of 5-chloro-2-methyl-9H-carbazole (4n) 
 
 





















HRMS (ESI) of N-([1, 1’-biphenyl]-2-yl) acetamide (2a) 
 
 














HRMS (DART+) of N-(2'-(trifluoromethyl)-[1, 1’-biphenyl]-2-yl)acetamide(2b) 
 
 















HRMS (DART+) of N-(2'-methyl-[1, 1’-biphenyl]-2-yl)acetamide (2c) 
 
 




































































HRMS (DART+) of N-(2'-methoxy-[1, 1’-biphenyl]-2-yl)acetamide (2f) 
 
 









HRMS (DART+) of N-(3'-methoxy-[1, 1’-biphenyl]-2-yl)acetamide (2g) 
 
 














HRMS (DART+) of N-(4'-methoxy-[1, 1’-biphenyl]-2-yl)acetamide (2h) 
 
 















HRMS (DART+) of 1-(9H-carbazol-9-yl) ethan-1-one (3a)  
 
 


































































HRMS (DART+) of 1-(2-ethyl-9H-carbazol-9-yl) ethan-1-one (3e) 
 
 






































HRMS (DART+) of 1-(3-methoxy-9H-carbazol-9-yl) ethan-1-one (3g) 
 
 















HRMS (DART+) of 1-(2-methoxy-9H-carbazol-9-yl) ethan-1-one (3h) 
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A Concise Synthesis to Benzo[c]cinnolines via
2,2’-Dinitro-1,1’-Biphenyls Attained from a Novel Tailored
Suzuki Cross-Coupling
Vijayaragavan Elumalai and Hans-René Bjørsvik*[a]
A new two-step synthetic process for the preparation of
unsymmetrically substituted benzo[c]cinnolines was developed.
The key intermediate 2,2’-dinitro-1,1’-biphenyl was prepared by
means of an unprecedented tailored Suzuki cross-coupling
protocol. The subsequent step is constituted by a domino
partial nitro group reduction and intramolecular diazo bond
formation, a process that afford target benzo[c]cinnoline
scaffold. The disclosed method tolerates both electron-with-
drawing- and electron-donating groups.
Cinnoline moieties are frequently found in biologically active
molecules,[1] whereof numerous with attractive pharmacolog-
ical properties such as antibacterial,[2a] anticancer,[2b] antimicro-
bial,[2c] anti-inflammatory,[2d] antifungal,[2e] antihypertensive,[2f]
antiulcer,[2f] cytotoxic,[2g] and topoisomerase inhibitor,[2h] see
Figure 1.
In a previous disclosure, we envisioned, established a
synthetic pathway, and process for the preparation of the
benzo[c]cinnoline scaffold.[3] However, this process was limited
to the synthesis of symmetrically substituted benzo[c]cinnolines
via 2,2’-dinitro-1,1’-biphenyls obtained via the Ullmann cou-
pling.[4] 2,2’-Dinitro-1,1’-biphenyl was also prepared by means
of a Suzuki cross-coupling protocol, although in low yield only.
This cross-coupling protocol requested high temperature and
long reaction time (150 oC, 20 h).[5] Widdowson and Wilhelm[6]
reported that the nitro group in the ortho position to the halo
atom of the haloarene 5 (Scheme 1) is not only acting as an
electron withdrawing group, but also as a coordinating group
for incoming palladium in the Suzuki cross-coupling and
thereby act a significant influence on the C–C coupling. This
was recently supported by a study disclosed by Sakaki, Nakao,
and collaborators,[7] which revealed that the NO2 group of
nitroarenes even operated as the leaving group in the Suzuki
cross-coupling. These observations explain the difficulties of
using ortho-NO2 substituted reagents in the Suzuki cross-
coupling experiments.
For a project in progress in our laboratory related to the
synthesis of the carbazole scaffold,[8] we needed access to 2-
nitro-1,1’-biphenyls that we only partly could produce by
means of our previously disclosed Suzuki cross-coupling
protocol that encompasses 2-nitro-1-iodobenzenes with phe-
nylboronic acids as reaction partners.[5]
We undertook therefore a revisit to this reaction protocol,
which afforded a new method allowing the use of both 1-
chloro-2-nitrobenzenes and 1-bromo-2-nitrobenzenes as reac-
tion partners to phenylboronic acids.[9] Propelled by these
encouraging results we sought to explore whether this method
could be further extended to prepare 2,2’-dinitro-1,1’-biphenyl
derivatives 3 and thereby offer an easy access to un-symmetri-
cally substituted benzo[c]cinnolines 8, as outlined in Scheme 1.
[a] V. Elumalai, Prof. Dr. H.-R. Bjørsvik
Department of Chemistry
University of Bergen
AllØgaten 41, N-5007 Bergen, Norway
E-mail: hans.bjorsvik@kj.uib.no
Supporting information for this article is available on the WWW under
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Figure 1. Biologically active cinnoline derivatives.
Scheme 1. A two step process to the benzo[c]cinnoline. 1 A tailored Suzuki
cross-coupling protocol allowing the preparation of 2,2’-dinitro-1,1’-biphenyls
3. 2 A domino partial nitro group reduction and intramolecular diazo bond
formation that provides the benzo[c]cinnoline scaffold 8.
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At the outset of the study whose results are disclosed
herein, we commenced exploring 2-nitro-chlorobenzenes 1 as
the coupling partner to 2-nitro-phenylboronic acid 2 in
attempts to approach our target key intermediate 2,2’-dinitro-
1,1’-biphenyls 3 using our recently disclosed Suzuki cross-
coupling protocol.[9] The subsequent step that involves the
domino partial nitro group reduction and intra-molecular diazo
bond formation that results in the cyclization and thus the
forming of the benzo[c]cinnoline scaffold was based on a redox
process firstly developed for oxidation of aromatics containing
an oxygen functionalized benzylic moiety.[3,10]
In addition to our method for the preparation of the benzo
[c]cinnoline scaffold, only few other methods have been
disclosed based on a strategy that involves 2,2’-nitro/amino-
1,1’-biphenyls.[11] However, our initial trials operated poorly or
not at all with 2-nitro-chlorobenzenes 1. Even with a deactivat-
ing substituent present, low yields only were achieved of target
coupling product 3 (entries 3–5 of Table 1).
Interestingly, an unexpected product 4 was formed via an
ipso-type nucleophilic substitution of the chlorine atom with
the solvent as the nucleophile. However, we abandoned further
investigation using 1-chloro-2-nitrobenzenes as reaction part-
ner in the cross-coupling step due to unfavourable selectivity
towards target biphenyl (3).
In the following, we continued to examine 1-bromo-2-
nitrobenzenes 5 in the place of 1-chloro-2-nitrobenzenes 1 as
reaction partner for 2-nitro-phenylboronic acid 2, Scheme 2.
Initial experiments involved un-substituted reaction partners,
which afforded target product 3a, although in a moderate yield
only. A library composed of different 1-bromo-2-nitrobenzenes
5 with a variety of electron-donating and electron-withdrawing
functional groups (R 2 [COCH3, CH3, Cl, OCH3, CF3, COOH]) were
successively reacted with 2-nitro-phenylboronic acid 2 using
the established Suzuki cross-coupling procedure. All of these
trials except for the experiment that involved 3-bromo-4-
nitrobenzoic acid 5g afforded target intermediate 2,2’-dinitro-
1,1’-biphenyl derivative 3 (3a–h), Scheme 2. Attempts to
protect the carboxylic acid group as a methyl ester (methyl 4-
bromo-3-nitrobenzoate) afforded a moderate yield of the
expected benzo[c]cinnoline scaffold, but the methyl ester was
hydrolysed to carboxylic acid (3h). Substrates that possessed
electron-donating groups afforded low yields only (3c and 3e).
With electron-withdrawing substituents present, e.g. COCH3
and CF3 (3b and 3f), high to excellent yields were obtained. In
the case with a weak deactivating group present (3d), a
moderate yield was obtained.
These results reveal that the electron withdrawing groups
deactivate the aromatic ring, decrease the electron density
around the C–Br bond and thus facilitates the oxidative
addition and the transmetallation with phenylboronic acid
even in the presence of the strong deactivating NO2 group. In
the experiments that afforded low to moderate yield of target
2,2’-dinitro-1,1’-biphenyl 3, substantial quantities (50%) of
hydrodebrominated 5 was observed. Furthermore, the method
appeared not to operate with a free carboxyl acid group
present, as revealed for the expected product 3g.
The second step of the process, the domino partial nitro
group reduction and intramolecular diazo bond formation is
constituted by a principal redox process that ultimately afford
the benzo[c]cinnoline framework 8 and the by-product 7.
Previously, this process was comprehensively investigated and
disclosed by our group.
For the present study, initially, we attempted to synthesize
target benzo[c]cinnoline framework 8 by treating 2,2’-dinitro-
1,1’-biphenyl 3 for a short period (30 min.), under microwave
irradiation at elevated temperature (120oC) in the place of
thermal heating, Scheme 3. However, benzo[c]cinnoline-N-
oxide 9 was obtained as the major product and the expected
benzo[c]cinnoline 8 as the minor product. Since the major
product 9 of this reaction experiment constitutes a less
reduced form of target molecule 8. Increased reaction time
(3 h) and reaction temperature (130 oC) were attempted, which
Table 1. Screening of reaction conditions for the synthesis of 2,2’-dinitro-
1,1’-biphenyls.
Scheme 2. A tailored Suzuki cross-coupling leading to 2,2’-dinitro-1,1’-
biphenyls.
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successfully afforded target molecule benzo[c]cinnoline 8 in an
excellent yield (95%).
The established method for the synthesis of the benzo[c]
cinnoline scaffold was then utilized on a selection of 2,2’-
dinitro-1,1’-biphenyls. The trials demonstrated that the ring
formation, that is the domino partial nitro group reduction and
intramolecular diazo bond formation (providing the benzo[c]
cinnoline scaffold) operates successfully for both the activating
and deactivating substituents including –CH3, –OCH3, –Cl, –CF3,
and –COOH, see Scheme 4. In line with our previous findings
for the symmetrically substituted 2,2’-dinitro-1,1’-biphenyls the
domino partial nitro group reduction and intramolecular diazo
bond formation does not operate successfully with oxidisable
functional groups such as –COCH3, –CHO, and –OH.
Benzo[c]cinnolines that shall possess the carboxylic acid
group, might be synthesized from the corresponding 2,2’-
dinitro-1,1’-biphenyl carboxylic acid methyl ester. Benzo[c]
cinnoline-3-carboxylic acid was synthesized from the analogous
1-(2,2’-dinitro-[1, 1’-biphenyl]-4-yl)ethan-1-one 3b. In this mole-
cule, the acetyl group acted as the reducing agent (in the place
of acetophenone 6) for the two nitro groups that lead to
formation of the benzo[c]cinnoline scaffold bearing the carbox-
ylic acid group (8b). When an experiment with identical
conditions was conducted, but with acetophenone 6 present,
benzo[c]cinnoline-3-carboxylic acid 8b was formed, which
revealed that the acetyl group of the substrate 3b again
operated as the reductant.
In summary, we have developed an unprecedented Suzuki
cross-coupling protocol for the synthesis of 2,2’-dinitro-1,1’-
biphenyls that taken together with an substantially improved
domino partial nitro group reduction and intramolecular diazo
bond formation process constitutes a two-step synthesis
applicable for the preparation of un-symmetrically (and sym-
metrically) benzo[c]cinnolines. Overall, the disclosed process
operates with both electron withdrawing and electron donat-
ing groups present in the molecular scaffold. Functional groups
susceptible to SET oxidation such as free hydroxyl and
carboxylic acid need to be protected before subjected for the
experimental conditions of the revealed procedure.
Supporting Information Summary
The supporting information provides complete experimental
procedures and spectral data (1H, 13C and HRMS) of synthesised
compounds 3a-3 f, 8a-8 f and 9.
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500	MHz.	 High-resolution	mass	 spectrometry	 (HRMS)	 were	 performed	with	 a	 Q-TOF	Micro	 YA263	
instrument.	
Analyses.	GC	analyses	were	performed	with	a	capillary	gas	chromatograph	equipped	with	a	fused	
silica	 column	 (l25	 m,0.20	 mm	 i.d.,0.33	 mm	 film	 thickness)	 at	 a	 helium	 pressure	 of200	 kPa,	 split	
less/split	 injector	 and	 flame	 ionization	 detector.	 Mass	 spectra	 were	 obtained	 with	 a	 GC–MS	
instrument,	with	a	gas	chromatograph	equipped	with	a	fused	silica	column	(l30	m,	0.25	mm	i.d.,	0.25	
mm	film	thickness)	and	helium	as	the	carrier	gas.	DART	mass	spectra	were	obtained	by	using	PEG	as	







=	 77.0	 ppm)	 and	 with	 DMSO-d6	 for	 proton	 (δ	 =	 2.50	 ppm)	 and	 for	 carbon	 (δ	 =	 39.0	 ppm)	 with	
tetramethylsilane	 as	 an	 external	 reference.	 Flash	 chromatography	 was	 performed	 by	 using	 the	
indicated	solvent	system	and	silicagel	(230–400	mesh).		
Microwave	 reactor.	The	microwave-assisted	experiments	were	performed	by	means	of	a	Biotage	
Initiator	 Sixty	 EXP	Microwave	 System,	 that	 operates	 at	 0–400	W	 at	 2.45	 GHz,	 in	 the	 temperature	
range	of	40–250	°C,	a	pressure	range	of	0–20	bar	(2	MPa,	290	psi),	and	with	reactor	vial	volumes	of	
0.2–20	mL.	
General	 procedure	 to	 2,2’-dinitro-1,1’-biphenyls.	 1-Bromo-2-nitrobenzene	 (1	 mmol),	 2-




The	 solvent	 (methanol)	 was	 then	 removed	 under	 reduced	 pressure.	 The	 residue	 was	 diluted	 with	
diethyl	ether	(50	mL)	and	washed	with	water	(50	mL).	The	aqueous	phase	was	extracted	with	diethyl	
ether	 (2	×	40	mL).	The	organic	 layers	were	combined	and	dried	over	Na2SO4.	The	drying	agent	was	
filtered	 off	 and	 the	 crude	 product	 was	 purified	 by	 silica-gel	 flash	 chromatography	 [ethyl	
acetate/hexane	(mixture	of	isomers)]	to	obtain	the	2,2’-dinitro-1,1’-biphenyl.	
2,2'-dinitro-1,1'-biphenyl	(3a)	[2436-96-6].	1-bromo-2-nitrobenzene	5a	(0.100	g,	0.495	mmol),	(2-






















7.28-7.30	 (dd,	 J	=	 1.5	Hz,	 J	=	 8	Hz,	 1H),	 2.72	 (s,	 3H)	 ;	
13







4-methyl-2,2'-dinitro-1,1'-biphenyl	 (3c)	 [106164-07-2].	 1-bromo-4-methyl-2-nitrobenzene	 5c	
(0.100	g,	0.463	mmol),	 (2-nitrophenyl)boronic	acid	2	(0.115	g,	0.689	mmol),	Na2CO3	(0.054	g,	0.509	















4-chloro-2,2'-dinitro-1,1'-biphenyl	 (3d)	 [72005-81-3].	1-bromo-4-chloro-2-nitrobenzene	5d	 (0.100	
g,	0.423	mmol),	(2-nitrophenyl)boronic	acid	2	(0.106	g,	0.635	mmol),	Na2CO3	(0.049	g,	0.462	mmol),	













4-methoxy-2,2'-dinitro-1,1'-biphenyl	 (3e)	 [55324-17-9].	 1-bromo-4-methoxy-2-nitrobenzene	 5e	
(0.25	g,	1.08	mmol),	(2-nitrophenyl)boronic	acid	2	(0.270	g,	1.62	mmol),	Na2CO3	(0.126	g,	1.19	mmol),	













2,2'-dinitro-4-(trifluoromethyl)-1,1'-biphenyl	 	 (3f)	 [NEW].	 1-bromo-2-nitro-4-(trifluoro-
methyl)benzene	 5f	 	 (0.100	 g,	 0.370	 mmol),	 (2-nitrophenyl)boronic	 acid	 2	 (0.093	 g,	 0.557	 mmol),	
Na2CO3	(0.043	g,	0.406	mmol),	TBAB	(0.010	g,	0.031	mmol)	and	Pd(PPh3)4	(0.011	g,	0.010	mmol)	The	















0.406	mmol),	 (2-nitrophenyl)boronic	 acid	2	 (0.103	 g,	 0.617	mmol),	 Na2CO3	 (0.048	 g,	 0.453	mmol),	
TBAB	 (0.011	 g,	 0.034	 mmol)	 and	 Pd(PPh3)4	 (0.012	 g,	 0.010	 mmol).	 The	 title	 compound	 was	 not	
observed	 instead	 only	 obtained	 nitrobenzoic	 acid	 (hydrodebrominated	 compound)	 after	 acidic	
workup	(pH	1-2).	
2,2'-dinitro-[1,1'-biphenyl]-4-carboxylic	 acid	 (3h)	 [NEW].	 methyl	 4-bromo-3-nitrobenzoate	 5h	
(0.100	g,	0.385	mmol),	 (2-nitrophenyl)boronic	acid	2	(0.096	g,	0.575	mmol),	Na2CO3	(0.045	g,	0.425	
mmol),	 TBAB	 (0.010	 g,	 0.031	mmol)	 and	 Pd(PPh3)4	 (0.012	 g,	 0.010	mmol)	were	 transferred	 to	 the	
microwave	reactor	tube,	that	was	sealed	and	flushed	with	Ar.	Then	methanol	(4	mL)	and	water	(1	mL)	
were	added.	The	reactor	tube	was	submerged	into	the	microwave	cavity	for	1	h	at	a	temperature	of	
150	 °C.	 	 After	 completion	 of	 the	 reaction,	 the	 solvent	 methanol	 was	 removed	 under	 reduced	
pressure.	 The	 residue	was	diluted	with	diethyl	 ether	 (50	mL)	 and	washed	with	water	 (50	mL).	 The	
product	 was	 in	 the	 aqueous	 phase	 since	 it	 was	 hydrolysed	 and	 form	 sodium	 salt	 under	 the	 basic	
conditions.	The	aqueous	layer	was	acidified	with	Conc.,	HCl	(pH	1-2)	and	extracted	with	ethyl	acetate	
(40	mL).	The	aqueous	phase	was	extracted	with	ethyl	acetate	(2	×	40	mL).		The	organic	extracts	were	















General	 procedure	 for	 the	 synthesis	 of	 benzo[c]cinnolines.	 2,2’-dinitro-1,1’-biphenyl	 (1	 mmol),	
acetophenone	(0.9	mmol)	and	NaOH	(5	mmol)	were	transferred	to	a	microwave	vial	(10	mL),	which	
was	sealed	and	flushed	with	Ar	whereupon	ethanol	(5	mL)	was	added.	The	mixture	was	stirred	for	10-
15	 s	 and	 then	 placed	 into	 the	microwave	 cavity	 for	 3	 h	 at	 130	 °C.	 The	 solvent	 ethanol	 was	 then	
removed	under	 reduced	pressure.	 The	 residue	was	diluted	with	 ethyl	 acetate	 (30	mL)	 and	washed	



















Method	 1	–	 intramolecular	 reaction	without	 acetophenone	 present.	To	 a	microwave	 vial,	 1-(2,2'-
dinitro-[1,1'-biphenyl]-4-yl)ethan-1-one		3b	(0.030	g,	0.105	mmol),	NaOH	(0.021	g,	0.525	mmol)	were	
added.	The	vial	was	sealed	and	flushed	with	Ar	and	solvent	ethanol	(5	mL)	was	added.	The	tube	was	
submerged	 into	microwave	 cavity	 for	 3	 h	at	 130	 °C.	 The	 reaction	 proceeded	 via	 an	 intramolecular	












C-NMR	 (125	 MHz,	 DMSO-d6):	 !=	 166.4,	 145.1,	 144.1,	 132.6,	 132.0,	 131.8,	 131.2,	 131.0,	 130.6,	
123.3,	 123.2,	 123.0,	 119.6.	 HR-MS	 (DART-):	 m/z	 [M-H]
-










phase	 since	 it	 form	 sodium	 salt	 under	 the	 basic	 conditions	 The	 aqueous	 phase	was	 acidified	with	
Conc.,	HCl	(pH	1-2)	and	extracted	with	ethyl	acetate	(40	mL).	The	aqueous	phase	was	extracted	with	











mmol),	 acetophenone	 6	 (0.015	mL,	 0.125	mmol),	 NaOH	 (0.028	 g,	 0.70	mmol)	 and	 ethanol	 (5	mL)	







C-NMR	 (125	MHz,	 CDCl3):	 !=	 145.6,	 145.2,	 139.7,	 133.5,	 131.4,	 131.3,	 130.4,	 128.7,	 121.3,	
121.2,	 121.1,	 118.7,	 21.7.	 HR-MS	 (DART+):	 m/z	 [M+H]
+






mmol),	 acetophenone	6	 (0.013	mL,	0.116	mmol),	NaOH	 (0.025	g,	0.625	mmol)	 and	ethanol	 (5	mL)	







145.6,	 145.4,	 135.1,	 132.3,	 132.1,	 131.6,	 130.3,	 129.6,	 128.5,	 125.4,	 123.2,	 121.3.	HR-MS	 (DART+):	
m/z	 [M+H]
+


























3-(trifluoromethyl)benzo[c]cinnoline	 (8f)	 [945927-97-9].	 2,2'-dinitro-4-(trifluoromethyl)-1,1'-
biphenyl	 	3f	(0.080	g,	0.256	mmol),	acetophenone	6	(0.027	mL,	0.233	mmol),	NaOH	(0.051	g,	1.275	

















stirred	 for	 10	 s	 before	 being	 subjected	 into	microwave	 heating	 for	 30	min.	 at	 120	 °C.	 The	 solvent	
ethanol	was	 removed	under	 reduced	pressure.	 The	 residue	was	diluted	with	diethyl	 ether	 (50	mL)	
and	washed	with	water	(50	mL).	The	aqueous	phase	was	extracted	with	ethyl	acetate	(3	×	40	mL).	The	
organic	 extracts	were	 combined	 and	 dried	 over	 Na2SO4.	 The	 drying	 agent	was	 filtered	 off	 and	 the	
crude	 product	 was	 purified	 by	 silica-gel	 flash	 chromatography	 [ethyl	 acetate/hexane	 (mixture	 of	













































































































































































































Supporting Information for Chapter 6 
 







Experimental Details: All reagents and solvents were purchased from commercial sources 
and used as received. Melting points were determined in open capillaries. Reagent grade 
chemicals were purchased from commercial sources and used without further purification. 
All reaction mixtures and column eluents were monitored by TLC (TLC plates Merck 
Kieselgel 60 F254). The TLC plates were observed under UV light at λ = 254 nm and λ = 
365 nm. IR spectra were recorded as KBr discs with a Shimadzu FTIR-8300 
spectrophotometer, and 1H and 13C NMR spectra were recorded with Bruker AV 400 MHz 
and 500 MHz instruments. High-resolution mass spectra (HRMS) were performed with a Q-
TOF Micro YA263 instrument. 
 
General Methods: GC analyses were performed with a capillary gas chromatograph 
equipped with a fused silica column (l25 m, 0.20 mm i.d., 0.33 mm film thickness) at a 
helium pressure of 200 kPa, split less/split injector and flame ionization detector. Mass 
spectra were obtained with a GC–MS instrument, with a gas chromatograph equipped with a 
fused silica column (l30 m, 0.25 mm i.d., 0.25 mm film thickness) and helium as the carrier 
gas. DARTmass spectra were obtained by using PEG as an internal standard in positive 
ionization mode with a TOF mass analyzer. 1H and 13CNMR spectra were recorded at 
ambient temperature at a frequency of 400, 500 MHz and 100, 125 MHz respectively. The 
chemical shifts are reported in ppm relative to residual CDCl3 for proton (δ = 7.26 ppm) and 
CDCl3 for carbon (δ = 77.0 ppm) with tetramethylsilane as an external reference. Flash 
chromatography was performed by using the indicated solvent system and silica gel (230–
400 mesh). All reagents used were commercially available from Aldrich Chemical Co. For 
new compounds, HRMS data were also recorded. 
 
The microwave-assisted experiments were performed by means of a Biotage Initiator Sixty 
EXP Microwave System, that operates at 0–400 W at 2.45 GHz, in the temperature range of 
40–250 °C, a pressure range of 0–20 bar (2 MPa, 290 psi), and with reactor vial volumes of 
0.2–20 mL. 
 
2,4-Dimethoxy-3-methyl phenol (6.2) [19676-67-6]. To a solution of 2, 6-dimethoxy 
toluene 6.1 (3 g, 19.7 mmol) in acetonitrile (25 mL), was added trifluoroacetic acid (1.3 mL, 
19.7 mmol ) and hydrogen peroxide (35%, 3.5 mL, 39.4 mmol). The reaction mixture was 
stirred for 2 h at 75 oC. The reaction mixture was cooled to room temperature and the solvent 
acetonitrile was removed under reduced pressure. The crude mixture was diluted with water 
(30 mL) and extracted with EtOAc (2x40 mL). The organic layers were combined and dried 
over Na2SO4. The solvent was evaporated under reduced pressure. The title compound was 
isolated by silica gel column chromatography [(EtOAc:Hx, 20:80)] as orange liquid (1.75 g, 
53%); Rf =0.49 [(EtOAc:Hx, 20:80)]; 1H-NMR (500 MHz, CDCl3): δ = 6.67 (d, J= 9 Hz, 
1H), 6.46 (d, J= 9 Hz, 1H), 5.10 (s, br, 1H), 3.69 (s, 6H), 2.09 (s, 3H); 13C-NMR (125 MHz, 
CDCl3,): δ =151.9, 145.9, 142.8, 120.1, 111.8, 106.9, 60.9, 56.1, 9.3; MS (EI): m/z (%);  168 
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(100, M+), 153 (61), 125 (49), 107 (23), 93 (9), 79 (11), 65 (21), 53 (12); IR (cm-1): 3406, 
2996, 2940, 2834, 1486, 1259, 1098, 730. 
 
 
2, 4-Dimethoxy-3-methylphenyl acetate (6.3) [96502-90-8]. To a solution of 2, 4-
Dimethoxy-3-methyl phenol 6.2 (1.5 g, 8.9 mmol) in CHCl3 (15 mL), was added acetyl 
chloride (1.3 mL, 17.8 mmol). The reaction mixture was heated for 2 h under reflux. The 
reaction mixture was cooled to ambient temperature and the solvent was removed under 
reduced pressure to afford the title compound as a dark- orange liquid (1.75 g, 94 %); Rf 
=0.78 [(EtOAc:Hx, 40:60)]; 1H-NMR (500 MHz, CDCl3): δ = 6.86 (d, J= 9 Hz, 1H ), 6.60 
(d, J= 8.5 Hz, 1H), 3.80 ( s, 3H), 3.75 ( s, 3H),  2.32 (s, 3H), 2.17 (s, 3H); 13C-NMR (125 
MHz, CDCl3): δ = 169.7, 156.4, 150.5, 137.6, 121.2, 119.7, 105.6, 60.8, 55.7, 20.7, 9.2; MS 
(EI): m/z (%): 210 (9, M+), 168 (100), 153 (53), 139 (4), 125 (19), 107 (12),  79 (6),  65 (8), 
53 (7); IR (cm-1): 2940, 2838, 1759, 1484, 1199, 1106, 728. 
2,4-Dimethoxy-3-methyl-5-nitrophenyl acetate (6.4) [192188-84-4]. 2,4-Dimethoxy-3-
methylphenyl acetate 6.3 (1.6g, 7.6 mmol) was dissolved in a solution of AcOH/Ac2O (1:3 
ratio, 12 mL) at 0-5 oC. A solution of HNO3 (65 %, 1.0 mL, 14.5 mmol) in AcOH/Ac2O (1:3 
ratio, 12 mL) was added dropwise to the reaction mixture under vigorous stirring at 0-5 oC. 
When the addition was completed, the reaction mixture was stirred for 30 minutes at ambient 
temperature. The reaction mixture was poured into water (100 mL) and extracted with 
CH2Cl2 (3×30 mL). The organic layers were combined and washed with NaHCO3 (2×50 
mL) and dried over Na2SO4. The solvent was evaporated under reduced pressure to afford 
the title compound as a yellow liquid (1.45 g, 75 %); Rf = 0.70 [(EtOAc:Hx, 40:60)]; 1H-
NMR (500 MHz, CDCl3): δ = 7.54 (s, 1H), 3.87 ( s, 3H, ), 3.83 ( s, 3H ),  2.33 (s, 3H), 2.26 
(s, 3H); 13C-NMR (125 MHz, CDCl3): δ=  168.7, 155.2, 151.3, 139.1, 138.8, 129, 118, 62.1, 
60.9, 20.6, 10; MS (EI): m/z (%): 255 (4, M+), 213 (100), 166 (26), 152 (8), 137 (8), 123 
(11), 107 (10), 77 (14), 53 (14); IR (cm-1): 2946,1770, 1522, 1343, 1187, 88, 729. 
2,4-Dimethoxy-3-methyl-5nitrophenol (6.5) [136763-93-3]. A solution of Conc.HCl (12 
mL) in MeOH (25 mL) was added dropwise to 2, 4-Dimethoxy-3-methyl-5-nitrophenyl 
acetate 6.4 (1.5 g, 5.9 mmol) at 0 oC . The reaction mixture was stirred for 1 h at 70 oC under 
reflux. The reaction mixture was cooled to ambient temperature and the solvent was 
removed under reduced pressure. The crude product was diluted with water (40 mL) and 
extracted with EtOAc (2× 40 mL). The organic layers were combined and dried over Na2SO4  
to afford the title compound as  orange solid (1.05 g, 83 %); Rf = 0.34 [(EtOAc:Hx, 20:80)]; 
mp 53-55 oC; 1H NMR (500 MHz, CDCl3): δ = 7.26 (s, 1H), 3.78 ( s, 6H), 2.21 (s, 3H); 
13CNMR (125 MHz, CDCl3): δ = 150.2, 146.3, 145.1, 140.0, 127.5, 109.4, 62.1, 61.0, 10; 
MS (EI): m/z (%): 213 (100, M+), 166 (59), 152 (21), 137 (36), 125 (43), 122 (28), 91(23), 
83(40),  77 (32), 53 (49); IR (cm-1): 3418, 2944, 1519, 1338, 1245, 1102, 988, 733. 
2-Chloro 4, 6-dimethoxy-5-methyl-3-nitrophenol (6.7a) [NEW]. To a solution of 2,4-
dimethoxy-3-methyl-5-nitrophenol 6.5 (0.311 g, 0.145 mmol) in EtOH (15 mL), DCH 6.6 
(146 mg, 0.074 mmol) was added followed by conc. H2SO4 dropwise (≈ 24 drops) with good 
stirring. After the addition was completed, the reaction mixture was quenched with NaOH 
(4.1 M, 5 mL). A heavy red precipitation was observed during the addition of NaOH, which 
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was neutralized with acetic acid (pH≈ 4), and the resulting mixture was diluted with water 
(25 mL) and extracted with diethyl ether (3 × 40 mL). The organic layers were combined 
and dried with Na2SO4. The crude product was isolated by silica gel column chromatography 
(CH2Cl2/hexane, 40:60) to afford the title compound as pale yellow crystals (0.34 g, 95 %), 
m.p. 118.5 °C. Rf =0.29 (CH2Cl2/hexane, 60:40). 1H-NMR (400 MHz, CDCl3): δ = 5.91 (s, 1 
H), 3.87 (s, 3 H), 3.80 (s, 3 H), 2.26 (s, 3 H) ppm. 13C-NMR (100 MHz, CDCl3): δ = 147.5, 
144.0, 142.7, 125.6, 109.3, 62.9, 61.0, 9.9 ppm. MS (EI): m/z (%) = 247 (100, M+), 217 (5), 
213 (16), 186 (25), 171 (27), 138 (26), 108 (20), 83 (22), 77 (48), 67 (32). HRMS (EI): 
calcd. For C9H10ClNO5 247.0248; found 247.0248. IR (cm-1) = 3406, 3083, 2970, 2929, 
2846, 1500, 1108. 
 
3,5-Dimethoxy-4-methyl-6-nitrobiphenyl-2-ol (6.9) [NEW].   In a microwave tube, 2-
Chloro 4,6-dimethoxy-5-methyl-3-nitrophenol 6.7a (0.21 g, 0.85 mmol), phenylboronic acid 
6.8 (0.155 g, 1.27 mmol), Na2CO3 (0.10 g, 0.97 mmol), TBAB (0.021 g, 0.065 mmol) and 
Pd(PPh3)4 (0.025 g, 0.022 mmol) were added. The reaction mixture was carefully flushed 
with argon before adding a mixture of MeOH (4 mL) and water (1 mL), The tube was sealed 
and submerged in the microwave cavity for 30 min at 120 oC. The reaction mixture was 
diluted with water (40 mL) and extracted with diethyl ether (2×30 mL). The organic layers 
were combined and dried over Na2SO4. The crude product was isolated by silica gel column 
chromatography [(DCM:Hx, 40:60)] eluent to afford the title compound  as yellow solid 
(0.122 g, 50 %); Rf =0.1 (CH2Cl2/hexane, 40:60); mp: 102.7oC; 1H- NMR (500 MHz, 
CDCl3): δ = 7.46-7.40 (m, 3H), 7.37 -7.35 (m, 2H), 5.55 (s, 1H), 3.88 (s, 3H), 3.84 (s, 3H), 
2.33 (s, 3H); 13C-NMR (125 MHz, CDCl3): δ = 147.2, 143.2, 142.9, 142.6, 130.8, 129.4, 
128.9, 128.8, 125.6, 119.4, 62.8, 61.0, 10; MS (EI): m/z (%): 289 (100, M+), 272 (7), 246 
(20), 207 (24), 199 (13), 169 (13), 141 (20), 129 (40), 115 (33), 102 (12), 83 (23), 77 (20); 
HR-MS (EI): (M+Na)+: Calcd for C15H15NNaO5 312.0848; Found 312.0846);: IR (cm-1) = 
3413, 2937, 2929, 2849, 1528, 1101, 991, 748. 
 
3,3',5-trimethoxy-4-methyl-6-nitro-[1,1'-biphenyl]-2-ol (6.9a) [NEW].   In a microwave 
tube, 2-Chloro 4,6-dimethoxy-5-methyl-3-nitrophenol 6.7a (0.168 g, 0.68 mmol), 3-methoxy 
phenylboronic acid 6.8a (0.155 g, 1.02 mmol), Na2CO3 (0.079 g, 0.75 mmol), TBAB (0.019 
g, 0.05 mmol) and Pd(PPh3)4 (0.020 g, 0.018 mmol) were added. The reaction mixture was 
carefully flushed with argon before adding a mixture of MeOH (4 mL) and water (1 mL), 
The tube was sealed and submerged in the microwave cavity for 30 min at 120 oC. The 
reaction mixture was diluted with water (40 mL) and extracted with diethyl ether (2×30 mL). 
The organic layers were combined and dried over Na2SO4. The crude product was isolated 
by silica gel column chromatography [(DCM:Hx, 40:60)] eluent to afford the title compound  
as yellow oil (0.109 g, 50 %); Rf =0.1 (CH2Cl2/hexane, 40:60); 1H- NMR (500 MHz, 
CDCl3): δ = 7.28 (t, J= 8Hz, 1H), 6.88-6.85 (m, 2H), 6.82 (s, 1H), 5.48 (s, 1H), 3.80 (s, 3H), 
3.76 (s, 3H), 3.73 (s, 3H), 2.25 (s, 3H); 13C-NMR (125 MHz, CDCl3): δ = 159.8, 147.2, 
143.2, 142.8, 142.4, 131.9, 130, 125.7, 121.6, 119.2, 114.9, 114.8, 62.8, 60.9, 10; MS (EI): 
m/z (%): 320 (17), 319 (100, M+), 276 (33), 257 (15), 244 (22), 159 (32), 128 (35), 115 (45), 
83 (38), 55 (22); HR-MS (DART): (M+H)+: Calcd for C16H18NO6 320.1134; Found 
320.1136)IR (cm-1) = 3450, 2942, 2837, 1530, 1238, 1103, 997, 765. 
 
6-amino-3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-ol (6.10) [NEW]. 3,5-Dimethoxy-4-
methyl-6-nitrobiphenyl-2-ol 6.9 (0.20 g, 0.69 mmol) was dissolved in EtOH (4 mL) and 
transferred to a tube reactor. Then, a mixture of NH4Cl (0.073 g, 1.38 mmol) in H2O 
(1.2 mL) and indium powder (0. 238 g, 2.01 mmol) were added whereupon a magnetic 
stirrer bar was transferred to the tube. The tube was then sealed and the reaction mixture was 
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stirred and heated at 120 °C for 3 h. The reaction mixture was cooled to room temperature 
and diluted with ethyl acetate (30 mL) and filtered through a pad of celite. Another portion 
(20 mL) of ethyl acetate was used to wash through the filter pad. The resulting organic phase 
was dried over Na2SO4, filtered and the solvent was removed under reduced pressure to 
obtain title compound in purple oil (0.175 g, 98%).; Rf = 0.44 [(EtOAc:Hx, 30:70)]; 1H-
NMR (500 MHz, CDCl3): !=  7.50-7.47 (m, 3H), 7.43-7.40 (m, 2H), 5.30 (s, 1H), 3.76 (s, 
3H), 3.74 (s, 3H), 2.27 (s, 3H); 13C-NMR (125 MHz, CDCl3): != 142.8, 138.5, 137.2, 134.4, 
134.0, 130.5, 129.1, 127.7, 123.3, 113.0, 61.1, 59.5, 9.5; MS (EI): m/z (%): 260 (9), 259 (58, 
M+), 244 (100), 229 (9), 216 (22), 201 (36), 184 (11), 144 (14), 128(11), 89 (8), 77(9); HR-
MS (DART): (M+H)+: Calcd for C15H18NO3 260.1287; Found 260.1287); IR (cm-1): 3458, 
3334, 3057, 2933, 2849, 1580, 1460, 994, 727. 
 
6-amino-3,3',5-trimethoxy-4-methyl-[1,1'-biphenyl]-2-ol (6.10a) [NEW]. 3,3',5-
trimethoxy-4-methyl-6-nitro-[1,1'-biphenyl]-2-ol 6.9a (0.08 g, 0.25 mmol) was dissolved in 
EtOH (4 mL) and transferred to a tube reactor. Then, a mixture of NH4Cl (0.027 g, 0.50 
mmol) in H2O (1.2 mL) and indium powder (0. 086 g, 0.75 mmol, 99.99% 100 mesh, use 
preferably a freshly opened bottle or stored under Ar) were added whereupon a magnetic 
stirrer bar was transferred to the tube. The tube was then sealed and the reaction mixture was 
stirred and heated at 120 °C for 3 h. The reaction mixture was cooled to room temperature 
and diluted with ethyl acetate (20 mL) and filtered through a pad of celite. Another portion 
(20 mL) of ethyl acetate was used to wash through the filter pad. The resulting organic phase 
was dried over Na2SO4, filtered and the solvent was removed under reduced pressure using a 
rotary evaporator to obtain the title compound in purple oil (0.071 g, 98%).; Rf = 0.36 
[(EtOAc:Hx, 30:70)]; 1H-NMR (500 MHz, CDCl3): !=  7.40 (t, J= 8 Hz, 1H), 6.99-6.97 (m, 
1H), 6.95-6.94 (m, 1H), 6.93-6.91 (m, 1H), 5.29 (s, 1H), 3.82 (s, 3H), 3.76 (s, 3H), 3.74 (s, 
3H), 2.27 (s, 3H),; 13C-NMR (125 MHz, CDCl3): != 160.1, 142.8, 138.5, 137.1, 135.3, 
134.4, 130.2, 123.4, 122.7, 115.8, 113.6, 112.8, 61.0, 59.5, 55.3, 9.5; MS (EI): m/z (%): 290 
(12), 289 (74, M+), 274 (100), 259 (12), 246 (26), 231 (25), 137 (14), 130 (32), 115 (15), 83 
(14), 77(10);HR-MS (DART): (M+H)+: Calcd for C16H20NO4 290.1392; Found 290.1395); 
IR (cm-1): 3458, 3341, 3057, 2933, 2849, 1580, 1360, 994, 727. 
6-acetamido-3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-yl acetate (6.11) [NEW]. In a 50 
mL RB-flask, 6-amino-3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-ol 6.10 (0.12 g, 0.46 
mmol) was dissolved in dry CH2Cl2 (10 mL) under inert atmosphere. To the stirred solution 
added triethylamine (0.14 mL, 0.97 mmol). The solution was cooled under ice bath and 
added acetic anhydride (0.09 mL, 1.01 mmol) dropwise to the reaction mixture. The reaction 
mixture was stirred at room temperature for 1 hour. The residue was diluted in EtOAc (50 
mL) and washed with water (40 mL). The organic layer was washed with NaHCO3 (30 mL) 
and finally dried over Na2SO4. The solvent was evaporated under reduced pressure to obtain 
the title compound  (0.148 g, purple liquid) in 94 % crude yield. Rf = 0.74 [(EtOAc:Hx, 
50:50)]; 1H-NMR (500 MHz, CDCl3): !=  7.34 (m, 3H), 7.20 (m, 2H), 6.50 (s, br, 1H), 3.76 
(d, J=8.5Hz, 6H), 2.29 (s, 3H), 2.17 (s, 3H), 1.99 (s, 3H); MS (EI): m/z (%): 343 (11, M+), 
301 (46), 270 (24), 244 (100), 201 (24), 144 (51), 128 (39), 115 (60), 89 (72), 83(94), 
77(47), 55(43); HR-MS (DART): (M+H)+: Calcd for C19H22NO5 344.14980; Found 




6-acetamido-3,3',5-trimethoxy-4-methyl-[1,1'-biphenyl]-2-yl acetate (6.11a) [NEW]. In a 
50 mL RB-flask, 6-amino-3,3',5-trimethoxy-4-methyl-[1,1'-biphenyl]-2-ol 6.10a (0.13 g, 
0.45 mmol) was dissolved in dry CH2Cl2 (10 mL) under inert atmosphere. To the stirred 
solution added triethylamine (0.13 mL, 0.97 mmol). The solution was cooled under ice bath 
and added acetic anhydride (0.09 mL, 1.01 mmol) dropwise to the reaction mixture. The 
reaction mixture was stirred at room temperature for 1 hour. The residue was diluted in 
EtOAc (50 mL) and washed with water (40 mL). The organic layer was washed with 
NaHCO3 (30 mL) and finally dried over Na2SO4. The solvent was evaporated under reduced 
pressure to obtain the title compound (0.131 g, purple liquid) in 85% (crude yield). Rf = 0.67 
[(EtOAc:Hx, 50:50)]; MS (EI): m/z (%): 373 (16, M+), 332 (12 
), 331 (68), 316(7),  300 (26), 274 (100), 256 (11), 242 (13), 231 (11), 174 (12), 115 (9), 83 
(15);  
9-acetyl-1,3-dimethoxy-2-methyl-9H-carbazol-4-yl acetate (6.12) [NEW]. 6-acetamido-
3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-yl acetate 6.11 (0.063 g, 0.183 mmol) was 
dissolved in glacial acetic acid (5mL), Pd(OAc)2 (2.1 mg, 0.009 mmol), Imes.HCl (3.2 mg, 
0.009 mmol) and H2O2 (35%, 0.05 mL, 0.53 mmol) were added. The vial was sealed 
whereupon a magnetic stirrer bar was transferred to the tube. The tube was submerged in the 
microwave cavity at 120oC for 5 hours. The reaction mixture was monitored by GC (94% 
yield). The crude product was dissolved in EtOAc (20 mL) and washed with water (25 mL). 
The water phase was extracted with EtOAc (2×15 mL). The combined layer was washed 
with aq.NaHCO3 (20 mL). The organic layer was dried over Na2SO4 and filtered off. The 
solvent was evaporated under reduced pressure. The crude product was purified by using 
silica gel column chromatography (20:80, EtOAc:Hx) to attain the title compound (0.043 g, 
brown liquid) in 70% yield. Rf = 0.33 [(EtOAc:Hx, 20:80)]; 1H-NMR (500 MHz, CDCl3): ! 
=  8.26 (d, J= 8.5 Hz, 1H), 7.83 (d, J= 7.5 Hz, 1H), 7.45 (t, J= 7.5 Hz, 1H), 7.33 (t, J= 7.5 
Hz, 1H),  3.85 (s, 3H), 3.73 (s, 3H), 2.62 (s, 3H), 2.54 (s, 3H), 2.39 (s, 3H); 13C-NMR (125 
MHz, CDCl3): != 172.8, 168.6, 147.4, 144.0, 140.4, 134.8, 128.5, 127.7, 124.9, 123.7, 
123.6, 121.1, 119.7, 115.1, 61.1, 60.0, 26.8, 20.8, 10.2; MS (EI): m/z (%): 341 (11, M+), 299 
(19), 257 (46), 242 (100), 226 (11), 196 (12), 168 (22), 154 (23), 127 (22), 115 (27), 89(12), 
77(12), 55(12);HR-MS (DART): (M+H)+: Calcd for C19H20NO5 342.1341; Found 342.1343); 
IR (cm-1): 2935, 1766, 1702, 1445, 1398, 1367, 1269, 1254, 1183, 1082, 1002, 749. 
9-acetyl-1, 3, 6-trimethoxy-2-methyl-9H-carbazol-4-yl acetate (6.12a) & 9-acetyl-1, 3, 8-
trimethoxy-2-methyl-9H-carbazol-4-yl acetate (6.12b) [NEW]. 6-acetamido-3,3',5-
trimethoxy-4-methyl-[1,1'-biphenyl]-2-yl acetate 6.11a (0.130 g, 0.348 mmol) was dissolved 
in glacial acetic acid (5 mL), Pd(OAc)2 (8 mg, 0.024 mmol), Imes.HCl (12 mg, 0.024 mmol) 
and H2O2 (35%, 0.09 mL, 1.0 mmol) were added. The vial was sealed whereupon a magnetic 
stirrer bar was transferred to the tube. The tube was submerged in the microwave cavity at 
120oC for 5 hours. The reaction mixture was monitored by GC (50% conversion yield). 
Acetic acid was removed under reduced pressure. The crude product was dissolved in EtOAc 
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(40 mL) and washed with water (25 mL). The water phase was extracted with EtOAc 
(2×40mL). The combined organic layer was washed with aq.NaHCO3 (30 mL). The organic 
layer was dried over Na2SO4 and filtered off. The solvent was evaporated under reduced 
pressure. The crude product was purified by using silica gel column chromatography (20:80, 
EtOAc:Hx) afforded a mixture of isomers in 30% yield. 1H-NMR (500 MHz, CDCl3): !=  
8.13 (d, J= 9 Hz, 1H), 7.64 (d, J= 7.5 Hz, 1H),  7.54-7.55 (m, 1H), 7.32 (t, J= 8 Hz, 1H), 
7.25 (m, 1H), 6.96-6.98 (dd, J= 2.5, 9 Hz, 1H), 3.82 (s, 1H), 3.79 (s, 3H), 3.77 (s, 1H), 3.65 
(s, 3H), 2.54 (s, 3H), 2.47 (s, 3H), 2.31 (s, 3H),; 13C-NMR (125 MHz, CDCl3): != 172.5, 
168.6, 159.6, 156.3, 147.4, 144.2, 135.1, 134.7, 130.5, 129.5, 129.1, 125.1, 124.6, 122.6, 
120.4, 119.7, 116.2, 114.4, 114.3, 105.5, 61.1, 59.9, 55.8, 55.5, 26.6, 20.8, 10.2; MS (EI): 
m/z (%): 371 (7, M+), 331 (11), 287 (28), 272 (62), 207 (69), 115 (34), 96 (38), 83 (42), 
77(76) 
1,3-dimethoxy-2-methyl-9H-carbazol-4-ol (6.13) [NEW]. To a stirred solution of 9-acetyl-
1,3-dimethoxy-2-methyl-9H-carbazol-4-yl acetate 6.12 (0.023 g, 0.07 mmol) in methanol 
(10 mL) at 0 oC , was added a solution of conc.HCl (2 mL) in MeOH(5 mL) dropwise. The 
reaction mixture was stirred for 1 h at 70oC. The reaction mixture was cooled to room 
temperature. The reaction mixture was diluted with water (40 mL) and extracted with EtOAc 
(2x 20 mL). The combined organic layer was dried over Na2SO4. The solvent was filtered 
off to obtain the title compound as a brown solid (0.017 g, 94%). Rf = 0.42[(EtOAc:Hx, 
20:80)]; 1H-NMR (500 MHz, CDCl3): !(ppm)=  8.24 (d, J= 8 Hz, 1H), 8.10 (s, br, 1H), 7.41 
(m, 1H), 7.39-7.35 (td, J= 1.0 Hz, 6.5 Hz, 1H), 7.24-7.20 (m, 1H), 6.03 (s, 1H), 3.90 (s, 3H), 
3.85 (s, 3H), 2.42 (s, 3H),; 13C-NMR (125 MHz, CDCl3): !(ppm)= 140.7, 139.1, 137.6, 
135.8, 130.7, 125.0, 123.2, 122.6, 121.0, 119.5, 110.6, 110.2, 61.3, 60.8, 9.8; HR-MS 
(DART): (M+H)+: Calcd for C15H16NO3 258.1130; Found 258.1133); IR (cm-1): 3309, 3244, 
2973, 2924, 2896, 1624, 1321, 1087, 1046, 879. 
3-methoxy-2-methyl-1H-carbazole-1,4 (9H)-dione (6.14) [192188-88-8]. To a solution of 
1, 3-dimethoxy-2-methyl-9H-carbazol-4-ol 6.13 (40 mg, 0.155 mmol) in glacial acetic acid 
(3 mL), HNO3 (90%, 0.01 ml, 0.186 mmol) was added slowly at 0-5oC. Then, the reaction 
mixture was stirred at ambient temperature for 15 min. After the reaction time, H2O (20 ml) 
was added to the solution and extracted with EtOAc (3 × 30 ml). The combined organic 
extracts were washed with H2O (2 × 40 ml) and dried over MgSO4 and filtered. The solvent 
was evaporated under reduced pressure. The crude product was purified by using silica gel 
column chromatography (50:50, DCM:Hx) to obtain the title compound  as a pale-green 
solid (36 mg, 0.124 mmol) Rf = 0.86[(EtOAc:Hx, 50:50)]; 1H-NMR (500 MHz, DMSO-d6): 
!(ppm)=  12.85 (s, br, 1H), 8.01 (d, J= 8 Hz, 1H), 7.53 (d, J= 8.5 Hz, 1H), 7.35-7.38 (td, J= 
1.0, 8.0 Hz, 1H), 7.29-7.32 (td, J= 1.0 Hz, 8.0 Hz, 1H), 4.03 (s, 3H), 1.92 (s, 3H); 13C-NMR 
(125 MHz, DMSO-d6): !(ppm)= 180.5, 178.7, 157.8, 137.6, 136.4, 129.3, 128.4, 126.6, 
126.0, 123.8, 121.4, 113.7, 61.2, 8.4; HR-MS (ESI-): (M-H)+: Calcd for 
C14H10NO3 240.06606; Found 240.06632); IR (cm-1): 3257, 2958, 2923, 2853, 1639, 1258, 





Carbazomycin G (1-hydroxy-3-methoxy-1,2-dimethyl-1,9-dihydro-4H-carbazol-4-one) 
(6.15) [115920-44-0]. In a vacuum dried Schlenk tube, the solution of compound 6.14 (0.022 
g, 0.091 mmol) dissolved in THF (10 mL) was added under Ar atmosphere.  The solution 
was cooled to -78 oC (dry ice and acetone mixture). A solution of methyllithium (1.6 M in 
Et2O, 0.26 mL, 0.42 mmol) was added dropwise at -78 oC. The reaction mixture was 
warmed to room temperature for about 30 minutes, then quenched with NH4Cl (10%, 10 
mL). The reaction mixture was extracted with EtOAc (2× 50 mL). The organic extracts were 
combined and dried over Na2SO4. The solvent was removed under reduced pressure. The 
crude product was purified by using silica gel column chromatography (50:50, EtOAc:Hx) to 
obtain the target compound  as a pale-yellow solid (51%, 12 mg, 0.047 mmol) Rf = 
0.41[(EtOAc:Hx, 50:50)]; 1H-NMR (850 MHz, DMSO-d6): !(ppm)=  12.19 (s, br, 1H), 8.01 
(d, J= 7.7 Hz, 1H), 7.44 (d, J= 7.7 Hz, 1H), 7.22 (t, J= 7.7 Hz, 1H), 7.17 (t, J= 7.7 Hz, 1H), 
5.92 (s, 1H), 3.69 (s, 3H), 1.98 (s, 3H), 1.57 (s, 3H); 13C-NMR and DEPT (212.5 MHz, 
DMSO-d6): !(ppm)= 177.6 (C=O), 154.4 (C), 147.7 (C), 140.8 (C), 136.5 (C), 123.9 (C), 
122.9 (CH), 121.4 (CH), 120.5 (CH), 112.0 (CH), 108.4 (C), 67.4 (C), 59.2 (CH3), 27.9 
(CH3), 10.1 (CH3); HR-MS (ESI-): (M-H)+: Calcd for C15H14NO3 256.09737; Found 
256.09799); IR (cm-1): 3255 br, 2924, 2853, 1719, 1643, 1618, 1468, 1375, 1289, 1138, 
1092, 1011, 961, 804, 748. 
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 MS(EI) of 2,4-Dimethoxy-3-methyl phenol (6.2)  
 
 

































































1H-NMR of 2-Chloro 4, 6-dimethoxy-5-methyl-3-nitrophenol (6.7a) in CDCl3
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13C-NMR of 2-Chloro 4, 6-dimethoxy-5-methyl-3-nitrophenol (6.7a) in CDCl3
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 MS (EI) of 3,5-Dimethoxy-4-methyl-6-nitrobiphenyl-2-ol (6.9) 
 






























 MS (EI) of 3,3',5-trimethoxy-4-methyl-6-nitro-[1,1'-biphenyl]-2-ol (6.9a)  
 
 
































 MS (EI) of 6-amino-3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-ol (6.10)  
 

























1H-NMR of 6-amino-3,3',5-trimethoxy-4-methyl-[1,1'-biphenyl]-2-ol 
(6.10a) in CDCl3 
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13C-NMR of 6-amino-3,3',5-trimethoxy-4-methyl-[1,1'-biphenyl]-2-ol 
(6.10a) in CDCl3 
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1H-NMR of 6-acetamido-3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-yl 
acetate (6.11) in CDCl3 
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MS(EI) of 6-acetamido-3,5-dimethoxy-4-methyl-[1,1'-biphenyl]-2-yl 
acetate (6.11)  
 











MS(EI) of 6-acetamido-3,3',5-trimethoxy-4-methyl-[1,1'-biphenyl]-2-yl 








































1H-NMR of 9-acetyl-1,3,6-trimethoxy-2-methyl-9H-carbazol-4-yl acetate (6.12a) 
& 9-acetyl-1,3,8-trimethoxy-2-methyl-9H-carbazol-4-yl acetate (6.12b) in CDCl3 
 
 49 
13C-NMR of 9-acetyl-1,3,6-trimethoxy-2-methyl-9H-carbazol-4-yl acetate 




MS (EI) of 9-acetyl-1,3,6-trimethoxy-2-methyl-9H-carbazol-4-yl acetate 




























 HRMS (DART+) of 1,3-dimethoxy-2-methyl-9H-carbazol-4-ol (6.13) 
 
 













HRMS (ESI-) of 3-methoxy-2-methyl-1H-carbazole-1,4(9H)-dione (6.14)  
 




4-one (6.15) in DMSO-d6 (Carbazomycin G) 
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13C-NMR (DEPT) of 1-hydroxy-3-methoxy-1,2-dimethyl-1,9-dihydro-4H-
carbazol-4-one (6.15) (Carbazomycin G) 
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HRMS (ESI-) of 1-hydroxy-3-methoxy-1,2-dimethyl-1,9-dihydro-4H-
carbazol-4-one (6.15) (Carbazomycin G) 
 
 
IR of 1-hydroxy-3-methoxy-1,2-dimethyl-1,9-dihydro-4H-carbazol-4-one 
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General methods: All chemicals were used as received. GC analysis were performed on a 
capillary gas chromatograph equipped with a fused silica column ( L 25 m, 0.20 mm 
i.d.,0.33mm film thickness) at a helium pressure of 200 kPa, split less/split injector and 
flame ionization detector. Mass spectra were obtained on a GC-MS instrument, using a gas 
chromatograph equipped with fused silica column (l30 m, 0.25 mm i.d., 0.25mm film 
thickness) and helium as carrier gas. DART-mass spectra were obtained using PEG as an 
internal standard in the positive ionization mode with a TOF mass analyzer. 1H-NMR and 
13C-NMR were recorded at ambient temperature at a frequency of 500 and 125 MHz, 
respectively. The Chemical shifts were reported in ppm relative to residual CHCl3 for proton 
(� = 7.26) and CDCl3 for carbon (� = 77.0) and residual DMSO-d6 for proton (� = 2.50) and 
for carbon (� = 39.51) using TMS as an external reference. Flash chromatography was 
perrmed by means of the hexane (mixture of isomers) and ethyl acetate solvent system using 
silica gel (230-400 mesh).  
The microwave-assisted experiments were performed by means of Biotage Initiator Sixty 
EXP Microwave System, that operates at 0–400 W at 2.45 GHz, in the temperature range of 
40–250 °C, a pressure range of 0–20 bar (2 MPa, 290 psi), and with reactor vial volumes of 
0.2–20 mL. 
4'-chloro-2-nitro-1,1'-biphenyl (8.3) [6271-80-3] 
To a microwave vial, 1-Chloro-2-nitrobenzene (8.1) (0.25 g, 1.58 mmol), 4-
chlorophenylboronic acid (8.2) (0.373 g, 2.39 mmol), Na2CO3 (0.184 g, 1.75 mmol), TBAB 
(0.041 g, 0.13 mmol), and Pd(PPh3)4 (0.047 g, 0.042 mmol) were added. The vial was sealed 
and argon was flushed through the septa and then a mixture of EtOH (4 mL) and water (1 
mL) were added. After stirring for 10s, the vial was submerged in the microwave cavity for 
30 min at 120 oC. After the reaction time, the solvent methanol was removed under reduced 
pressure. The reaction mixture was diluted in diethyl ether (50 mL) and washed with water 
(50 mL). The aqueous phase was extracted with diethyl ether (2 × 50 mL) and the organic 
phases were combined and dried over Na2SO4. The drying agent was filtered off and the 
crude product was purified by flash column chromatography using [EtOAc:Hx, 10:90] to 
afford the title compound as a pale-yellow solid (0.315 g, 85 %). Rf = 0.55 (EtOAc/hexane, 
10:90). 1H -NMR (500 MHz, CDCl3): δ (ppm) = 7.79–7.82 (dd, J =1.0, 8.0 Hz, 1 H), 7.54–
7.57 (td, J = 1.5, 8.0 Hz, 1 H), 7.41–7.45 (td, J =1.5, 8 Hz, 1 H), 7.32–7.34 (m, 3 H), 7.17–
7.18 (m, 2 H); 13C-NMR (125 MHz, CDCl3): δ (ppm) = 149.1, 135.9, 135.2, 134.5, 132.5, 
131.9, 129.3,128.9, 128.6, 124.3; HR-MS (EI): (M)+: Calcd for C12H835ClNO2+ 233.02381; 
Found 233.02417); Calcd for C12H1837ClNO2 235.02086; Found 235.02146); MS (EI): m/z 
(%) = 232.8 (22, M+), 198.0 (24), 170.0 (29), 168.0 (30), 153.0 (16), 152.0 (100), 151.0 
(52), 142.0 (41), 139.0 (39), 126.0 (29), 115 (52), 87 (18),76 (55), 75 (53), 74 (30), 63 (38), 
62 (16). 
 
4'-chloro-[1, 1’-biphenyl]-2-amine (8.4) [1204-44-0 ] 
4'-chloro-2-nitro-1, 1’-biphenyl (8.3) (119 mg, 0.51 mmol) was dissolved in ethanol (5 mL). 
To the stirred solution, CoSO4.7H2O (143 mg, 0.51 mmol) dissolved in water (0.7 mL) was 
added. The reaction mixture was cooled to 0oC. After cooling at 0oC, NaBH4 (77 mg, 2.04 
mmol) was dissolved in ethanol (1.5 ml) was added slowly and instantly observed a black 
granular precipitate (Co2B) and copious quantities of hydrogen. The reaction mixture was 
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stirred at ambient temperature for 10 min. After the reaction time, the reaction mixture was 
filtered using Buchner funnel to remove the precipitate. The filtered solution was diluted 
with EtOAc (50 mL) and washed with water (50 mL). The aqueous layer was then extracted 
with EtOAc (2×50 mL). The organic layers were combined and dried over Na2SO4. The 
drying agent was filtered off and the solvent was evaporated under reduced pressure to 
obtain the title compound as a brown solid (0.099 g, 95%). Rf = 0.63 [(EtOAc:Hx, 30:70)]; 
1H-NMR (500 MHz, CDCl3): � (ppm)=  7.41-7.42 (m, 4H), 7.16-7.19 (td, J= 1.5 Hz, 8 Hz, 
1H), 7.09-7.11 (dd, J= 1.5 Hz, 7.5 Hz, 1H), 6.82-6.85 (td, J= 1 Hz, 7.5 Hz, 1H), 6.76-6.78 
(dd, J= 1 Hz, 8 Hz, 1H), 3.73 (s, br, 2H); 13C-NMR (125 MHz, CDCl3): � (ppm) = 143.4, 
138.0, 133.1, 130.5, 130.3, 129.0, 128.8, 126.3, 118.8, 115.7; HR-MS (DART+): (M+H)+: 
Calcd for C12H1135ClN+ 204.05745; Found 204.05764); Calcd for C12H1137ClN 206.05450; 
Found 206.05148); MS (EI): m/z (%) = 205. (29), 204 (16), 203 (95, M+), 168 (56), 167 
(100), 141 (10), 140 (12), 139 (20), 115 (12), 89 (7), 84 (12), 83.4 (19), 70.5 (12). 
2-chloronicotinoyl chloride (8.6) [49609-84-9 ] 
To the stirred solution of 2-chloronicotinic acid (8.5) (0.30 g, 1.59 mmol) in diethyl ether (10 
mL), Pyridine (0.16 ml, 3.18 mmol) and thionyl chloride (0.24 ml, 3.18 mmol) were added 
slowly under N2 atmosphere  at 0oC . After the addition, the reaction mixture was stirred at 
ambient temperature for 60 minutes. After the reaction time, water (20 ml) was added and 
extracted with diethyl ether (2 ×50 mL). The organic layers were combined and dried over 
Na2SO4. The drying agent was filtered off and the solvent was removed under reduced 
pressure to afford the title compound as a white powder (0.270 g, 96%). 1H-NMR (500 
MHz, DMSO-d6): � (ppm)=  8.55-8.56 (dd, J= 2 Hz, 5 Hz, 1H), 8.22-8.24 (dd, J= 2 Hz, 7.5 
Hz, 1H), 7.53-7.55 (m, 1H); 13C-NMR (125 MHz, DMSO-d6): � (ppm)= 165.7, 151.7, 147.7, 
140.0, 128.1, 123.1.  
2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-yl)nicotinamide (8.8) (Boscalid) 
[188425-85-6 ]  
Method 1: Amide coupling using amine (8.4) and acid chloride (8.6) 
To the stirred solution of 2-amino-4’-chlorobiphenyl (8.4) (0.050 g, 0.246 mmol) in CH2Cl2 
(10 mL), triethylamine (0.068 mL, 0.492 mmol) and 2-chloronicotinoyl chloride (8.6) (0.043 
g, 0.246 mmol) were added slowly at 0oC under inert atmosphere. After the addition, the 
reaction mixture was stirred at room temperature for 10 minutes. After the reaction time, the 
reaction mixture was quenched with water (40 ml) and extracted with CH2Cl2 (2 × 40 mL). 
The organic extracts were combined and dried over Na2SO4. The drying agent was filtered 
off and the solvent was removed using rotary evaporator. The crude product was purified by 
using flash chromatography using [EtOAc:Hx, 15:85] eluent to afford title compound as a 
white solid (0.070 g, 83%). Rf = 0.13 [(EtOAc:Hx, 15:85)]; 1H-NMR (500 MHz, CDCl3): � 
(ppm)=  8.38-8.39 (dd, J= 2Hz, 5 Hz, 1H), 8.34-8.36 (d, J= 8 Hz, 1H), 8.07-8.09 (m, 2H), 
7.36-7.38 (m, 2H), 7.26-7.30 (m, 3H), 7.19-7.20 (m, 3H); 13C-NMR (125 MHz, CDCl3): � 
(ppm)= 162.5, 151.4, 146.7, 140.2, 136.3, 134.5, 134.4, 132.2, 131.1, 130.8, 130.2, 129.3, 
128.9, 125.3, 122.9, 122.1; HR-MS (DART+): (M+H)+: Calcd for C18H13Cl2N2O+ 
343.03994; Found 343.03789); Calcd for C18H1335Cl37ClN2O+ 345.03699; Found 
345.03581); Calcd for C18H1337Cl2N2O+ 347.03404; Found 347.03422); MS (EI): m/z (%)= 
341.9 (3, M+), 204.0 (3), 167.0 (11), 166.0 (10), 142.0 (30), 141.0 (8), 140.0 (100), 139.0 
(12), 138.0 (3), 114.0 (31), 111.9 (44), 76.0 (12). 
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Method 2: Amide coupling using amine (8.4) and acid (8.5) via 
sulfiniylaniline (8.7) 
 
To the stirred mixture of 2-chloronicotinic acid (8.5) (0.050 g, 0.317 mmol) in CH2Cl2 (10 
mL), thionyl chloride (0.047 mL, 0.630 mmol) and pyridine (0.077 ml, 0.951 mmol) were 
added slowly to the reaction mixture at 0oC under inert atmosphere, followed by the solution 
of 4'-chloro-[1, 1’-biphenyl]-2-amine (8.4) (0.064 g, 0.317 mmol) in CH2Cl2 (5 mL) was 
added to the reaction mixture. The reaction mixture was stirred for 10 min at room 
temperature and monitored by using GC-MS, observed a quantitative conversion yield of 
sulfiniylaniline intermediate (6a) after 10 min. Then prolonged a reaction to 60 minutes at 
room temperature afforded a title compound in quantitative yield based on GC-MS. After the 
reaction time, the reaction mixture was quenched with water (40 ml) and extracted with 
CH2Cl2 (2 × 50 mL). The organic layers were combined and dried over Na2SO4. The drying 
agent was filtered off and the solvent was removed under reduced pressure to afford the title 
compound as a pale-white solid (0.105 g, 97%). Rf = 0.30 [(EtOAc:Hx, 30:70)]; 1H-NMR 
(500 MHz, DMSO-d6): �=  10.15 (s, 1H), 8.47-8.48 (dd, J= 2 Hz, 4.5 Hz, 1H), 7.86-7.88 
(dd, J= 1.5 Hz, 7.5 Hz, 1H), 7.59 (d, J= 8 Hz, 1H), 7.50-7.52 (m, 3H), 7.45-7.48 (m, 3H), 
7.39-7.40 (m, 2H); 13C-NMR (125 MHz, DMSO-d6): �= 164.2, 150.3, 146.5, 137.8, 137.7, 
136.4, 133.9, 132.9, 132.1, 130.7, 130.2, 128.3, 127.8, 127.4, 126.9, 123.0; HR-MS 
(ESI+DI): (M+H)+: Calcd for C18H13Cl2N2O+ 343.03994; Found 343.04098); Calcd for 
C18H1335Cl37ClN2O+ 345.03699; Found 345.03881); Calcd for C18H1337Cl2N2O+ 347.03404; 
Found 347.08921; (M+Na)+: Calcd for C18H12Cl2N2NaO+ 365.02189; Found 365.02277); 
Calcd for C18H1235Cl37ClN2NaO+ 367.01894; Found 367.02042); Calcd for 
C18H1237Cl2N2NaO+ 369.01599; Found 369.02030; MS (EI): m/z (%)= 343.9 (9), 342.9 (3), 
341.9 (14, M+), 204 (5), 201.0 (3), 167.0 (13), 166.0 (13), 142 (30), 141.0 (8), 140.0 (100), 























HR-MS (EI) of 4’-chloro-2-nitro-1,1'-biphenyl (8.3)  
 
 


















HR-MS (DART+) of 4'-chloro-[1,1'-biphenyl]-2-amine (8.4)  
 






















1H-NMR of 2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-yl)nicotinamide (8.8) in 
CDCl3 [method 1] 
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13C-NMR of 2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-yl)nicotinamide (8.8) 
in CDCl3 [method 1]
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HR-MS (DART+) of 2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-yl)nicotinamide 
(8.8) [method 1] 
 
 












1H-NMR of 2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-yl)nicotinamide (8.8) in 
DMSO-d6 [method 2] 
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13C-NMR of 2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-yl)nicotinamide (7) in 
DMSO-d6 [method 2] 
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HR-MS (ESI+DI) of 2-chloro-N-(4'-chloro-[1,1'-biphenyl]-2-
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A High Rate and Efficient Reduction 
Method Based on Sodium Borohydride and 







Chemicals. All reagents and solvents were purchased commercially and used without 
being purified. All the reaction mixtures were monitored by means of TLC (TLC plates 
Merck Kieselgel 60 F254). The TLC plates were observed under UV light at λ = 254 nm and 
λ = 365 nm. 1H and 13C NMR spectra were recorded with BrukerAV 500 MHz.  
 
Analyses. GC analyses were performed with a capillary gas chromatograph equipped with 
a fused silica column (l25 m, 0.20 mm i.d., 0.33 mm film thickness) at a helium pressure 
of200 kPa, split less/split injector and flame ionization detector. Mass spectra were obtained 
with a GC–MS instrument, with a gas chromatograph equipped with a fused silica column 
(l30 m, 0.25 mm i.d., 0.25 mm film thickness) and helium as the carrier gas. 1H and 13C-
NMR spectra were recorded at ambient temperature at a frequency of 500 and 125 MHz, 
respectively. The chemical shifts are reported in ppm relative to residual CHCl3 for proton (δ 
= 7.26 ppm) and CDCl3 for carbon (δ = 77.0 ppm) and with DMSO-d6 for proton (δ = 2.50 
ppm) and for carbon (δ = 39.0 ppm) with tetramethylsilane as an external reference.  
 
General procedure for the reduction of nitro/nitrile/azide compounds. Substrate (1 
mmol) was dissolved in ethanol (5 mL). To the stirred solution, CoSO4.7H2O (1 mmol) 
dissolved in water (0.7 mL) was added. The reaction mixture was cooled to 0oC and then 
NaBH4 (4 mmol) was added gradually and instantly observed a black granular precipitate of 
cobalt boride (Co2B) and copious quantities of hydrogen. The reaction mixture was stirred at 
ambient temperature for 10 min. The reaction mixture was quenched with water (15 mL) and 
filtered by using Buchner funnel to remove the precipitate. The filtered solution was diluted 
with EtOAc (100 mL) and washed with water (50 mL). The aqueous phase was then 
extracted with EtOAc (2×50 mL). The organic phase was combined and dried over sodium 
sulfate, the drying agent was filtered off and the solvent was evaporated using Rota vapor to 
obtain the amine compound. 
4'-chloro-[1,1'-biphenyl]-2-amine (9.11a) [1204-44-0]. 4'-chloro-2-nitro-1,1'-biphenyl 
(0.119 g, 0.510 mmol), NaBH4 (0.077 g, 2.04 mmol) and CoSO4.7H2O  (0.143 g, 0.510 
mmol). The title compound was isolated as a pale-brown solid (0.104 g, 95 %). Rf = 0.76 
[(EtOAc:Hx, 50:50)]; 1H-NMR (500 MHz, DMSO-d6): � (ppm) =  7.48-7.50 (m, 2H), 7.43-
7.45 (m, 2H), 7.04-7.08 (m, 1H), 6.97-6.99 (dd, J = 1.5 Hz, 7.5 Hz, 1H), 6.76-6.78 (dd, J = 
1.0 Hz, 8 Hz, 1H), 6.62-6.6.66 (td, J = 1.0 Hz, 7.5 Hz, 1H), 4.83 (s, br, 2H) ; 13C-NMR (125 
MHz, DMSO-d6): � (ppm) = 145.1, 138.5, 131.3, 130.5, 129.9, 128.6, 128.5, 124.4, 116.7, 
115.4. MS(EI): m/z(%): 205(33), 204(19), 203(100, M+), 169(8), 168(65), 167(94), 141(9), 
140(12), 139(20), 115(12), 89(29), 83.6(44), 69.4(11); IR (cm-1): 3433, 3338, 2921, 2851, 
1616, 1481, 1025, 1004, 826, 749. 
 
[1,1'-biphenyl]-2-amine (9.11b) [ 90-41-5 ]. 2-nitro-1,1'-biphenyl (0.10 g, 0.50 mmol), 
NaBH4 (0.076 g, 2.04 mmol) and CoSO4.7H2O  (0.141 g, 0.510 mmol). The title compound 
was isolated as a yellow solid (0.081 g, 96 %). Rf = 0.74 [(EtOAc:Hx, 50:50)]; 1H-NMR 
(500 MHz, CDCl3): � (ppm) =  7.42-7.46 (m, 4H), 7.32-7.35 (m, 1H), 7.12-7.17 (m, 2H), 
6.81-6.84 (td, J = 1.0 Hz, 7.0 Hz, 1H), 6.75-6.77 (dd, J = 1.0 Hz, 8 Hz, 1H), 3.74 (s, br, 2H); 
13C-NMR (125 MHz, CDCl3): � (ppm) = 143.5, 139.6, 130.5, 129.1, 128.8, 128.5, 127.7, 
127.2, 118.7, 115.6. MS(EI): m/z(%): 170.1(13), 169.1(100, M+), 168.1(55), 167(44), 
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154(4), 139(7), 115(10), 89(2), 83.5(14), 77(23), 63(5), 51(4); IR (cm-1): 3480, 3386, 3194, 
1611, 1479, 1434, 1284, 1156, 749. 
5-amino-2,4-dimethoxy-3-methylphenol (9.11c) [111223-14-4]. 2,4-dimethoxy-3-methyl-
5-nitrophenol (0.150 g, 0.704 mmol), NaBH4 (0.107 g, 2.04 mmol), CoSO4.7H2O  (0.198 g, 
0.510 mmol), ethanol (5 mL) and water (1 mL). The title compound was isolated as a dark 
blue liquid (0.121 g, 94 %). Rf = 0.5 [(EtOAc:Hx, 50:50)]; 1H-NMR (500 MHz, CDCl3): � 
(ppm) =  6.23 (s, 1H), 3.70 (s, 3H), 3.68 (s, 3H), 2.20( s, 3H); 13C-NMR (125 MHz, CDCl3): � (ppm) = 145.5, 138.9, 137.5, 136.5, 124.2, 100.1, 61.0, 59.6, 9.5; MS(EI): m/z(%): 184(4), 
183(45, M+), 169(11), 168(100), 153(24), 140(22), 125(38), 96.9(19), 83(25), 69(25), 
54.9(28); IR (cm-1): 3327, 2973, 2927, 2882, 1380, 1087, 1045, 879. 
 
2-chloro-5-methylaniline (9.11d) [95-81-8]. 1-chloro-4-methyl-2-nitrobenzene (0.086 g, 
0.500 mmol), NaBH4 (0.076 g, 2.04 mmol) and CoSO4.7H2O (0.141 g, 0.510 mmol). 
m/z(%): 143.1(35), 142.1(26), 141.1(100, M+), 139.1(31), 113(7), 107.1(9), 106.1(100), 
89.1(5), 79.1(27), 77.1(34), 63.1(6), 51.1(8). 
 
 2-bromo-5-chloroaniline (9.11e) [823-57-4 ]. 1-bromo-4-chloro-2-nitrobenzene (0.118 g, 
0.500 mmol), NaBH4 (0.076 g, 2.04 mmol) and CoSO4.7H2O (0.141 g, 0.510 mmol). The 
title compound was isolated as a brown solid (0.096 g, 93 %). Rf = 0.88 [(EtOAc:Hx, 
50:50)]; 1H-NMR (500 MHz, CDCl3): � (ppm) =  7.30 (d, J = 8.5 Hz, 1H), 6.74 (s, 1H), 
6.58-6.60 (dd, J = 2.5 Hz, 8.5 Hz, 1H), 4.15 (s, br, 2H) ; 13C-NMR (125 MHz, CDCl3): � 
(ppm) = 145.0, 133.9, 133.3, 119.3, 115.2, 107.0; MS(EI): m/z(%): 208.9(21), 206.9(100, 
M+), 205(74), 128(11), 126(33), 99(24), 90(34), 73(6), 63(27), 52(11); IR (cm-1): 3188, 
2922, 1416, 1193, 720, 642. 
 
1,2-diphenyldiazene 1-oxide (9.11g) [495-48-7]. Nitrobenzene (0.126 g, 1.02 mmol), 
NaBH4 (0.154 g, 2.04 mmol), CoSO4.7H2O (0.254 g, 0.510 mmol), ethanol (6 mL) and 
water (1.5 mL). MS(EI): m/z(%): 198.1(12, M+), 169.1(13), 141.1(8), 105(11), 91(24), 
77(100), 65.1(23), 51.1(29). 
 
1,2-bis(2-chlorophenyl)diazene 1-oxide (9.11h) [13556-84-8]. 1-chloro-2-nitrobenzene 
(0.080 g, 0.510 mmol), NaBH4 (0.077 g, 2.04 mmol) dissolved in ethanol (3 mL), 
CoSO4.7H2O (0.143 g, 0.510 mmol), ethanol (3 mL) and water (1.5 mL). MS(EI): m/z(%): 
233(18), 231(25, M+), 168.1(12), 139(16), 113(31), 111(100), 99(17), 90.1(32), 75(65), 
63.1(21).  
2-chloroaniline (9.11f) [95-51-2]. 1-chloro-2-nitrobenzene (0.080 g, 0.510 mmol), NaBH4 
(0.077 g, 2.04 mmol) and CoSO4.7H2O (0.143 g, 0.510 mmol). MS(EI): m/z(%): 129(32), 
128(8), 127(100, M+), 100(8), 92(20), 73(5), 65(26), 52(8), 45.6(5).  
naphthalene-1,8-diamine (9.11l) [479-27-6]. 1,8-dinitronaphthalene (0.112 g, 0.51 mmol), 
NaBH4 (0.077 g, 2.04 mmol), CoSO4.7H2O  (0.141 g, 1.02 mmol), TBAB (0.032, 0.1 
mmol). MS(EI): m/z(%): 159.1(9), 158.1(100, M+), 140(7), 130.1(32), 114.1(6), 103.1(8), 
77.1(32), 65.1(5), 51(4). 
[1,1'-biphenyl]-2,2'-diamine (9.11i) [1454-80-4]. 2,2'-dinitro-1,1'-biphenyl (0.125 g, 0.510 
mmol), NaBH4 (0.077 g, 2.04 mmol) and CoSO4.7H2O  (0.143 g, 0.510 mmol). MS(EI): 
m/z(%): 185(13), 184.1(100, M+), 183(37), 167.1(77), 166(31), 154(9), 139(14), 128(14), 
105(13), 91.1(26), 77.1(32), 65(16), 58.1(38).  
 
benzene-1,2-diamine (9.11j) [95-54-5]. 1,2-dinitrobenzene (0.171 g, 1.02 mmol), NaBH4 
(0.154 g, 4.08 mmol), CoSO4.7H2O  (0.287 g, 1.02 mmol), ethanol (6 mL) and water (1.5 
 5 
mL). MS(EI): m/z(%): 109.1(8), 108.1(100, M+), 107.1(25), 91(4), 81.1(22), 80(57), 
54.1(9), 53.1(13). 
 
benzene-1,3-diamine (9.11k) [108-45-2]. 1,3-dinitrobenzene (0.086 g, 0.510 mmol), NaBH4 
(0.144 g, 4.08 mmol) and CoSO4.7H2O  (0.246 g, 1.02 mmol). MS(EI): m/z(%): 109.1(7), 
108(100, M+), 91(6), 81(34), 80(52), 73(17), 53(12). 
 
dibenzylamine (9.11m) [103-49-1]. benzonitrile (0.105 g, 1.02 mmol), NaBH4 (0.154 g, 
4.08 mmol),  CoSO4.7H2O (0.286 g, 1.02 mmol), ethanol (6 mL) and water (1.5 mL) . The 
title compound was isolated as a pale-yellow solid (0.183 g, 91 %). Rf = 0.85 [(EtOAc:Hx, 
50:50)]; 1H-NMR (500 MHz, CDCl3): � (ppm) =  7.34 (s, 10H), 3.81 (s, 4H), 1.57 (s, br, 
1H); 13C-NMR (125 MHz, CDCl3): � (ppm) = 140.3, 128.4, 128.2, 127.0, 53.2; MS(EI): 
m/z(%): 197(9), 196.1(13, M+), 120.1(8), 106(55), 92(21), 91(100), 77(7), 65(16), 51(6); 
IR (cm-1): 3061, 3026, 1494, 1452, 731, 694. 
 
(2-nitrosophenyl)methanamine (9.11o) [NEW]. 2-nitrobenzonitrile (0.056 g, 0.510 mmol), 
NaBH4 (0.057 g, 2.04 mmol) and CoSO4.7H2O (0.106 g, 0.510 mmol). The title compound 
was isolated as a pale-brown solid (0.038 g, 75 %). Rf = 0.15 [(EtOAc:Hx, 50:50)]; 1H-NMR 
(500 MHz, DMSO-d6): � (ppm) =  7.56-7.58 (dd, J = 1.5 Hz, 8 Hz, 1H), 7.16-7.20 (m, 1H), 
6.71-6.73 (dd, J = 1.0 Hz, 8.5 Hz, 1H), 6.60 (s, br, 2H), 6.52( m, 1H) ; 13C-NMR (125 MHz, 
DMSO-d6): � (ppm) = 171.3, 150.2, 131.8, 128.7, 116.4, 114.3, 113.7, 40.0; MS(EI): 
m/z(%): 137(6), 136(73, M+), 119(100), 107(3), 92(66), 80(3), 65(32), 52(8); IR (cm-1): 
3393, 1660, 1621, 1023, 994, 824, 761; HRMS (ESI): m/z [M+H]+ : Calcd. for C7H9N2O+ 
137.07094; Found 137.07177. 
4-aminobenzonitrile (9.11q) [873-74-5]. 4-nitrobenzonitrile (0.074 g, 0.510 mmol), 
NaBH4 (0.077 g, 2.04 mmol) and CoSO4.7H2O (0.143 g, 0.510 mmol). MS(EI): m/z(%): 
119(9), 118(100, M+), 91(34), 64(11), 154(13), 52(6).  
 
4-(1-hydroxyethyl)benzonitrile (9.11r) [52067-35-3 ]. 4-acetylbenzonitrile (0.073 g, 0.510 
mmol), NaBH4 (0.077 g, 2.04 mmol) and CoSO4.7H2O (0.143 g, 0.510 mmol). MS(EI): 
m/z(%):147(8, M+), 130(17), 132(100), 116(3), 105(13), 103(12), 104(99), 103(12), 89(3), 
77(33), 63(5), 51(15); IR (cm-1): 3312, 2972, 2879, 1379, 1087, 1046, 880. 
 
4-(aminomethyl) aniline (9.11s) [4403-71-8]. 4-aminobenzonitrile (0.118 g, 1.00 mmol), 
NaBH4 (0.151 g, 4.00 mmol) and CoSO4.7H2O (0.281 g, 1.00 mmol). The title compound 
was isolated as a pale-brown solid (0.095 g, 78 %). 1H-NMR (500 MHz, CDCl3): � (ppm) =  
7.16-7.17 (m, 2H), 6.66-6.68 (m, 2H), 4.56 (s, 2H), 3.68 (s, br, 2H), 1.59 (s, br, 2H); 13C-
NMR (125 MHz, DMSO-d6): � (ppm) = 131.0, 128.2, 118.0, 113.5, 49.5. 
 
2-amino-N,N-dimethyl-1H-imidazole-1-sulfonamide (9.11t) [1258289-36-9]. 2-azido-
N,N-dimethyl-1H-imidazole-1-sulfonamide (0.054 g, 0.250 mmol), NaBH4 (0.038 g, 1.00 
mmol) and CoSO4.7H2O (0.070 g, 0.249 mmol). The title compound was isolated as a 
yellow solid (0.046 g, 96 %). Rf = 0.12 [(EtOAc:Hx, 50:50)]; 1H-NMR (500 MHz, CDCl3): � (ppm) =  6.77 (d, J = 1.5 Hz, 1H), 6.59 (d, J = 1.0 Hz, 1H), 5.24 (s, br, 2H), 2.91 (s, 6H); 
13C-NMR (125 MHz, CDCl3): � (ppm) = 148.5, 125.6, 113.4, 38.6; MS(EI): m/z(%): 
190(23, M+), 108(8), 99.1(6), 83(24), 82(100), 63.9(7), 55(29), 45.1(12); IR (cm-1): 3456, 












MS (EI) of 4'-chloro-[1,1'-biphenyl]-2-amine (9.11a)  
 
 


















MS (EI) of [1,1'-biphenyl]-2-amine (9.11b)  
 
 
















MS (EI) of 5-amino-2,4-dimethoxy-3-methylphenol (9.11c)  
  
 































MS (EI) of 2-bromo-5-chloroaniline (9.11e)  
 
 








MS (EI) of  1,2-diphenyldiazene 1-oxide (9.11g) 
 
 
MS (EI) of 1,2-bis(2-chlorophenyl)diazene 1-oxide (9.11h) 
 
 








MS (EI) of [1,1'-biphenyl]-2,2'-diamine (9.11i) 
 
 












MS (EI) of dibenzylamine (9.11m)  
 
 















MS (EI) of (2-nitrosophenyl)methanamine (9.11o)  
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MS (EI) of 4-aminobenzonitrile (9.11q)  
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IR of 2-amino-N,N-dimethyl-1H-imidazole-1-sulfonamide (9.11t)  
 
 
